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Abstract 
T cells develop in the thymus. The thymus provides a unique microenvironment 
with all the cytokines, cell surface ligands and extra-cellular matrix components 
necessary for thymocytes to develop. The cellular programme of this development 
is well characterized, whereby CD4
−
CD8
−
 double negative (DN) cells require pre-
TCR induced signals to give rise to the CD4
+
CD8
+
 double positive (DP) cells. 
The DP population undergoes selection to form self-MHC restricted and self-
tolerant CD4
+
 or CD8
+
 single positive (SP) T cells. The Hedgehog (Hh) family of 
secreted intracellular signalling molecules plays a major role in many patterning 
processes and organogenesis during embryonic development and are involved in 
the homeostasis and renewal of adult tissues. This thesis focuses on studying the 
functions of hedgehog-pathway components in the thymus by detecting 
differences in T cell differentiation and transition from one developmental stage 
to the next. 
The Hh family member, Sonic Hedgehog (Shh) has been previously found to 
influence T cell development and transition at the double negative stage (DN). We 
have utilized T cell receptor transgenic mice models (TCR-transgenics) to 
investigate the role of Shh in T cell development and repertoire selection. Our 
data from thymic organ cultures (FTOCs) have shown that Shh influences T cell 
selection and maturation during the later stages of T cell development in their 
transition from DP to SP cell population. Another Hh family member, Dhh has 
been previously found to negatively regulate multiple stages of erythrocyte 
differentiation. Using Dhh-wild type and Dhh-knockout mice models, our data 
have shown that Dhh also play a negative regulatory role in T cell production in 
4 
 
the thymus and peripheral lymphoid organs. Furthermore, we investigated the 
impact of Hh morphogene by utilizing Hh mutant mice and setting up different 
crosses to analyse transgenic repertoire selection in different mouse mutants, our 
data have shown that Hh-signalling regulate T cell development by attenuating 
gene transcription of various genes. 
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Chapter One: Introduction 
 
The mature mammalian blood system is made up of an array of functionally and 
morphologically diverse and distinct cell types, including erythrocytes (red blood 
cells), leukocytes (white blood cells) and thrombocytes (platelets). As diverse as 
these circulating blood cells are, they all originate from a common self-renewing 
multi-potent haematopoietic stem cell (HSC) (Rossi et al. 2012; Kondo et al. 
2003).  
 
1.1    Haematopoiesis 
Haematopoiesis is the process by which haematopoietic stem cells (HSCs) 
develop and differentiate, giving rise to all lineages of mature blood cells 
throughout the lifetime of an organism (Kondo et al. 2003; Clements & Traver 
2013). As the life-span of many haematopoietic cells is short, pool size of HSC is 
regulated through establishing a delicate balance between differentiation and self-
renewal to fulfil the continuous and enormous daily supply of blood cells in an 
adult human (reaching approximately 1x10
12
 cells per day to maintain 
homeostatic blood levels) (Weissman 2000; Kanji et al. 2011; Vaziri et al. 1994; 
Cheshier et al. 1999; Doulatov et al. 2012). This is possible as the multipotency of 
HSCs is conserved through continuous cell divisions, while their progeny are 
directed towards lineage differentiation (Wilson & Trumpp 2006; Mikkola & 
Orkin 2006). 
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1.1.1    Ontogeny of HSCs 
The pool of HSCs is formed during embryogenesis in a complex coherent process 
that involves several factors and multiple anatomical sites such as the yolk sac, the 
dorsal aorta (DA), placenta, foetal liver and eventually, after birth, the bone 
marrow (Kanji et al. 2011; Mikkola & Orkin 2006). During embryonic 
development the anatomy of the embryo changes resulting in a continuous site 
shift of haematopoiesis to multiple different anatomical locations that follows the 
embryo’s anatomical development and organogenesis (Kanji et al. 2011; Golub & 
Cumano 2013; Costa et al. 2012). The existence of multiple foetal haematopoietic 
sites is a common feature in many non-vertebrate and vertebrate animals, such as, 
flies, amphibians, fish, birds, rodents and humans (Ciau-Uitz et al. 2000; Traver & 
Zon 2002; Kanji et al. 2011). Murine HSC development is well characterized and 
serves as a model for human haematopoiesis (Tavian & Péault 2005b; Tavian & 
Péault 2005a).  
It has been established that during murine embryonic development, 
haematopoiesis is characterized by at least three sequential waves (Medvinsky et 
al. 2011; Ciau-Uitz et al. 2014). The first wave takes place in the yolk sac blood 
islands at embryonic day-7 (E7) (Golub & Cumano 2013; Ciau-Uitz et al. 2014). 
This wave produces progenitor cells that give rise to a primitive population of 
myeloid cells and a transient population of erythrocytes (Palis et al. 1999; Tober 
et al. 2007; Moore & Metcalf 1970; Ferkowicz & Yoder 2005). Subsequently, the 
second wave also occurs in the yolk sac but in the haemogenic endothelium 
embedded in the wall of functional blood vessels. This wave produces multipotent 
progenitor cells which migrate to the foetal liver and differentiate to give rise to 
primitive myeloid and lymphoid lineages (Ciau-Uitz et al. 2014). 
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Shortly after this, the third wave initiates in the haemogenic endothelium localized 
in the ventral wall of the dorsal aorta (DA) between embryonic days-10 and 11 
(E10-11) (Medvinsky et al. 1993; de Bruijn et al. 2000; Medvinsky & Dzierzak 
1996) producing functional HSCs that migrate to the placenta and foetal liver and 
are responsible for haematopoiesis in the late foetus until birth (Kumaravelu et al. 
2002; Mikkola et al. 2005).  
Finally, after birth, haematopoiesis relocates permanently to the bone marrow 
(BM) throughout adult murine life. HSCs produced in the bone marrow generate 
all of the haematopoietic progenitors that proliferate and differentiate into 
committed haematopoietic lineages (Yoder 2004; Fleischman et al. 1982; Muller 
et al. 1994; Orkin & Zon 1997). 
 
1.1.2   Lineage commitment of HSCs 
The earliest most primitive haematopoietic progenitors in the mouse bone marrow 
are known as LSK cells (Spangrude et al. 1988; Ikuta & Weissman 1992; 
Bhandoola et al. 2007). LSK cells lack lineage specific markers found on 
differentiated cells (Lin
−
) but possess self-renewal capacity and express stem cell 
marker antigen-1 (Sca-1) and c-Kit, which is the cytokine receptor for stem cell 
factor (SCF) (Adolfsson et al. 2005; Igarashi et al. 2002). The LSK cell 
population is heterogeneous and it has been further subdivided based on the 
expression of the cytokine receptor FMS-like tyrosine kinase-3 (FLT3) and other 
markers such as CD150 and CD48 (Kiel et al. 2005; Love & Bhandoola 2011). 
The FLT3
−
 CD150
+
 subset of LSK contains long-term self-renewing 
haematopoietic stem cells (HSCs). Furthermore, FLT3
LOW
 CD150
−
 cells 
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downstream of HSCs are cells which have reduced self-renewal capacity but have 
the ability to differentiate into all blood cell types, these cells are known as 
multipotent progenitors (MPPs) (Christensen & Weissman 2001; Morrison & 
Weissman 1994; Love & Bhandoola 2011).  
MPPs are a heterogeneous population of cells, which upon differentiation give 
rise to two oligopotent progenitors, the common myeloid erythroid progenitors 
(CMPs) and common lymphoid progenitors (CLPs) (Kondo et al. 1997; Serwold 
et al. 2009). CMPs give rise to all myeloid and erythroid cells, including 
erythrocyte, megakaryocyte, granulocyte and monocyte lineages (Pronk et al. 
2007; Nakorn et al. 2002; Kanji et al. 2011; Chen et al. 2005). CLPs mostly 
produce all T and B lymphocytes and natural killer cells (NK) (Bell & Bhandoola 
2008; Kondo et al. 1997) (Figure 1.1). However, recent studies have shown that 
CLPs are a heterogeneous population of cells and only those which express 
recombination activating genes, Rag1 and Rag2 are lymphoid primed (Adolfsson 
et al. 2005; Igarashi et al. 2002).  
Studies in foetal haematopoiesis have suggested a conceptual change in building 
the hierarchical progeny of HSCs in regards to lineage commitment and cell fate. 
The classical original model proposes that the first HSC branch-point produces 
one or two distinct haematopoietic progenitors, the myeloid-erythroid lineage and 
lymphoid lineage. This model was strongly supported as progenitors with distinct 
cell surface phenotypes that qualify as CMP or CLPs have been identified. 
However, the segregation of myeloid and lymphoid lineages might not be clear as 
previously thought and another model of divergence has been proposed where the 
myeloid lineage is considered the default lineage. This model is based on the 
identification of foetal-liver-derived progenitors capable of producing myeloid 
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and lymphoid cells suggesting a deviation from the classical model (Kawamoto 
2006; Kawamoto et al. 1997; Adolfsson et al. 2005; Kawamoto et al. 1999). In 
regards to recent research findings, lineage commitment is not absolute as 
discrepancies regarding HCS hierarchy and lineage commitment still exist (Bell & 
Bhandoola 2008; Wada et al. 2008; Montecino-Rodriguez et al. 2001). 
 
1.1.3   T cell progenitors and lineage commitment 
Adult T cell progenitors originate in the bone marrow and seed the thymus where 
they differentiate to become T cell lineage committed progenitors (Wu 2006; 
Rodewald 1995; Schwarz & Bhandoola 2004). The molecular characteristics and 
degree of lineage specificity of the bone marrow-derived progenitor cells 
colonizing the thymus from the blood is still unclear. However, although many 
progenitor cells have been shown to possess T lineage commitment potentiality, 
only a very small number of progenitors are able to migrate and settle in the 
thymus (Basch & Kadish 1977; Spangrude & Scollay 1990). Given this 
observation, it has been proposed that regardless of their cellular origin, thymus 
seeding progenitors (TSPs) upon encountering the thymic microenvironment 
generate T cell progenitors, known as the early thymocyte progenitors (ETPs) 
(Allman et al. 2003; Porritt et al. 2004; Benz et al. 2008; Hosoya et al. 2010). 
ETPs are the earliest known intra-thymic T cell progenitors characterized. Shortly 
after entering the thymus, ETPs differentiate to become specified to the T cell 
lineage and lose their B cell potential (Sambandam et al. 2005; Tan et al. 2005). 
The greatest T cell developmental potential is found among a rare subset of ETPs 
expressing c-kit
hi
 Lin
− 
(Tan et al. 2005; Porritt et al. 2004; Matsuzaki et al. 1993; 
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Allman et al. 2003). This subset comprises approximately 0.01% of total 
thymocytes but can expand extensively and ultimately generate mature T cells 
(Allman et al. 2003).  
 
1.2     The role of the thymus in T cell development   
T cells or T lymphocytes belong to a group of white blood cells and play a major 
role in mediating the acquired immune response. They derive their name from 
their site of maturation, the thymus, where the majority of T cells develop.  
The basis of immune tolerance and adaptive immunity is associated with the 
ability of the immune system to orchestrate a series of developmental steps that 
take the undifferentiated stem cells to finally become mature thymocytes. T cell 
development takes place within the unique micro-environment of the thymus. 
Through a complex well orchestrated network of signals within the thymus, 
developing thymocytes acquire all necessary cell surface ligands, cytokines and 
extra-cellular matrix components to develop and mature, producing a repertoire of 
diverse and functional non-self reactive T cells (Boyd et al. 1993).  
 
1.2.1    Thymus structure 
The thymus is the primary lymphoid organ. Immediately after birth, the thymus 
grows considerably until it reaches its maximum size by sexual maturity then 
gradually involutes (Pearse 2006). In mammals, it is situated in the upper anterior 
thorax, just above the heart and consists of two identical lobes each surrounded by 
a capsule of thin connective tissue which extends into the parenchyma of the 
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organ forming trabeculae (or connective tissue wall) dividing the organ lobes into 
numerous lobules. Histological morphology divide each lobule into distinct 
regions of outer cortex (peripheral), inner medulla (central), separated by a 
cortico-medullary region (Haley 2003). The structure of the thymus is 
histologically consistent across species (Haley 2003).  
The unique functions of the thymus reside in a network of supporting framework 
composed of epithelial-reticular cells, known as the thymic stroma or thymic 
epithelial cells (TEC), which arise early during embryonic development from 
endoderm-derived structures known as the third pharyngeal pouch and the third 
branchial cleft (van Ewijk 1991; van Ewijk 1988; Boyd et al. 1993). Together, 
these structures form the rudimentary thymus which becomes colonized by bone 
marrow-derived progenitor cells which develop within the unique micro-
environment the thymus provides, and give rise to a large number of cells 
committed to T cell lineage (Cordier & Haumont 1980; Boyd et al. 1993; Von 
Gaudecker et al. 1997). 
 
1.2.2     TEC and thymocyte crosstalk 
Development of T cells in the thymus requires the dynamic migration of 
developing thymocytes through the thymus. Thymus architectural stroma and 
travelling thymocytes have to communicate with each other both in close 
proximity and remotely. This crosstalk or communication is pivotal, providing 
bidirectional signals at different stages between thymic stroma and developing 
thymocytes, essential for the maturation of both parties (Zinkernagel et al. 1978; 
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van Ewijk et al. 1994; Scollay et al. 1980; Shortman et al. 1991; Goldrath & 
Bevan 1999).  
Such crosstalk signals come in the form of chemokines, morphogens and cell 
adhesion molecules produced by thymic stromal cells guiding the direction of 
migrating thymocytes within the different compartments of the thymus. In 
contrast, developing thymocytes find their way by sequentially expressing 
different cell surface receptors to accomplish maturation, proliferation and 
selection during their constant motion.  
Early thymocyte progenitors (ETPs) migrate into the thymus, and depending on 
the stage of embryogenesis, they can come from two different origins. During the 
early stages of embryogenesis, before vascularisation of the thymus, the seeding 
of the thymus comes from the foetal liver. At this stage ETPs enter the thymus not 
through the bloodstream, but through the mesenchynal layer which later forms the 
capsule of the adult thymus (Wilkinson et al. 1999; Suniara et al. 1999). In 
contrast, during the later stages of embryogenesis and postnatally after 
vascularisation, ETPs travel from the bone marrow through the bloodstream 
(Bleul & Boehm 2000; Takahama 2006). Thymic seeding begins as early as 
embryonic day 11.5 (E11.5) in mice, and around the eighth week of gestation in 
humans (Owen & Ritter 1969; Haynes & Heinly 1995) and continues in adulthood 
(Foss et al. 2001; Le Douarin & Jotereau 1975; Havran & Allison 1988).  
During the early stages of embryogenesis, chemokine ligand-21 (CCL21) and 
chemokine ligand-25 (CCL25) among several other chemokines are expressed by 
foetal thymus primordium providing a chemotactic attraction to colonize the 
thymus for lymphoid progenitors expressing chemokine receptor-7 (CCR7), the 
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receptor for CCL21, and chemokine receptor-9 (CCR9), the receptor for CCL25 
(Liu et al. 2005; Wurbel et al. 2001; Bleul & Boehm 2000). Mutant mice with 
deficiency in CCL21 or its receptor (CCR7) exhibit a partial but significant 
decrease in total thymocytes number until they reach E14.5 compared to normal 
mice (Liu et al. 2005). Furthermore, mice deficient in CCR9 or its receptor 
CCL25 show a three-fold decrease in total thymocyte number until E17.5 
compared to normal mice (Wurbel et al. 2001).  However, it is unclear whether 
the combination of ligands, CCL21 and CCL25 or their receptors, CCR7 and 
CCR9, is sufficient for foetal thymus progenitor colonization or if other 
chemokines are involved in this process. In contrast, the chemokine ligand-12 
(CXC12) and its receptor, chemokine receptor-4 (CXCR4) have been found not to 
be involved in the colonization process by progenitors during the early stages of 
embryogenesis (Ara et al. 2003).  
The role of chemokines in seeding the postnatal thymus is as yet unclear, 
however, it has been reported that the adhesive interaction between platelet (P)-
selectin expressed by the adult thymic endothelium, and the P-selectin 
glycoprotein ligand-1 (PSGL1) expressed by circulating lymphoid progenitor cells 
guide the transmigration of lymphoid progenitors from blood to the thymus 
parenchyma (Takahama 2006; Rossi et al. 2005). It has been reported that mice 
deficient in either of these molecules exhibit severe inhibition of thymic seeding 
by progenitors (Takahama 2006; Rossi et al. 2005; Ladi et al. 2006). 
Following their entry into the thymus, T cell progenitors begin their maturation 
and development into T cells, a process accomplished by expression of different 
chemokine receptors to enable them to dynamically relocate between the distinct 
compartments of the thymus (Carpenter & Bosselut 2010). The specific roles of 
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chemokines and their receptors in guiding the thymic progenitors and developing 
thymocytes on their way to maturation are not yet fully understood (Koch & 
Radtke 2011). The main reason behind this is due to the fact that T cell maturation 
requires them to migrate in a continuous circular motion inward and outward 
within the thymus compartments including, the cortico-medullary junction (CMJ), 
the cortex, the subcapsular zone (SCZ) and medulla. This motion results in a 
continuous upregulation and downregulation of chemokines and their ligands to 
guide their migration and subsequently their development within the thymus. 
It has been postulated that several chemokines including, CXCR4, CCR7 and 
CCR9 may influence the survival of T cells during selection and mediate 
thymocyte development (Plotkin et al. 2003; Benz et al. 2004; Misslitz et al. 
2004). CXCR4-deficient thymocytes fail to migrate outward from the cortico-
medullary junction (CMJ) towards the cortex resulting in a defect in 
differentiation of T cells during their early stages of development (Plotkin et al. 
2003). CCR7-deficient thymocytes are arrested at the cortico-medullary junction 
(CMJ) and are blocked from progressing to further developmental stages (Misslitz 
et al. 2004). CCR9-deficient mice exhibit normally distributed thymocytes within 
the cortex but that they are inefficient at accumulating in the sub-capsular zone 
(SCZ) (Benz et al. 2004). Furthermore, it has been found that the sphingosin-1-
phosphate receptor-1 (S1P1) facilitates T cell exit from the thymus after 
maturation. S1P1 deficient thymocytes are unable to exit and are retained inside 
the thymus (Chaffin & Perlmutter 1991; Matloubian et al. 2004; Allende et al. 
2004).  
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1.3     T cell development 
In order for the immune system to be capable of anticipating all manner of 
pathogenic entities, immature thymocytes must undergo several critical 
developmental stages followed by fastidious tests to select those cells amongst the 
immature thymocytes that express antigen receptor (T-cell receptor (TCR)) 
restricted to and tolerant of self-peptides presented by the major histocompatibilty 
complexes (MHC-I, MHC-II). The result of this crucial selection is a repertoire of 
mature T cells that under healthy conditions, does not attack or destroy host 
tissues, but reacts efficiently against the unlimited range of foreign antigens. 
 
1.3.1    T cell selection and maturation 
In postnatal thymus, the first site of entry of ETPs from blood is around the highly 
vascularised cortico-medullary junction (CMJ) (Lind et al. 2001) where 
progenitors commit to the T cell lineage and undergo subsequent developmental 
stages marked by changes in the rearrangement status of T cell receptor genes and 
in the expression of T cell surface receptors as they migrate towards the sub-
capsular zone (Porritt et al. 2003; Benz et al. 2008). These surface changes reflect 
the functional maturation of T cells and are used as markers of different stages of 
maturation (Shortman & Wu 1996). 
The earliest T cell subset is identified by lack of the expression of CD4 and CD8 
surface receptors, these cells are known as double-negative cells (DN) (Pearse et 
al. 1989; Shinkai et al. 1992). The DN cell population is heterogeneous and is 
further subdivided into four large fractions (DN1 to DN4) based on the 
differential expression of CD25, CD44 and CD117 (c-kit). DN1 cells reside in the 
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cortico-medulary junction and express cell surface markers CD25
−
 CD44
+
 
CD117
+
 (Porritt et al. 2003; Prockop & Petrie 2000) In these cells, the genes 
encoding the T cell receptor (TCR) α and β chains are in the germline 
configuration. As they mature, they leave the cortico-medullary junction and 
migrate deeper toward the sub-capsular zone where they acquire the expression of 
CD25 and become DN2, expressing CD25
+
 CD44
+ 
CD117
+ 
surface markers 
(Shortman & Wu 1996). Rearrangement of TCRγ, TCRδ and TCRβ gene loci are 
initiated at the DN2 stage, a process that is completed later on at the DN3 stage 
(Capone et al. 1998; Livák et al. 1999; Petrie & Zúñiga-Pflücker 2007; Godfrey et 
al. 1993; MacDonald et al. 2001). 
Maturation of the DN2 population proceeds within the sub-capsular zone and 
requires the loss of CD44 and CD117 expression where they become DN3, 
expressing the surface markers, CD25
+
 CD44
−
 CD117
−
. When thymocytes reach 
the DN3 stage, they continue to rearrange their DNA at the β, γ and δ loci to 
express functional TCR chains. Lineage specification occurs at this stage when α 
β versus γδ T cell fate is specified. The expression of recombination-activating 
genes 1 and 2 (RAG1 and RAG2), is required for successful recombination. γδ T 
cells require production of a complex composed of TCRδγ and CD3. In contrast, 
recombination of TCRβ chain and an invariant pre-TCR receptor α chain called 
(pTα) produces the pre-TCR complex composed of TCRβ, pre-TCRα chain (pTα) 
and CD3. The formation of this complex causes signals that lead to αβ T cell 
lineage commitment and takes the thymocytes into an important check point 
known as the β-selection, which requires that pTα and β chains to signal through a 
functional pre-TCR (Burtrum et al. 1996; von Boehmer 2005; Mallick et al. 
1993).  
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The β-selection check point at the DN3 stage requires the expression of a 
consistency functional pre-TCR for further development. This check point is 
critical as it ceases further recombination of the TCRβ chain loci and promotes 
differentiation of thymocytes into the DN4 stage (Marrella et al. 2012). However, 
unsuccessful rearrangement of the TCRβ chain forces developing thymocytes to 
undergo apoptosis (Wilson et al. 1996; Dudley et al. 1995). 
DN3 thymocytes expressing pre-TCR receptor develop into DN4 cells when they 
lose the expression of both surface markers and become CD25
−
 CD44
−
. DN4 
thymocytes begin to migrate from the sub-capsular zone toward the medulla. 
During this migration within the cortex, they acquire the expression of CD4 and 
CD8 and become double-positive (DP) (Porritt et al. 2003; Koch & Radtke 2011). 
DP thymocytes express both co-receptors, CD4 and CD8 via a rapidly cycling 
immature intermediate single positive thymocyte population expressing CD8 
(ISP) (MacDonald et al. 1988).   
Within the cortex, the DP thymocytes begin rearrangement of their α chain and 
RAG genes are expressed. DP thymocytes expressing correctly assembled αβ 
TCR, undergo a critical survival and differentiation checkpoint determined by the 
specificity and binding strength of a functional TCR to major histocompatibilty 
complex (MHC). This crucial step is known as positive-selection, which 
ultimately produces single-positive thymocytes (SP) committed to either CD4 or 
CD8 T cell lineages, with self-MHC-restricted TCRs. DP thymocytes interacting 
with intermediate avidity to MHC class I, are selected to become SP8 thymocytes, 
where they lose the expression of CD4 surface marker. DP thymocytes interacting 
with intermediate avidity to MHC class II, are selected to become SP4 
thymocytes, where they lose the expression of CD8 surface marker. Thymocytes 
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successfully completing the positive-selection stage travel towards the medulla 
where they express either, CD4 or CD8 surface markers. DP thymocytes which 
fail to react with any of the two MHC molecules undergo apoptosis (Klein et al. 
2009). 
In the medulla, SP thymocytes undergo another critical developmental stage 
known as negative-selection to eliminate thymocytes that are self-reactive. SP4 
and SP8 thymocytes with high affinity TCRs reacting strongly against self-
antigens undergo apoptosis. Mature thymocytes which successfully pass the 
negative-selection stage egress from the thymus and migrate toward the peripheral 
lymphoid organs through the blood stream (Figure 1.2) (Klein et al. 2009; Koch & 
Radtke 2011). 
 
1.3.2    The pre TCR and β-selection 
Thymocytes must pass through a major developmental checkpoint known as, the 
β-selection, to progress from DN to DP. At the DN3 stage of thymocyte 
development, rearrangement of the gene loci of TCRβ chain and the surrogate 
non-polymorphic pre T cell receptor α chain (pTα ) produce a multi-subunit 
receptor complex expressed on the surface of developing thymocytes known as 
pre-TCR (Boehmer & Fehling 1997; Malissen & Malissen 1996). The Pre-TCRα 
chain is unique and differs in its structure from the TCRα chain, in the position of 
the cysteine residue which promotes pairing with TCRβ. Furthermore, TCRα 
chain is not interchangeable with pre-TCRα chain during thymocyte development. 
Several studies conducted on mutant mice have shown that the differences 
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between the pre-TCR and TCR reside in their α chain (Fehling et al. 1995; Saint-
Ruf et al. 1998).  
Successful rearrangement and production of the TCRβ chain and signalling 
through the pre-TCR complex suppresses the rearrangement of other TCRβ genes 
(allelic exclusion) and promotes thymocytes to continue their development and 
maturation by upregulating CD4 and CD8 cell surface expression and TCRα gene 
rearrangement (Malissen & Malissen 1996; Wilson et al. 1994; Uematsu et al. 
1988; Levin et al. 1993; Boehmer & Fehling 1997).  
The signalling mechanism is very similar in both the pre-TCR and TCR 
complexes, as they both rely on the CD3 chains to transmit signals from the 
surface of T cells to the nucleus. However, pre-TCR signal transduction does not 
require ligand binding but at a lower threshold allows cell-autonomous signalling, 
whereas the mature TCR require ligand engagement with MHC molecules and 
peptides to transmit signals (Michie & Zúñiga-Pflücker 2002; Irving et al. 1998). 
Several factors have been found to play a role in regulating the early stages of 
thymocyte development and maturation in the thymus. Lymphoid-specific 
recombinase proteins (Rag1 and Rag2) are critical in regulating thymocyte 
development through controlling the process of TCR chain rearrangement. Mice 
lacking Rag1 and Rag2 show defects in the thymocytes maturation and 
thymocytes are arrested at the DN3 stage (Shinkai et al. 1992; Mombaerts et al. 
1992; Oettinger et al. 1990). Furthermore, the thymocyte arrest at the DN3 stage 
observed in these mice is rescued by anti-CD3 antibody treatment. This 
observation highlights the importance of CD3 cross-linking in pre-TCR signal 
transduction (Shinkai & Alt 1994). Other studies also support this view as it has 
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been shown that the pre-Tα amino acid charged extracellular domain induces 
spontaneous oligomerization attracting CD3 subunits to close proximity to 
promote pre-TCR signal transduction (Yamasaki et al. 2006; Pang et al. 2010).  
The tyrosine kinase receptor proteins, Lck and Fyn play a crucial role in 
regulating T cell development during their early stages. Lck and Fyn double 
deficient mice show completely arrested development at the DN stage (van Oers 
et al. 1996). However, mice deficient in Fyn show normal thymocyte 
development, while Lck-deficient mice show partial arrest of thymocytes at the 
DN stage (Molina et al. 1992),  suggesting a functional redundancy between Fyn 
and Lck in pre-TCR signal transduction. 
Recent studies have shown the role of several other signalling molecules in pre-
TCR signal transduction. Activation of Zap-70/Syk causes phosphorylation of 
LAT and SLP-76 which in turn leads to activation of Ras-MAPK signalling 
pathway and mobilization of Ca
2+
 resulting in the activation of the Nuclear factor 
of activated T cells (NFAT), in addition to the Nuclear factor-kb (NF-κb) (von 
Boehmer 2005; Crompton et al. 1996; Molina et al. 1992; Mombaerts et al. 1994; 
Pivniouk et al. 1998).  
The basic loop helix E-protein (E2A and HEB) has been found to play a key role 
in regulating β-selection of thymocytes. Mice deficient in both proteins exhibit 
reduced pre-Tα expression and thymocyte proliferation is blocked 
(Wojciechowski et al. 2007).  
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1.3.3    T cell receptor (TCR) and gene rearrangement 
The development of T cells in the thymus is tightly regulated and only about 3% 
of mature T cells are selected to leave the thymus and egress to the peripheral 
lymphoid organs, such as the spleen and lymph nodes (Egerton et al. 1990). Their 
immunological response is mediated by a potent cell surface structure, the T cell 
receptor (TCR).  
The TCR is a disulfide-linked membrane-anchored heterodimer of α and β chains 
expressed as a complex structure in conjunction with the invariant CD3 
molecules. Both α and β chains contains two extracellular domains, the constant 
(C) and variable (V) region. The amino terminal domain in the V region of α and 
β chains harbour sequence variations, whereas, the C-terminal domains have a 
constant sequence (Sherman et al. 2013). 
The development and maturation of T cells requires them to undergo TCR gene 
rearrangement which is essential for numerous cell lineage and fate decisions 
(Kanji et al. 2011). The somatic rearrangement of the four TCR genes (Tcrα, 
Tcrβ, Tcrγ, Tcrδ) generate a diverse repertoire of T cells. TCR genes are 
assembled through the recombination of the variable (V), diversity (D) and 
joining (J) gene segments in a sequential manner of events analogous to the 
immunoglobulin rearrangement. These events are directed by a site specific 
recombination process of the Rag proteins and ubiquitously expressed DNA repair 
proteins (Bassing et al. 2002). In mouse, the TCRα locus is organized in 100 (V), 
50 (J) and (C) gene segments, while the TCRβ locus is organized in 25 (V), 2 (D) 
and 12 (J) and (C) gene segments (Fugmann et al. 2000). Rag (Rag1) and (Rag2) 
proteins recognize recombination signal sequences (RSS) and flank V, D, and J 
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segments by creating double strand breaks resulting in random continuous non-
homologous end joining (Krangel 2009; Fugmann et al. 2000). The combinational 
joining of the many TCR gene segments allows for great diversity among the 
TCR repertoire of cells. Furthermore, the imprecise joining (junctional flexibility) 
and base insertion between the segments create further diversity of T cell 
repertoire (Nikolich-Zugich et al. 2004).  
Thymocyte lineage commitment to either αβ, or γδ is controlled by the outcome of 
TCR gene recombination events (Bassing et al. 2002; Hayday & Pennington 
2007). At the DN2/DN3 stage D-J rearrangement takes place first at both alleles 
of TCRβ locus followed by V-DJ rearrangement at different alleles (Capone et al. 
1998; Livák et al. 1999). The two gene clusters of the β-chain locus allow 
thymocytes to increase their chances of a productive rearrangement of the gene by 
attempting a second rearrangement. TCRα gene rearrangements occur at the DP 
stage and are initiated at the V-J gene segment following pre-TCR signal 
transduction (Capone et al. 1998).  
 
1.3.4   T cell positive and negative selection  
Immune tolerance is provided by the ability of T cells to distinguish between self 
and non-self antigens. This is done through the engagement of TCR with peptide-
associate MHC (pMHC) complex. This interaction is crucial for elimination of 
self reactive T cells. TCR repertoire tuning is ensured by undergoing two 
consecutive key selection events, positive and negative selection. The basis of this 
selection is the specificity and affinity of TCR interaction with pMHC molecules. 
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Positive selection ultimately produces SP cells committed to either CD4 or CD8 T 
cell lineages whereas negative selection eliminates self-reactive SP thymocyts. 
Historically, the first evidence for repertoire selection was presented using 
thymectomized (AXB)H-2
a/b
 F1 mice grafted with strain B-thymus and 
reconstituted with (AXB) bone marrow cells (Zinkernagel et al. 1978). These 
mice were infected with lymphocytic choriommenegitis (LCM) virus and probed 
in vitro for ability of cytotoxic T cells to eliminate LCM-infected strain-A or 
strain-B. This study showed that only those thymocytes bearing the TCRs that are 
able to recognize the virus in the context of strain B MHC were selected in the 
thymus for maturation (Zinkernagel et al. 1978; Doherty & Zinkernagel 1975).  
Evidence for deletion of self-reactive cells was demonstrated using the elegant 
HY-TCR transgenic mouse model. The TCR of these transgenic mice recognizes 
the male specific HY peptide (derived from the Smy gene) presented by the 
MHC-I molecule H-2D
b 
(Kisielow et al. 1988; Markiewicz et al. 1998). It was 
found that all transgenic cells expressing CD8 (including DP cells) were deleted 
in male HY-TCR-transgenic mice. While in female HY-TCR-transgenic mice, 
CD8 expressing cells survived as the male specific HY-peptide is not present 
(Kisielow et al. 1988; Markiewicz et al. 1998). These observations suggest that 
auto-reactive thymocytes were “negatively” selected for deletion at the DP stage 
of thymocyte development (Kisielow et al. 1988). 
Another study used the 2B4-TCR transgenic mouse model where the transgenic 
TCR recognizes moth cytochrome c presented by the MHC-II associated I-E
k
. 
2B4-TCR transgenic mice expressing I-E
k
 molecules on H-2
k
 background, 
showed a higher proportion of CD4SP cells compared to mice not expressing I-E
k
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molecules on H-2
b
 background. Furthermore, mice with restricted-epithelial 
expression of I-E
k
 in the cortical or medullary compartments strongly suggested 
that DP cells undergo positive selection before reaching the medulla (Berg et al. 
1989).  
It is clear from the extensive research on thymic-selection that positive and 
negative selection mechanisms involve the interaction of TCR with pMHC 
complexes. Binding of the TCR complex to its ligand suggested a later divergence 
in signals downstream of the initial interaction that determine whether a cell is 
positively or negatively selected (Gil et al. 2005).  
Two hypotheses were postulated to explain the mechanism of thymic-selection 
after the initial engagement of TCR with pMHC (Moran & Hogquist 2012). First 
is a quantitative model which explains the events of selection by measuring the 
differential strength or avidity of TCR interactions. Thymocytes with TCRs able 
to weakly bind a diverse collection pMHC molecules, are selected for survival. 
While thymocytes with TCRs that are unable to react with pMHC molecules are 
selected to die, and those with strong interaction with deleted. 
The avidity model is supported by experiments applied using TCR transgenic 
mice deficient in Tap-1 peptide transporter, which is essential in the transportation 
of antigens from the cytoplasm to the endoplasmic reticulum to become 
associated with MHC-I molecules. Foetal thymic organ cultures (FTOCs) 
experiments showed that the number of SP CD8 T cells increased rapidly when a 
low concentration of the peptide specific for the transgenic TCR is added. 
However, adding higher concentration of the same peptide reduced the number of 
SP CD8 T cells (Abele & Tampé 2004).  
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The second model is qualitative based on measuring the differential signalling of 
TCR interactions with pMHC. This model postulate that pMHC molecules either 
deliver a partly or complete activating signal which decides the fate of selected 
thymocytes. pMHC delivering a partly activating signal leads to positive 
selection, while the delivery of a complete activating signal results in negative 
selection (Hogquist et al. 1994). 
Thymic expression and presentation of self-peptides to developing thymocytes is 
the key requirement for a successful deletion of self-reactive T cells. The 
autoimmune regulator (Aire) transcription factor has been found to regulate 
expression of several ectopic peripheral proteins (Anderson et al. 2002). Aire 
transcription factors are expressed in medullary thymic epithelial cells and 
monocyte populations which play an essential role in presenting self-peptides to 
developing thymocytes (Anderson et al. 2002; Kogawa et al. 2002; Liston et al. 
2003).  
Experiments on Aire deficient mice show that the negative selection of 
thymocytes is defective as T cells which are normally deleted were allowed to 
escape selection in the thymus (Liston et al. 2003). Mutations in Aire gene have 
been linked to autoimmune polyglandular syndrome type 1 (APS1) (Nagamine et 
al. 1997), suggesting that Aire controls the mechanism of screening of thymocytes 
for auto-reactivity to antigens they encounter before leaving the thymus 
(Nagamine et al. 1997).  
Other factors have been postulated to play a role in regulating thymocyte selection 
in the thymus. One study showed that the disruption of the extracellular-regulate-
kinase (Erk) activation influenced positive selection (Neilson et al. 2004). 
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However, another study showed that phosphorylation of p53 disrupted T cell 
signalling by influencing its ability to undergo negative selection (Gong et al. 
2001). The Ikaros transcription factor is essential in positive and negative 
selection of thymocytes. Deficiency of Ikaros has been shown to cause defects in 
TCR selection and lineage decision (Urban & Winandy 2004; Tinsley et al. 2013).   
 
1.3.5    T cell lineage commitment  
DP thymocytes express both co-receptors CD4 and CD8 on their cell surface, and 
will eventually downregulate the expression of either CD4 or CD8 and continue 
their lineage commitment as CD4SP or CD8SP T cells. Cells expressing TCRs 
restricted by MHC-II become CD4SP cells, and cells expressing TCRs restricted 
by MHC-I become CD8SP cells (Teh et al. 1988). Several models have been put 
forward to explain lineage commitment (Singer et al. 2008). The stochastic 
selection model, postulates that the transcription of one of the two co-receptors is 
terminated stochastically, independent of TCR specification, following their 
interaction with MHC molecules and thereafter the newly generated SP cells must 
express TCRs and either one of the co-receptors CD4 or CD8, with matching 
specificities with MHC molecules or otherwise, they will be induced to die (Chan 
et al. 1993; Davis et al. 1993; Itano et al. 1994; Leung et al. 2001). However, 
experimentally, this model has not been found to be completely true (Keefe et al. 
1999; Sarafova et al. 2005).  
The instructive model is based on the signal strength of the interaction between 
DP thymocytes co-receptor and their TCRs with MHC molecules. The differential 
signals expressed by MHC-I or MHC-II restricted TCRs promote DP thymocytes 
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to terminate expression of their mismatching co-receptor molecules (Itano et al. 
1996). It has been shown that CD4 generates stronger signals upon its engagement 
than CD8, as CD4 have been found to bind more lymphocyte-specific protein 
kinase (Lck) on its intracellular cytoplasmic tail than CD8 (Itano et al. 1996). 
Another study used chimeric co-receptor transgenes, where a CD8 molecule was 
constructed expressing the cytoplasmic tail of CD4 (Shaw et al. 1989). The 
chimeric CD8 expressing cells developed into MHC-II restricted ‘CD4’ cells 
suggesting that quantitative signalling differences between CD4 and CD8 
coreceptors lead to lineage determination and commitment (Wiest et al. 1993). 
However, research conducted on the basis of changing TCR-signalling strength by 
manipulating several kinase activities to influence lineage commitment, failed to 
support this model influence TCR (Broussard et al. 2006; Fischer et al. 2005; 
Hernández-Hoyos et al. 2000; Schmedt & Tarakhovsky 2001; Sohn et al. 2001). 
Furthermore, ITAM deficient mice revealed results contradicting the basis of the 
instructive model (Holst et al. 2008).  
The third model is instructional based on TCR signal duration, known as the 
duration-of-signal model. This model postulate that during positive selection, 
longer TCR signals terminate CD8 transcription, while shorter TCR signals 
terminate CD4 transcription (Yasutomo et al. 2000). This model promotes the 
idea that during positive selection, DP thymocytes on TCR-mediated signalling 
undergo cell surface complex changes, the result of this is a disruption in the 
MHC-I restricted TCR signalling (but not MHC-II) which in turn lead to a 
reduction in CD8 expression. However, it is unclear why DP thymocytes express 
the asymmetric phenotype CD4
+
CD8
low
, but it is strongly believed that these cells 
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are CD4SP and CD8SP precursors not committed to either lineages (Lundberg et 
al. 1995; Suzuki et al. 1995).  
These collective experimental observations led to the formulation of non-classical 
model based on the classical kinetic signalling model where lineage commitment 
is mediated by TCR signal duration (Singer et al. 2008). It suggests that regardless 
of TCR specificities, DP thymocytes terminate CD8 gene transcription and 
convert to CD4
+
CD8
−
 transcription which appear phenotypically as CD4
+
CD8
low
 
cells. Cells of this phenotype are thought to be responsible for thymocyte SP 
lineage decision (Singer et al. 2008). The non-classical model is based on the 
signal duration controlled by the common cytokine receptor γ chain signalling 
cascade which in turn is induced by interlukin-7 (IL-7) (Brugnera et al. 2000; 
Singer et al. 2008). IL-7 influences co-receptor reversal by the enhancement of 
CD4 gene silencing and re-initiates CD8 transcription (Yu et al. 2003). 
It has been found that IL-7 mediated signalling events are blocked by persistent 
TCR signalling resulting in the formation of CD4SP cells. On the contrary, 
disruption of TCR signalling enables continuous IL-7 signalling which results in 
the formation of CD8SP cells (Singer et al. 2008). Furthermore, experiments 
based on modulation of the interleukin-7 receptor (IL-7R) signals by using 
specific antibodies against γc receptors and blocking the expression of negative 
regulators, (Gfi-1), resulted in a decrease and an increase of CD8SP and CD4SP 
cells respectively. These findings support the idea of TCR and cytokine-receptor 
cross-talk playing a role during T cell development (Yu et al. 2003; Yücel et al. 
2003). It has also been shown that in DP cells, CD8 enhancer activity is 
suppressed by prolonged TCR signalling (Sarafova et al. 2005), while IL-7R 
signalling can enhance the activity of the CD8 enhancer through a signal 
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transducer and activator of transcription-5 (Stat-5) mediated process (Park et al. 
2007). Further support for the non-classical model comes from the Zap-70 
deficient mice where, Zap-70 signalling activity is blocked in cells expressing 
CD4
+
CD8
low
 leading to rapid TCR signal disruption. As a result, thymocytes 
become CD8SP including MHC-II restricted cells (Liu & Bosselut 2004).  
In addition to the four models discussed, an ordinary differential model has been 
put to explain the 4:1 bias in CD4SP over CD8SP expression in total thymocytes. 
One study revealed that DP TCR
int
CD5
hi
 cell population exhibits asymmetry in 
death rates, as a result of higher apoptosis among MHC-I restricted cells 
compared to MHC-II restricted cells, regardless of the fact that their initial counts 
were similar (Sinclair et al. 2013).  
The identification of several transcription factors has subsequently advanced our 
understanding of SP lineage determination and commitment. Research studies 
identified The–helper-inducing POK/Kruppel like factor (Th-POK) as essential in 
determining CD4 lineage choice, as it is expressed by CD4SP cells but not 
CD8SP cells (He et al. 2005; Sun et al. 2005). Positive selection was directed to 
CD4 lineage under forced expression of Th-POK, while in Th-POK knockout 
mice, the thymus lacks CD4SP cells despite the equivalent total number of SP 
cells. Furthermore, it has been shown that Th-POK suppresses the enhancer 
activity of CD8 and at the same time maintains the transcription of CD4 by 
preventing the run-related-transcription-factor-3 (Runx3), from silencing CD4 
(Jenkinson et al. 2007). Runx3 is upregulated in CD4
+
CD8
low
 thymocytes, and it 
has been shown to bind the enhancer of CD8 in addition to the silencer element of 
CD4, mediating co-receptor reversal (Sato et al. 2005; Taniuchi et al. 2002; 
Grueter et al. 2005). Experimental evidence have shown that Runx3 binds Zbtb7b 
45 
 
gene which codes for Th-POK and blocks its expression. This interaction plays a 
central role in mediating CD4/CD8 transcription and lineage determination 
(Setoguchi et al. 2008).  
Another key transcription factor is the Gata binding protein-3 (Gata3) which upon 
binding to Zbtb7b gene can regulate Th-POK activity. Gata3 deficient mice 
exhibit DP cells which did not express Th-POK and had markedly decreased CD4 
differentiation (Pai et al. 2003; Wang et al. 2008). However, Gata3 does not 
induce MHC-I restricted thymocytes to commit to CD4SP, which suggest a more 
complicated role for this protein in thymocyte development (Hernández-Hoyos et 
al. 2003). Furthermore, the thymus high mobility group box protein (Tox) has 
been found to play a similar role to Gata3 protein in T cell development. DP 
thymocytes deficient in Tox protein, fail to produce CD4SP thymocytes and lack 
the expression of Th-POK. During positive selection Tox have been found to be 
upregulated and may influence the activity of Th-POK in a Gata3-dependent 
manner (Wilkinson et al. 2002; Aliahmad & Kaye 2008; Aliahmad et al. 2004). 
 
1.3.6    T cell activation 
Mature CD4SP and CD8SP thymocytes egress from the thymus after completing 
their development and migrate to the secondary lymphoid organs such as the 
lymph node and spleen. These un-primed T cells are in the G0 resting phase of cell 
cycle and require the engagement with their cognate antigen for further 
maturation, as the initial engagement of their TCRs and co-receptors CD4 and 
CD8 with pMHC molecules during development, is not sufficient to stimulate 
signals necessary for clonal expansion. The co-stimulatory signals from antigen 
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presenting cells (APCs) result in the initiation of multiple signalling pathways 
necessary for proliferation, survival and effector functions of T cells.  
The interaction of CD28 expressed on the surface of T cells with the B7 co-
stimulatory molecules, glycoproteins CD80 and CD86 on APCs is essential for T 
cell maturation and clonal expansion. In the absence of this co-stimulation during 
TCR engagement anergic T cells are produced (Chen & Flies 2013). Treatment 
with anti-CD3 and anti-CD28 antibodies can mimic T cell clonal expansion in 
vitro. Co-stimulatory signals promote IL-2 RNA stabilization and increase the 
synthesis of IL-2 by activated T cells (Hombach et al. 2001). IL-2 production 
supports T cell survival and proliferation. The CD40 molecule expressed on the 
surface of APCs interacts with CD40 ligand (CD40L) expressed on T cells 
leading to upregulation of CD80 and CD86 molecules expressed on the surface of 
APCs, thus stimulating T cell proliferation. The activation process slowly 
upregulates the CD28-like molecule, CTLA-4 (CD125) on T cells, which interacts 
with B7 glycoproteins with a higher avidity but at the same time, in an 
antagonistic manner (Linsley et al. 1991; Azuma et al. 1993; Hathcock et al. 
1993). CTLA-4 can be detected after 24 hours of stimulation but reaches its peak 
expression only after 2 to 3 days.  
A diverse range of molecules are regulated upon the activation of T cells 
including CD69 and CD25 (IL2-α). Activated CD8 T cells express tumour 
necrosis factor (TNF-α) and secrete interferon γ (IFNγ) (Zhang & Bevan 2011). 
On the other hand, CD4 activation subsequently results in the differentiation of 
CD4 into several types of effector cells, including T-helper-1 (Th1) and T-helper-
2 (Th2) (Luckheeram et al. 2012). Th1 differentiation is promoted by IL-27, IL-12 
and IFNγ produced by APCs and regulated by the transcription factor Tbx21 (or 
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Tbet) (Owaki et al. 2005; Trinchieri et al. 2003; Afkarian et al. 2002; Lugo-
Villarino et al. 2003). Th2 cells produce IL4 and play an essential role in 
mediating the acquired immune response by coordinating the antibody response. 
Th2 cells are regulated by the cytokine signals of IL-4 and Gata3 expression. Th2 
cells produce cytokines including IL-4 and IL-13 which are involved in the 
defence mechanism against extracellular pathogens and in allergic reactions, In 
addition, there are other Th populations, including Th17 cells (Kaplan et al. 1996; 
Glimcher & Murphy 2000).  
 
1.3.7    Peripheral T cell tolerance 
In the thymus, thymocytes are educated during their selection to achieve central 
tolerance, however, this selection process is not sufficient to induce tolerance to 
all peripheral antigens and T cells must undergo further maturation in the 
periphery to ensure their tolerance to self-antigens, and their activation on 
encountering non-self antigens (Kuklina 2013).  
Peripheral tolerance of T cells occurs at various levels. Immunological ignorance 
of T cells means that they never have been exposed to a range of additional 
antigens because of their anatomical isolation, such as, the eye lens. 
Immunological ignorance also occurs when the processed peptide on the cell 
surface exists in concentrations which are not sufficient to activate auto-reactive T 
cells. Furthermore, peripheral tolerance can occur when T cells recognize pMHC 
in the absence of the co-stimulatory molecule CD28 making them anergic so that 
they become impossible to activate (Jenkins & Schwartz 1987; Boussiotis et al. 
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1993; Wells et al. 2000; Quill & Schwartz 1987; Jenkins et al. 1990; Macián et al. 
2004).   
Regulatory T cells (Tregs) are involved in the mechanism of peripheral tolerance 
and this population of cells is categorized as two subsets of cells. CD4
+
CD25
+
 
natural T regulatory cells (nTregs) develop in the thymus following strong self-
MHC-II recognition during TCR repertoire selection. The adaptive regulatory 
cells (aTregs) develop in the periphery as a result of activation, and specific 
cytokines, such as, IL-10 and transforming growth factor β (TGFβ) (Maggi et al. 
2005; Bensinger et al. 2001). Furthermore, expression of The Forkhead/winged 
helix transcription factor (Foxp3) plays a key role in determining the fate of naive 
T cell by converting them into Tregs (Hori et al. 2003). 
 
1.3.8   Notch and T cell lineage commitment 
The Notch signalling pathway in vertebrates regulates many developmental 
processes and plays an essential role in thymocyte development and maturation, 
by inducing T cell lineage commitment (Guidos 2006; Jenkinson et al. 2007; 
Artavanis-Tsakonas 1999). There are four mammalian Notch receptors identified, 
(Notch1-4) and five Notch ligands (Delta1,3,4 and Jagged1,2) which have been 
found to be expressed on thymocytes and thymic epithelial cells (Felli et al. 
1999). Ligand binding of Notch results in cleavage of the intracellular domain of 
the Notch receptor allowing its translocation into the nucleus and interaction with 
Cbf1/Rbp-jk cofactor, and mastermind-like (Maml) coactivator, to form a 
transcriptional complex, which eventually activates Notch target genes (Mumm & 
Kopan 2000; Nam et al. 2003; Struhl & Adachi 1998).  
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Hes proteins 1 and 5 have been found to be important effectors of the Notch 
signalling pathway in haematopoietic cells (Kawamata et al. 2002; Tomita et al. 
1999). The removal of Notch signalling by a conditional deletion of Notch1, or 
inhibition of the Notch signalling pathway by receptor-ligand binding interference 
in haematopoietic progenitors led to the development of B cells in the thymus 
rather than T cells (Radtke et al. 1999; Koch et al. 2001; Wilson et al. 2001; 
Tanigaki et al. 2004; Maillard et al. 2004). Furthermore, overexpression of 
Notch1 can lead to the generation of T cells in the bone marrow where they 
overshadow B cell production (Radtke et al. 1999; Koch et al. 2001; Wilson et al. 
2001; Maillard et al. 2004; Tanigaki et al. 2004). These observations showed that 
Notch signalling plays a key role in influencing progenitor cells in the thymus to 
commit to become T cells. However, other studies have suggested that the role of 
Notch signalling is to support T cell development in the thymus (Schwarz et al. 
2007; Masuda et al. 2005).  
Notch signalling plays a crucial role in the survival of early DN thymocytes and 
until the DN3 stage where Notch activation is required for induction of pre-TCR 
expression through co-operation with E2A protein (Michie et al. 2007; Wolfer et 
al. 2002). Notch signalling is downregulated during β-selection as Id3 protein 
rapidly increases as a result of the signal transduction of pre-TCR, and E2A-
mediated Notch expression is suppressed (Yashiro-Ohtani et al. 2009). Notch is 
involved in determining CD4:CD8 cell ratio as a result of the differential 
expression of Notch receptors and ligands during foetal and adult development 
(Jiménez et al. 2001). 
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1.4     Morphogens influence thymocytes development 
Many protein families first identified as developmental regulators of Drosophila 
have been found to influence thymocyte development and T cell lineage 
commitment. Among these are the Wnt family (Wnt), Bone morphogenic protein 
2 and 4 (BMP2/4), and Hedgehog family of proteins (Hh) (Outram et al. 2000; 
Staal & Clevers 2003; Varas et al. 2003). While Wnt signalling promotes 
thymocyte development, the Bmp2/4 and Hh molecules promote and negatively 
regulate thymocyte development in the thymus (Crompton et al. 2007; Varas et al. 
2003). 
The secreted signalling molecules of the Wnt family are required for normal 
thymocyte development (Varas et al. 2003). It has been shown that Wnt signalling 
is necessary for normal thymic cellularity, and it promotes thymocyte survival and 
regulates their proliferation at the DN stage (Hsu et al. 2001; Mulroy et al. 2002; 
Staal et al. 2001). Wnt family signalling molecules transduce their signal into 
developing thymocytes through the Frizzled family of serpentine receptors and the 
low-density lipoprotein receptor-related proteins in addition to the Wnt/Ca
2+
 
pathway (Tamai et al. 2000; Yang-Snyder et al. 1996; Bhanot et al. 1996; Liang et 
al. 2007). Wnt signalling results in the stabilization and nuclear translocation of β-
catenin which acts via the lymphoid enhancer factor 1 (Lef1) and T cell factors 1 
and 3 (Tcf1 and Tcf3), which leads to the activation of target genes including, 
those encoding Gata3 and Bcl11b, which are important for thymocyte 
development (Schilham et al. 1998; Hinck et al. 1994; Moon et al. 2002). In the 
absence of Wnt signalling, β-catenin is degraded causing an arrest in thymocyte 
development at the pro-T cell stage due to the absence of Lef1 and Tcf1 and 
overexpression of an inhibitor of the Wnt co-receptor, mDkk-1 (Weber et al. 
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2011; Weerkamp et al. 2006; Hinck et al. 1994; Moon et al. 2002; Okamura et al. 
1998). The induction of the non-canonical pathway Wnt5a/C
2+ 
through Wnt5a 
over-expression, increased apoptosis in foetal thymocytes (Liang et al. 2007).  
The Bone morphogenic proteins 2 and 4 (Bmp2/4), regulate the development of 
many tissues and are secreted by thymic epithelium and their receptors are 
expressed by both the thymic stroma and thymocytes (Winnier et al. 1995; Zhang 
& Evans 1996; Outram et al. 2000; Graf et al. 2002; Hager-Theodorides et al. 
2002; Hager-Theodorides et al. 2014). It has been shown that Bmp4 inhibits 
thymocyte proliferation and survival. Treatment of FTOCs with Bmp4 arrested 
thymocyte differentiation at the DN stage before T cell lineage commitment, and 
during the transition from DN to DP (Hager-Theodorides et al. 2014; Hager-
Theodorides et al. 2002; Graf et al. 2002). Bmp2 and Bmp4 are members of the 
transforming growth factor-β (TGF β) family of secreted proteins. They transduce 
their signal through the ligation and hetero-dimerization of type I and type II 
serine-theronine kinase receptors, which phosphorylate R-smads (Smad-1, Smad-
5, and Smad-8) (Wall & Hogan 1994; Miyazono et al. 2001). The phosphorylation 
of Smads, recruit Co-Smad/Smad4 and translocate to the nucleus forming 
complexes with several transcription factors to eventually activate Bmp target 
genes. The extracellular inhibitors of Bmp, Nogin, Cordin and Twisted 
gastrulation (Tsg) help regulate its signalling (Gazzerro & Canalis 2006). Tsg is 
expressed by the thymic epithelium and thymocytes and is upregulated after pre-
TCR signalling after TCR signalling during the transition from DP to SP (Graf et 
al. 2002). It has been suggested that Bmp4’s negative regulation of thymocyte 
development helps to control thymocyte numbers and maintain a pluripotent 
precursor population (Sacedón et al. 2003).  
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1.4.1   The discovery of Hedgehog  
The Hedgehog (Hh) family of secreted proteins are found in all bilaterians and are 
key mediators of embryonic development and are implicated as essential 
regulators in many fundamental processes such as, growth, patterning and 
morphogenesis during animal development (Ingham et al. 2011).  
The hedgehog (Hh) gene was first identified by Nusslein-Volhard and Wieschaus 
in 1980 by a large scale phenotype-driven screen for mutations that impair or 
change the development of the Drosophila melanogaster (fruit fly) larval body 
plan, which led to them to win the Nobel prize in 1995 (Nüsslein-Volhard & 
Wieschaus 1980). Hh mutant larvae appear to have ventral cuticle that has little 
segmental patterning compared to wild type and each segment is entirely covered 
with denticles. This appearance of a spiky larva inspired the name ‘hedgehog’ 
(Nüsslein-Volhard & Wieschaus 1980). Shortly after hh discovery in Drosophila, 
multiple homologues from invertebrates and vertebrates were identified, including 
Leech, sea-urchins, mouse, rat, chick, zebra, and human (Echelard et al. 1993; 
Roelink et al. 1994; Marigo et al. 1995; Chang et al. 1994; Riddle et al. 1993; 
Krauss et al. 1993). 
The molecular mechanisms of Hh signal transduction have been characterized 
primarily using Drosophila genetics. In contrast, mammalian Hh signalling 
pathway is incompletely understood and harbours some differences and additional 
pathway components compared with Drosophila. However, most of the key events 
in the Hh signalling pathway are conserved between vertebrates and invertebrates 
(Varjosalo & Taipale 2008).  
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1.4.2     Hedgehog proteins 
The Hh family of secreted intracellular signalling molecules play a major role in 
many patterning processes and organogenesis during embryonic development 
(Ingham & McMahon 2001) and are involved in the homeostasis and renewal of 
adult tissues, including skin, lung, gut, blood and thymus (Bhardwaj et al. 2001; 
Taipale & Beachy 2001; Sacedón et al. 2003; Outram et al. 2000). Hh proteins 
can function in both short and long-range signalling and also in a dose dependent 
manner, inducing cell fate and regulating cell survival and proliferation within a 
target field (Ingham & McMahon 2001; Duman-Scheel et al. 2002; Roy & 
Ingham 2002). 
Philip Ingham, Andrew McMahon and Clifford Tabin identified three mammalian 
Hh proteins, Sonic Hedgehog (Shh), Desert Hedgehog (Dhh), and Indian 
Hedgehog (Ihh) (Krauss et al. 1993; Echelard et al. 1993; Riddle et al. 1993; 
Hammerschmidt et al. 1997). All three Hh proteins share 90% homology to each 
other and function as morphogens controlling multiple developmental processes, 
where they play essential non-redundant roles due to their diverse pattern of 
expression (Ingham & McMahon 2001; McMahon et al. 2003; Shimeld 1999; 
Pasca di Magliano & Hebrok 2003). A molecular evolutionary study found that 
the mammalian Hedgehog gene family arose by two gene duplications from an 
original single gene, the first gave rise to DHH, whereas the second produced the 
IHH and SHH (Kumar et al. 1996). As a result, SHH and IHH has been found to 
be more closely related to each other than to DHH. Furthermore,  based on 
sequence similarity, DHH was found to be the closest vertebrate to the Drosophila 
hh gene (Varjosalo & Taipale 2008), whereas upon ectopic expression, Shh has 
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been shown to mimic embryonic Drosophila hh (Chang et al. 1994; Krauss et al. 
1993). 
1.4.2    (1) Sonic Hedgehog 
Multiple homologues of SHH have been found in >104 organisms, and Zebrafish 
contain duplicated copies of Shh (Shha and Shhb) (Krauss et al. 1993; Ekker et al. 
1995; Concordet et al. 1996; Koudijs et al. 2008). Shh homologues are highly 
conserved in vertebrates, with highest conservation found to be in the amino-
terminal half (Echelard et al. 1993; Krauss et al. 1993; Riddle et al. 1993). Human 
SHH is 92.4% identical to its mouse homologue, whereas mouse and chicken are 
84% identical, and mouse and zebrafish are 68% identical (Marigo et al. 1995). 
Human SHH consists of 3 exons and spans 9410 bps of the long arm (q) of 
chromosome 7 at position 36 (Marigo et al. 1995). Whereas the mouse Shh gene 
consists of 5 exons and spans 10262 bps of chromosome 5 in a region showing 
homology to human chromosome 7 (Marigo et al. 1995). 
Amongst the three Hh proteins, Shh is the most broadly expressed Hh protein in 
mammals controlling development from embryo to adult. Its expression starts 
shortly after the onset of gastrulation in the presumptive midline mesoderm, from 
the node, throughout the notochord, the floorplate of the neural tube, the early gut 
endoderm, and the posterior of the limb buds (Ekker et al. 1995; Krauss et al. 
1993; Chang et al. 1994; Echelard et al. 1993; Roelink et al. 1994; 
Hammerschmidt et al. 1997; Riddle et al. 1993; Johnson et al. 1994). During 
vertebrate embryogenesis, it is involved in many developmental processes, 
including left-right axis asymmetry (Dale et al. 1997; Logan et al. 1998), anterior-
posterior polarity of the limbs and patterning of the brain and spinal cord (Riddle 
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et al. 1993; Roelink et al. 1995). Throughout embryonic development and in 
adults, Shh is mainly expressed in epithelial tissues and affects the development 
of a wide range of organs and tissues including, spinal cord, brain, heart, lung, 
gut, kidney, pancreas, pituitary gland, ovary, prostate, bone, thymus, cartilage, 
muscle, sensory organs, tooth and hair follicles (Ingham & McMahon 2001).  
Shh plays a critical role as a morphogen controlling patterning during 
embryogenesis. The expression of Shh in the midline tissues, including the node, 
notochord and floorplate, controls left-right and dorsal-ventral asymmetry by 
regulating patterning of both, the left-right axes and dorso-ventral axes (Dale et al. 
1997; Logan et al. 1998; Schilling et al. 1999; Watanabe & Nakamura 2000; 
Meyer & Roelink 2003). Blocking Shh expression leads to various biological 
defects, including cyclopia, ventral neural tube defects, somite and foregut 
patterning defects (Chiang et al. 1996; Varjosalo & Taipale 2008). Failure of 
patterning during embryogenesis affects the organogenesis of many systems 
resulting in various defects including, absence of the vertebrate and ribs, lung 
branching defects and sever distal limb malformation (Pepicelli et al. 1998; 
Litingtung et al. 1998; Varjosalo & Taipale 2008). Shh knockout in mice is 
embryonically lethal; they appear much smaller than their littermates and exhibit 
major craniofacial, limb and neural defects (Chiang et al. 1996). 
The development of the central nervous system (CNS) is promoted by the 
expression of Shh through establishing a gradient expression emanating from the 
notochord and floorplate that is responsible for inducing the ventral-
neuroepithelium into generating distinct neural subtypes of neural progenitor 
domains (Jessell 2000). Ectopic expresstion of Shh in-vivo and in-vitro, revealed 
that Shh induces the formation of the floorplate and regulates the differentiation of 
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the ventral motor neurons (Martí, Bumcrot, et al. 1995; Ericson et al. 1996). 
Blocking the expression of Shh produced in the notochord demonstrated that it is 
an essential regulator of notochord-mediated induction of motor neuron fates, and 
Shh mutants lack neuron induction and exhibit no floorplate and ventral spinal 
cord characteristics (Hammerschmidt et al. 1997; Martí, Takada, et al. 1995; 
Chiang et al. 1996).  
Studies of Shh expression levels have shown that increasing the concentration 
levels of Shh induce the development of the ventral neuron fates (Dessaud et al. 
2007; Ericson et al. 1997; Stamataki et al. 2005; Hammerschmidt et al. 1997; 
Martí, Takada, et al. 1995). It has been found that the lower concentration of Shh 
produced by the notochord and floorplate, induces motor-neurons at more distant 
regions (Yamada et al. 1993). Furthermore, the duration of Shh expression has 
been implicated in the regulation of neural-subtype identity as more ventral-neural 
identities require longer durations of Shh expression (Dessaud et al. 2007; 
Dessaud et al. 2010). 
In the development and patterning of the vertebrate limb buds, the expression of 
Shh by a subset of posterior mesenchymal cells known as the ‘zone of polarizing 
activity (ZPA)’ located in the posterior limb bud region, regulates patterning of 
the distal elements of the limbs, including the anterior-posterior digit identity 
(Riddle et al. 1993; Chang et al. 1994; Johnson et al. 1994; Martí, Takada, et al. 
1995; Hammerschmidt et al. 1997). A mirror-image duplication of limb digits has 
been generated through ectopic expression of Shh (Chang et al. 1994; Riddle et al. 
1993; López-Martínez et al. 1995). Digit identity has been found to be primarily 
dependent on Shh concentration. It has been found that reducing Shh expression 
in the ZPA resulted in the loss of the ulna and posterior digits (Miller & Sassoon 
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1998). In addition to the anterior-posterior regulation of the limbs, Shh has been 
implicated in the regulation of the proximal and distal outgrowth of the limbs by 
inducing the expression of fibroblast growth factor 4 (FGF-4) in the posterior 
apical ectodermal ridge (AER) (Laufer et al. 1994; Niswander et al. 1994). Shh 
mutants lack distal limb structures as a consequence of the loss of FGF-4 
expression in the dorsal ectoderm region (Chiang et al. 1996).  
Shh has also been found to regulate vertebrate paraxial regions, the somites in the 
trunk, and the head mesenchyme rostral of the somites (Fan et al. 1995; 
Hammerschmidt et al. 1996; Johnson et al. 1994; Weinberg et al. 1996). Research 
conducted in chick and mouse found that Shh induces the expression of 
sclerotome-specific markers, including Pax1 and Twist (Hammerschmidt et al. 
1997; Fan & Tessier-Lavigne 1994). 
Shh has also been implicated in the development of the brain as ectopic 
expression of Shh lead to ventralization of the mid- and hind- regions of the brain 
in mouse (Goodrich et al. 1996; Echelard et al. 1993). A study revealed that Shh 
controls patterning from a distance during brain development as the size, shape 
and orientation of the cell population produced depends on Shh source of 
signalling (Agarwala et al. 2001).  
In the animal visual system, Shh has also been found to be expressed in the first 
retinal neurons as it induces neuronal differentiation across the retina (Neumann 
& Nuesslein-Volhard 2000). In the early tooth development, Shh plays a role 
positional signalling necessary for tooth growth (Thesleff 2003; Hardcastle et al. 
1998). 
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Shh’s role in cancer has also been studied. Shh signalling promotes lung 
development and plays a role in the regeneration and carcinogenesis of airway 
epithelium. During the repair of acute airway injury, extensive activation of Hh 
expression has been found characterized by induced signalling of Shh within 
epithelial compartment leading to neuroendocrine differentiation (Watkins et al. 
2003). Furthermore, inhibition of Shh signalling induced chemoresistance in 
human cancer cell lines by increasing drug-efflux in an ABC transporter-
dependent manner. It has been shown that Shh regulates ABC transporters 
ABCB1 and ABCG2 as targeted knockdown of these two transporters reversed 
Shh-induced chemoresistance (Sims-Mourtada et al. 2007).  
 
1.4.2   (2) Desert Hedgehog 
Multiple homologues of DHH have been found in 101 organisms. To determine 
the evolutionary relationship of these homologues to mammalian DHH, a 
phylogenetic tree constructed using complete sequences of all three Hh genes 
showed that non-mammalian “DHH” do not cluster with mammalian DHH, 
suggesting an independent evolutionary origin (O’Hara et al. 2011; Lewis & Eisen 
2001). Several organisms have been identified to share putative homologs of 
human DHH gene, including cattle, dog, rat, mouse and western clawed frog. 
Human DHH spans 5398 bps of the long arm (q) of chromosome 12 at position 
13.1 (Echelard et al. 1993; Kamisago et al. 1999; Marigo et al. 1995; Tate et al. 
2000). The mouse Dhh gene spans 5510 bps of chromosome 15 in a region 
showing homology to human chromosome 12 (Tate et al. 2000; Kamisago et al. 
1999; Marigo et al. 1995).  
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In the murine embryo, Dhh was found to be expressed by several tissues, 
including the heart, blood vessels, epithelium, peripheral nerve tissues, foetal 
liver, testis and ovaries (Bitgood & McMahon 1995; Bitgood et al. 1996; 
Parmantier et al. 1999; Ren et al. 2012). In adults, Dhh expression is restricted to 
the thymus, spleen, bone marrow, testis, ovaries and peripheral nerves (Bajestan 
et al. 2006; Spicer et al. 2009; Szczepny et al. 2006; Sacedón et al. 2003; Perry et 
al. 2009; Lau et al. 2012). The distinct expression pattern of Dhh during 
embryogenesis indicates a wide range of functions during the early stages of 
embryonic development. In contrast, the restricted pattern of expression in adults 
may indicate maintenance and regulatory functions restricted to Dhh-expressed 
tissues and their interacting cells and molecules.  
Dhh has been found to play a role in gonadal development and gametogenesis. 
Dhh is expressed in the presumptive testis in mouse from E11.5 through to the 
adult stages and it has been found to be a key molecule in male germ line 
proliferation and spermatogenesis (Szczepny et al. 2006; Bitgood et al. 1996; 
O’Hara et al. 2011). Dhh-knockout male mice are infertile and have small gonads, 
devoid of sperm as a result of a deficiency in the production of male steroid 
hormone accompanied by a dramatic decrease in Leydig cell numbers (Bitgood & 
McMahon 1995; Bitgood et al. 1996). However, over-expression of Dhh in 
somatic cells can induce Leydig cell development indicating its role as an 
important regulator of Leydig cell development (Yao et al. 2002). In contrast, in 
females, Dhh expression has been detected in the granulose cells of pre-antral and 
antral follicles, however, Dhh-knockout female mice do not show disrupted 
ovarian phenotype and are fertile (Bitgood et al. 1996; Yao et al. 2002; Barsoum 
et al. 2009; Wijgerde et al. 2005).  
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In Human, DHH mutations have been identified in a small number of people with 
swyer syndrome also known as 46,XY complete or pure gondal dysgenesis 
(PGD). Homozygous Dhh mutations in 46,XY male patients impair the process of 
male sexual differentiation by causing a range of phenotypic spectrums, including 
complete pure gonadal dysgenesis (PGD), bilateral streak gonads, normally 
developed Mullerian ducts and female external genitalia (Canto et al. 2004; 
O’Hara et al. 2011). These patients develop a female appearance despite having 
the male chromosome pattern. In contrast, patients with a heterozygous mutation 
of DHH  exhibit partial PGD and exhibit ambiguous genitals which do not appear 
clearly as male or female (Umehara et al. 2000; Canto et al. 2004). 
Dhh is important for development of the nervous system as it is expressed in 
Schwann cells and signals to the connective tissues surrounding peripheral 
neurons to form a collagenous sheath around peripheral nerves. In Dhh-knockout 
mice the perineurial sheaths surrounding the nerve fascicles were abnormally thin 
as extensive minifascicles consisting of perineurial-like cells were found to be 
formed within the endoneurium (Bitgood et al. 1996). It has also been found that 
Dhh may play a key role in the maintenance of the adult nervous system and is 
responsible for its degeneration and regeneration after injury through nerve-
schwan cell interactions (Parmantier et al. 1999; Mirsky et al. 1999; Bitgood & 
McMahon 1995). Induced sciatic nerve injury revealed a severe degeneration of 
the myelinated fibres in Dhh-knockout mice compared to WT. Furthermore, 
minifascicular formation in regenerated nerves was more severe compared to 
intact nerves in Dhh-knockout mice. Additionally, Dhh expression was down 
regulated in WT mice post-injury during nerve degeneration and upregulated 
following nerve regeneration (Bajestan et al. 2006).  
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Neuro-psychiatric and behavioural abnormalities are linked to Dhh gene mutation. 
Genome wide association studies (GWAS) have implicated it in risk for 
psychiatric disorders.  A GWAS analysis on 1218 bipolar individuals and 2913 
controls identified genetic variations in four genes including DHH, suggesting a 
link between Dhh as a causative agent in bipolar disorder (Green et al. 2013). In 
Autism, a study performed on 57 autistic individuals and 27 controls, found that 
serum levels of Dhh in autistic individuals are lower than those of controls (Bashir 
et al. 2014).  
Behavioural abnormalities linked to the low testosterone levels and abnormal 
development in the testes are found in Dhh-knockout mice. Motor, sensory, 
learning, memory functions and mood fluctuations has been examined in Dhh-
knockout mice. In a forced swimming test, Dhh-knockout male mice exhibited a 
prolonged immobility time indicating a depressive and anxiety-like behaviour 
compared to WT male mice. In contrast, Dhh-knockout female mice did not show 
any significant behavioural abnormalities (Umehara et al. 2006).  
Dhh has been implicated in prostate cancer as the expression of  Dhh is 
upregulated in androgen-deprived and castration-resistant prostate cancer (CRPC) 
(Ibuki et al. 2013). Childhood Acute Myeloid Leukemia (AML) has also been 
linked to Dhh. A recent study performed a whole-transcriptome sequencing of 237 
cases of cytogenetically normal paediatric AML identified Dhh as a recurrent 
fusion transcript in the worse survival outcome group of AML. Furthermore, gene 
expression analysis carried on these patients also revealed over-expression of Dhh 
(Masetti et al. 2013). 
62 
 
In mouse erythropoiesis, our laboratory showed that Dhh is involved in murine 
erythropoiesis by negatively regulating multiple stages of erythrocyte 
differentiation. Bone marrow analysis of Dhh-knockout mice revealed an increase 
in the common myeloid progenitor (CMP) population. However, CMP 
differentiation to granulocyte/macrophage progenitors was decreased, and there 
was a decreased granulocyte population compared to WT. In contrast, CMP 
differentiation to megakaryocyte/erythrocyte progenitors was found to be 
increased in Dhh-knockout compared to WT. The same study revealed that Dhh 
negatively regulated erythroblast differentiation and erythroblasts were Dhh-
responsive in-vitro and and ex-vivo (Lau et al. 2012). Under stress-induced 
erythropoiesis, erythrocyte differentiation was increased in both bone marrow and 
spleen of Dhh-knockout mice compared to WT (Lau et al. 2012).  
 
1.4.2    (3) Indian Hedgehog 
Multiple homologues of IHH have been found in about 119 organisms. Several 
organisms have been identified to share putative homologs to human IHH, 
including chimpanzee, rhesus monkey, cattle, dog, mouse, rat, chicken, western 
clawed frog and zebrafish. Two extra Ihh homologs have been found in zebrafish, 
echidna hedgehog (Ehh) and Qiqihar hedgehog (Qhh) (Currie & Ingham 1996; 
Ingham & McMahon 2001). Human IHH consists of 3 exons and spans 6097 bps 
of the long arm (q) of chromosome 2 between positions 33 and 35 (Marigo et al. 
1995; Leek et al. 1997). The mouse Ihh gene consists of 3 exons and spans 6358 
bps of chromosome 1 (Marigo et al. 1995). 
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Ihh is expressed by epithelial cells in a restricted number of tissues, including the 
primitive endoderm, gut, pre-hypertrophic chondrocytes in the growth plates of 
bones, kidney, liver and in the thymus (St-Jacques et al. 1999; Outram et al. 2000; 
Dyer et al. 2001; van den Brink 2007; Marigo et al. 1995). The expression of Ihh 
starts from the early somite stages and is mainly involved in bone morphogenesis, 
gastrointestinal development and uterine-embryo implantation (Bitgood & 
McMahon 1995; Echelard et al. 1993).  
Several studies found that Ihh is important in endochondrial bone development 
through regulating chondrocyte and perichondrial differentiation. Ihh is expressed 
in the prehypertrophic chondrocytes of cartilage elements regulating the rate of 
hypertrophic differentiation (Vortkamp et al. 1996). Disruption of Ihh expression 
prevents chondrocytes undergoing proliferation from imitating the hypertrophic 
differentiation process resulting in abnormal limb development (Lai & Mitchell 
2005; St-Jacques et al. 1999).  
Ihh knockout in mice is embryonically lethal as all embryos die during 
embryogenesis, or at birth due to respiratory failure as a result of restrictive under-
development of the rib cage (Varjosalo & Taipale 2008; St-Jacques et al. 1999).  
Surviving embryos do not have gross visible abnormalities, however, they exhibit 
shortened limbs compared to WT littermates as a result of cortical bone defects 
and aberrant chondrocyte development in the long bones (St-Jacques et al. 1999; 
Colnot et al. 2005). Shh and Ihh double mutant embryos die much earlier than the 
single knockouts, indicating that overlapping functions and redundancies exist 
between Shh and Ihh proteins (Zhang et al. 2001; Pathi et al. 2001). In post natal 
mouse, Ihh has been found to be reduced as osteoblasts matured, and performing 
selective upregulation of Ihh resulted in sever osteopenia characterized by 
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increased bone formation and excessive bone resorption (Mak et al. 2008). 
Furthermore, inhibiting Ihh signalling in mature osteoblasts increase bone mass 
and protection from bone loss in older mice (Mak et al. 2008). 
In human, homozygous hypomorphic mutations of IHH has been linked to two 
congenital conditions, brachydactyly type A-1 characterized by shortness of the 
fingers and toes, and acrocapitofemoral dysplasia characterized by exhibiting 
bone defects with short stature (Hellemans et al. 2003; Gao et al. 2001). 
Ihh has also been found to regulate the development of mammalian 
gastrointestinal tract and is involved in human gastrointestinal malformations 
(Ramalho-Santos et al. 2000). Ihh mutant mice show reduced epithelial stem cell 
proliferation and differentiation accompanied by reduced smooth muscle, gut 
malrotation and annular pancreas (Ramalho-Santos et al. 2000; Hebrok et al. 
2000). On the contrary, a wide range of digestive tract tumors have been linked to 
Ihh ligand expression, including oesophagus, stomach, biliary tract, colon and 
pancreas suggesting a role in Ihh essential for tumor growth (Berman et al. 2003). 
Research has also found that Ihh is a key mediator of progesterone signalling in 
the mouse uterus. Uterine epithelial tissues express Ihh under the control of the 
steroid hormone, progesterone. The role of Ihh has been found important in 
regulating progesterone action in the uterus and mediating uterine-epithelium 
communication with stroma essential for embryo implantation (Lee et al. 2006). 
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1.4.3   Hedgehog proteins synthesis and modification 
 Hh proteins, Shh, Dhh and Ihh are synthesized as a pro-protein of 45KDa which 
contains all functions necessary for signalling. The N-terminal (N-Hh) contains 
signal activity sequence and a conserved “hedge” domain, the C-terminal (C-Hh) 
contains auto-proteolysis activity sequences and a conserved “Hog” domain (Lee 
et al. 1994). The C-Hh peptide cleaves Hh precursor through nucleo-philic attack 
catalysed by auto-proteolysis. This reaction releases the 19KDa N-Hh peptide 
from the precursor, which immediately undergoes lipid modifications by the 
addition of cholesterol at its C-termini (C-termini of N-Hh peptide) via covalent 
coupling, followed by palmitoylation of the cystein residue closest to its N-
terminal (N-terminal of N-Hh peptide) by acyl-transferase, Hhat (Figure 1.3) 
(Porter et al. 1996; Pepinsky et al. 1998). 
These lipid modifications promote Hh signalling by helping secretion of the 
proteins and enable a longer range of action by the formation of a freely diffusible 
multimeric complexes (Zeng et al. 2001; Peters et al. 2004). Both domains, the 
“hedge” and “hog” have been linked to a wide variety of ancient organisms by 
several independent pre-existing proteins. It has been suggested that both domains 
first appeared together as hedgehog in the common ancestor of Cnidarians and 
bilateria about 650 million years ago (Ingham et al. 2011). 
 
1.4.4      The Hedgehog signalling mechanism 
All three mammalian Hh proteins trigger a common signalling pathway. The 
secretion of Hh intracellular proteins from Hh producing cells initiates a 
signalling cascade by modulating gene transcription upon Hh proteins binding 
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with their receptor patched (Ptc1), a 12-span transmembrane protein on the 
surface of Hh responsive cells. In the absence of Hh, Ptc represses the functions of 
Smoothened (Smo), a 7-span transmembrane protein that acts as the central 
transducer for Hh signalling (Figure 1.4) (McMahon et al. 2003; Hooper & Scott 
2005; Alcedo et al. 1996). Two mammalian homologues of Ptc has been 
identified, Ptc1 and Ptc2, which all bind to Hh proteins (Goodrich et al. 1996; 
Stone et al. 1996; Motoyama et al. 1998). Ptc1 is expressed close to Shh and Ihh 
expressing cells, whereas Ptc2, is expressed in Shh expressing cells.  
Ptc mutations in fly and mouse reveal that Ptc suppress Hh target genes 
suggesting that Hh proteins act by antagonising the activity of Ptc (Goodrich et al. 
1997; Ingham et al. 1991). Mutation and biochemical studies revealed that Ptc 
directly binds to Hh through its first transmembrane domain and two extra cellular 
loops, following their binding, both proteins become internalised inside the cell 
and to intra-cellular vesicles or lysosomes (Marigo & Tabin 1996; Stone et al. 
1996; Philip W. Ingham & McMahon 2001; Mullor & Guerrero 2000; Incardona 
et al. 2000; Mastronardi et al. 2000).  
Binding of Hh with its receptor Ptc releases Smo from inhibition and activates 
members of the gliomma-associated oncogene transcription factors (Gli1-Gli3) (P 
W Ingham & McMahon 2001; Lum & Beachy 2004; Hooper & Scott 2005; 
Rowbotham et al. 2007). The molecular basis of Ptc mediated Smo inhibition is 
not fully understood. However, there is consensus agreement that it is not a direct 
one to one interaction, as Ptc at sub-stoichiometric ratios can inhibit Smo (Taipale 
& Beachy 2001). Several studies have shown that the activation of the Hedgehog 
pathway induces opposite effects on the localization of Ptc and Smo inside the 
cell (Denef et al. 2000; Incardona et al. 2002). Additionally, approximately 50 
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molecules of Smo are inhibited as a result of only one Ptc molecule, suggesting 
that Ptc regulates Smo via unidentified intermediates.  
Recent studies have shown that Ptc mediates inhibition through the synthesis of 
phosphotidylinsositol-4-phosphate (Yavari et al. 2010). It has been shown that Ptc 
has a sterol-sensing domain which shares structural similarities with other proteins 
involved in cellular tracking (Nakano et al. 1989; Scott & Ioannou 2004; Carstea 
et al. 1997). It has been suggested that Ptc may act as a transporter by trafficking 
hydrophobic molecules that regulate Smo activity (Huangfu & Anderson 2006). 
Furthermore, it has been found that Ptc has dual actions on Smo, by inhibiting 
Smo activation and also limiting its expression on the plasma membrane (PM) 
through the transportation of an unidentified small-molecule inhibitor which alter 
the localization of Smo upon binding with Ptc (Denef et al. 2000; Incardona et al. 
2002; Taipale et al. 2002).  
Downstream of Hh signalling are the Glioma-associated oncogene family of 
transcription factors (Gli) which play a critical role as principal regulators or 
effectors of Hh signalling (Sasaki et al. 1999). There are three mammalian 
members of Gli (Gli1-3). However, Drosophila has one downstream 
transcriptional mediator, coded by cubitus interruptus (Ci) gene (Medvinsky & 
Dzierzak 1996). Gli1 was the first to be discovered and was initially identified as 
an amplified gene and a potential oncogene in a human glioma line (Kinzler et al. 
1987; Kinzler et al. 1988). 
Upon activation of Hh signalling, Gli proteins are transported to the nucleus to 
promote target gene transcription. In the absence of Hh signalling, Gli2 and Gli3 
undergo modification by phosphorylation and truncation of their transactivation 
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domain and are transported to the nucleus where they function as repressors of 
target gene transcription (Matise & Joyner 1999; Koebernick & Pieler 2002; 
Crompton et al. 2007; Aza-Blanc et al. 2000; Sasaki et al. 1999). The 
phosphorylation of Gli proteins is induced through kinase recognition motifs near 
the C-terminal of Gli proteins by protein kinase-A (PKA), casein kinase-1 (CKI) 
and glycogen synthase kinase-3 (GSK3), followed by ubiquitylation catalysed by 
Btrcp protein resulting in protesome degradation of the C-terminal (Wang et al. 
2000; Pan et al. 2009; Price & Kalderon 2002; Tempé et al. 2006; Jia et al. 2005).  
Several studies have shown that the fruit-fly motor protein, Costal2 (Cos2) is 
essential in the recruitment of Ci, PKA, CKI, and GSK3 to form a Hh signalling 
complex (HhSc) (Stegman et al. 2000; Forbes et al. 1993). Following Hh binding 
to Ptc, the activity of Ptc is blocked allowing the translocation of Smo to the PM, 
where it undergoes phosphorylation by PKA, CKI and GSK3. This binding leads 
to a conformational change enhancing its interactions with Cos resulting in the 
phosphorylation of Cos by another serine/threonine kinasse, Fused (Fu) (Park et 
al. 2007) and eventually, Ci is released from the HhSc. Fu-dependent 
phosphorylation of the kinase suppressor of Fused (Su(fu)) ensures the 
disassociation and translocation of the full length form of Ci into the nucleus 
(Lum et al. 2003; Ruel et al. 2003). The full length form of Ci is mildly activated 
and promotes transcription activation of Hh genes by undergoing further 
processing into a more activating form Ci-A (Ruel et al. 2003; Lum et al. 2003; 
Sisson et al. 1997; Robbins et al. 1997).  
In mice, Hh signal transduction is similar with Kif7, the mouse orthologue of 
Cos2, controling the processing of Gli proteins by regulating their intracellular 
localization (Robbins et al. 1997; Sisson et al. 1997). Furthermore, non-
69 
 
haematopoietic murine cells rely on the primary cilium to transduce Hh signalling. 
In these cells, high exposure to Hh localizes Smo to the axoneme of the cilium 
followed by Sufu-Gli accumulation at the tip which aids the dissociation of the 
complex in response to Smo activity by a yet unknown mechanism (Goetz & 
Anderson 2010). 
Other co-receptors have also been identified in mice, including, Cdo (brother of 
Cdo (Boc)) and Gas1, which upon binding with Hh, result in enhanced signal 
transduction by either facilitating ligand presentation to Ptc or counteracting the 
effects of the feedback mediated sequestration (Kang et al. 2007; Tenzen et al. 
2006). Mice deficient in any of these co-receptors develop holoprocencephaly. 
The cell surface receptor Hedgehog-interacting protein (Hhip), has also been 
identified in vertebrates. However, it has been found to have no role in signal 
transduction but exclusively sequesters Hh ligands unlike Ptc, Boc, Cdo and Gas 
(Allen et al. 2011; Beachy et al. 2010).  
In vertebrates, Gli2 and Gli3 have dual functions, as transcriptional activators or 
transcriptional repressors (Sasaki et al. 1999; Aza-Blanc et al. 2000). Gli1 can 
only act as a transcriptional activator and it is not required to initiate the Hh 
signalling cascade (Park et al. 2000). However, Gli1 itself is a target gene of Hh 
signalling and measurement of its transcription can indicate Hh signalling in a 
population of cells (Crompton et al. 2007). Mim/Beg4, the transcriptional target of 
Hh, has been shown to bind and upregulate the transcription activity of both, Gli1 
and Gli2 (Callahan et al. 2004; Gonzalez-Quevedo et al. 2005). It has been also 
shown that the Yak-1 related kinase Drk-1, maintains Gli1 in the nucleolus and 
enhances its activity (Mao et al. 2002).  
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Studies on mutant mice have shown that the three Gli proteins exhibit individual 
or partially overlapping functions. Gli2 and Gli3 knockouts are embryonically 
lethal, while the homozygous mutants of Gli1 are viable (Mo et al. 1997; Park et 
al. 2000; Hui & Joyner 1993). Gli2 knockout embryos are small in size and have 
defects in their palate, and exhibit flattened head and carniofacial abnormalities. 
Gli3 knockout embryos have polysyndactyly (extra toes), and suffer from skeletal 
defects. These defects become very severe in mice bearing double knockouts of 
Gli1 and Gli2, or Gli2 and Gli3, suggesting functional redundancies. This role is 
observed in a study showing a rescue from Gli2 knockout defects on the 
expression of Gli1, under control of the Gli2 promoter (Bai & Joyner 2001). 
 
1.4.5    Hedgehog target genes and associated conditions 
Members of the Gli family of proteins are characterized as large transcription 
factors which bind to a specific DNA consensus sequences through the last three 
fingers of their five-zinc finger domain (Hui et al. 1994). Gli1 and Gli3 recognize 
the DNA sequence GACCACCCA, and Gli2 recognizes a similar DNA sequence 
GAAACCACCCA (Tanimura et al. 1998; Vortkamp et al. 1995).  Ptc and Hhip1 
cell surface molecules were found to be upregulated by Hh signalling and are 
considered as an important negative feedback mechanism for Hh (Marigo & 
Tabin 1996; Chuang et al. 2003; Lipinski et al. 2006). Boc, Cdo and Gas1 co-
receptors have also been found to be targets of Hh signalling (Tenzen et al. 2006).  
Mutation in these co-receptors or Shh result in sever developmental abnormalities 
including, cyclopia in human and are embryonically lethal causing stillborn 
abnormalities. In humans, loss of Gli3 function leads to lung and skeletal 
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abnormalities including, Greig’s cephalopolysyndactyly (Hui & Joyner 1993; 
Vortkamp et al. 1991). Gli2 mutations cause cranio-facial abnormalities including 
a cleft-palate (Mo et al. 1997).  
Hh plays an essential role in regulating the development of a wide range of tissues 
and organs regulating genes involved in cell structure, proliferation and survival. 
Several studies have shown that Ccnd2 (Cyclin d2) and E2f1 genes to be involved 
in the G1 to S transition contain Gli binding sites, and are upregulated directly by 
Gli1 (Yoon et al. 2002; Brooks et al. 1996). Hh signals have also been shown to 
upregulate Bcl2, the anti-apoptotic gene, in addition to the growth factors, H19 
and Igf2 genes through Gli1 and Gli2, and downregulate the pro-apoptotic gene 
Tsc22 (TGF-β stimulated clone gene) (Bigelow et al. 2004). In epithelial and 
mesenchyme cells, Gli has been found to upregulate Snail factor involved in the 
metastasis, and increase Osteopontin and also decrease Embgin and Plakoglobin 
levels to promote reduced cell adhesion (Karhadkar et al. 2004). 
Many research studies have implicated Hh signalling in cancer. Ptc mutations in 
humans have been linked in the aetiology of several childhood cancers including, 
medulloblastoma, and rhabdomyosarcoma, and are the main cause of Gorlin 
syndrome which increases predisposition to Basal Cell Carcinoma (BCC) (Gorlin 
1995; Peters et al. 2004; Hahn et al. 1998). Most cases with BCC exhibit 
abnormal Gli1 and Gli2 increases (Dahmane et al. 1997; Regl et al. 2002). Many 
malignant tumours have been linked with abnormal Hh signalling including, 
stomach, prostate and pancreatic cancers. Unlike BCC, these tumours are 
dependent on Hh ligands where Hh neutralization can block them in both in-vivo 
and in-vitro (Thayer et al. 2003; Karhadkar et al. 2004; Chi et al. 2006).  
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1.4.6    Hedgehog signalling during T cell development 
Recent studies have shown that Hh signalling is essential in the human and mouse 
immune systems, especially in T cell development (Gutiérrez-Frías et al. 2004; 
Outram et al. 2000; Sacedón et al. 2003; Shah et al. 2004; El Andaloussi et al. 
2006). Our laboratory was first to report the expression and function of Hh 
signalling components in adult and foetal thymus and found that Hh signalling 
regulates thymocyte development during the transition from DN to DP stage 
(Outram et al. 2000).  
Reverse transcriptase polymerase chain reaction (RT-PCR) and immune-
histochemical studies revealed the presence of all three Hh proteins, Shh, Dhh and 
Ihh in the whole thymus (Sacedón et al. 2003). The thymus epithelial cells in the 
medulla, sub-capsular region and the cortico-medullary express Hh proteins, 
while the source of Ihh is mainly the DP thymocytes (Outram et al. 2000; Virts et 
al. 2006; Outram et al. 2009). However, the nature and strength of Hh signal to 
developing thymocytes depends on their position within the thymus.  
RT-PCR analysis of different thymocyte populations in mice revealed that Smo 
expression is highest in the DN cells, especially at the DN2 stage. It has also 
revealed that Smo expression is down-regulated in DP and SP thymocytes, while 
Ptc could be detected in the DN, DP, and CD8SP cells (Shah et al. 2004; Outram 
et al. 2000; El Andaloussi et al. 2006; Crompton et al. 2007). Furthermore, the 
foetal expression pattern of the Gli proteins reveals some activity of Gli2 and Gli3 
at the DN1 stage of thymocyte development followed by a rise in the expression 
of Gli2 at the DN2 stage in conjunction with a peak expression of Gli1 and a dip 
in that of Gli3. The expression of Gli2 then starts to dip before the formation of 
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the pre-TCR complex and then rises upon pre-TCR signal transduction. 
Interestingly, in adult thymus, the expression of Gli3 seems to be in the thymic 
stroma and not in developing thymocytes (Rowbotham et al. 2009; Rowbotham, 
Hager-Theodorides, Cebecauer, et al. 2007). In adult human whole thymuses, the 
expression of Hh pathway member proteins including, Shh, Dhh, Ihh, Smo, Ptc 
and Gli1-3 have been detected with Shh to be restricted to the medulla and 
subcapsular regions (Sacedón et al. 2003).  
Analysis of murine foetal thymocyte development in Shh-deficient embryos has 
shown that Shh is essential for the differentiation, proliferation and transition of 
thymocytes from the DN1 to DN2 stage. Thymi from Shh-knockout mice 
contained approximately 10 times fewer thymocytes with a partial arrest in the 
development of thymocytes at the DN1 stage compared to WT of the same litter  
(Shah et al. 2004; Crompton et al. 2007). These findings also revealed that Shh as 
a negative regulator of differentiation at the transition from DN3 to DP stage 
(Outram et al. 2000; Rowbotham et al. 2009). Human thymus reaggregation 
cultures revealed that the differentiation of CD34
+
 human precursors to DP cells 
was accelerated with treatment with a neutralizing anti-Shh antibody, and arrested 
with recombinant Shh (Gutiérrez-Frías et al. 2004). These findings suggest that 
the removal of the Shh signal accelerated the development of DP thymocytes and 
that Shh is a negative regulator during this transition. However, ex-vivo analysis 
of Shh knockout embryos revealed a smaller number and proportion of DP 
thymocytes compared to wild types (Shah et al. 2004). Furthermore, conditional 
Smo knockout mice have been reported to exhibit reduced thymic cell numbers 
and increased cellular apoptosis at the DN stage. These findings suggest that Shh 
is essential in promoting differentiation of thymocytes from the DN to the DP 
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stage (El Andaloussi et al. 2006). Studies on mutant mice embryos reveal that Hh 
signalling plays an essential role in regulating the homeostasis of DN progenitors 
during the transition from the DN1 to DN2 stage, as this process is hindered in 
mice lacking Shh or Gli3 (Outram et al. 2009; Shah et al. 2004; Gutiérrez-Frías et 
al. 2004; Hager-Theodorides et al. 2005). 
These collective findings suggest that Shh is a positive regulator during the 
transition of thymocytes from DN1 to DN2 stage, and negative regulator during 
the transition of thymocytes from DN3 to DP stage. Our laboratory have shown 
through using mouse models that Shh driven-negative regulation at the transition 
from DN3 to DP stage is Gli-dependent (Rowbotham et al. 2009). However, the 
mechanism of this arrest is still not known.  
Studies on Ihh have also shown a similar non-redundant dual role, suggesting that 
Ihh regulates T cell development prior pre-TCR signalling, and inhibits the 
development after pre-TCR signalling (Outram et al. 2009). Furthermore, Shh has 
been shown to reduce TCR signal strength during the later stage of T cell 
development, by attenuating TCR repertoire selection, T cell CD4SP/CD8SP 
lineage commitment and Th effector reponses in the periphery (Hager-
Theodorides et al. 2009; Rowbotham, Hager-Theodorides, Cebecauer, et al. 2007; 
Drakopoulou et al. 2010; Rowbotham, Hager-Theodorides, Furmanski, et al. 
2007; Lowrey et al. 2002; Stewart et al. 2002; Furmanski et al. 2012; Furmanski 
et al. 2013). 
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Figure 1.1 
Haematopoietic cell development. Haematopoietic cell development from HSC to mature blood 
cells. HSCs give rise to MPPs which differentiate into either CMPs or CLPs. CMP lineage gives 
rise to mature erythrocytes, platelets, basophil, neutrophil, eosinophil, macrophage and myeloid 
dendritic cells. CLP lineage gives rise to T lymphocytes, B lymphocytes, natural killer cells and 
lymphoid dendritic cells. HSC; Heamatopoietic stem cell. MPP; Multipotent progenitor. CMP; 
Common myeloid progenitor. CLP; Common lymphoid progenitor. Myeloblast lineage; (B; 
Basophil. N; Neutrophil. E; Eosinophil). Lymphocyte lineage; (T; T cells. B: B cells). Figure 
elements modified from (motifolio.com). 
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Figure 1.2 
Overall scheme of T cell development in the thymus. Early thymocyte progenitors (ETPs) upon 
entry to the thymus give rise to double negative (DN) thymocytes. As cells progress through the 
DN2 to the DN4 stages, they express the pre-TCR. Successful pre-TCR expression leads to cell 
proliferation during the DN4 promoting thymocyte transition to the double positive (DP) stage. 
The DP thymocytes interact with cortical epithelial cells expressing high density of MHC class-I 
and class-II molecules associated with self-peptides. Low signalling results in delayed apoptosis 
(death by neglect), whereas high signalling promote acute apoptosis (negative selection). The 
expression of an intermediate level TCR signalling, initiate effective maturation (positive 
selection). Thymocytes that express TCRs that bind self-peptide (MHC class-I) ligands become 
CD8
+
 T cells, whereas hymocytes expressing TCRs that bind self-peptide (MHC class-II) ligands 
become CD4
+
 T cells. Figure adapted from (Germain 2002). SCZ; Subcapsular zone. CMJ; 
Cortico-medullary junction. 
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Figure 1.3 
Hedgehog proteins synthesis and modification. Hh proteins are synthesized as a pro-peptide of 
45KDa. The N-terminal (N-Hh) contains signal activity sequence and a conserved “hedge” 
domain, the C-terminal (C-Hh) contains auto-proteolysis activity sequences and a conserved 
“Hog” domain. The C-Hh peptide cleaves Hh precursor through nucleo-philic attack catalysed by 
auto-proteolysis. This reaction releases the 19KDa N-Hh peptide from the precursor, which 
immediately undergoes lipid modifications by the addition of cholesterol at its C-termini (C-
termini of N-Hh peptide) via covalent coupling, followed by palmitoylation of the cystein residue 
closest to its N-terminal (N-terminal of N-Hh peptide) by acyl-transferase, Hhat. These lipid 
modifications promote Hh signalling by helping secretion of the proteins and enable a longer range 
of action by the formation of a freely diffusible multimeric complexes.  
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Figure 1.4 
Shh signalling mechanism. Patched (Ptc1) inhibits smoothened (SMO) activity in the absence of 
Shh, allowing the phosphorylation and truncation of Gli2 and Gli3 by the activity of protein kinase 
A (PKA). Gli2rep and Gli3rep are transported to the nucleus where they negatively regulate gene 
transcription. In the presence of Shh protein, the interaction of Shh with Ptc1 relives SMO from 
inhibition. Activated SMO protects Gli proteins from PKA-mediated modification and activates 
them. Gli1-act and Gli3-act are then translocated to the nucleus where they activate target gene 
transcription. Figure adapted from (Crompton et al. 2007). 
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1.5   Thesis Objectives 
Herein, we hypothesised that the Hedgehog family of secreted proteins play a 
central role in T cell development and maturation in the thymus. Their role in the 
periphery remains less understood. 
Specific aims of this thesis are: 
1. To determine the effect of Hedgehog signalling on thymocyte 
development and maturation by utilising mouse models that use 
genetically active/suppressor of Hh signalling. 
2. To determine the effect of Desert Hedgehog (Dhh) on T cell development 
and maturation in the periphery by utilizing mouse models where the 
physiological expression of Dhh is either suppressed or activated. 
3. To determine the effect of Hh-signalling on T cell repertoire selection by 
utilizing mouse models bearing rearranged αβ TCRs where lineage choice 
is biased by the specificity of their transgenic TCR. 
4. To determine the effect of Sonic Hedgehog (Shh) on T cell development 
and lineage choice by performing Shh-treated thymic organ cultures taken 
from mouse models bearing rearranged αβ TCRs. 
Despite extensive work, the function(s) of hedgehog-pathway components in the 
thymus as well as in the periphery, is still not fully understood.  To improve our 
understanding of this family of ligands, various knock-out murine models were 
employed. Differences in differentiation and transition from one developmental 
stage to the next in mouse models where Hh-signalling was either suppressed or 
activated was investigated.  In addition, similar analysis was performed where T 
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cell selection was biased by expressing transgenic TCRs expressing rearranged 
TCR αβ chains.  
The consequence of intrinsic Hh signalling in thymocytes during development (in 
models bearing an in-vivo reporter of Hh signalling where the physiological 
expression of Hh in T cells was either suppressed or over-activated) was recorded 
by measuring the impact of hh signalling on thymocyte gene expression. Whole 
genome microarray analysis was performed on sorted double-positive (DP) 
thymocytes and compared between various systems (Chapter 3). 
The role of Desert Hedgehog (Dhh) in T cell development and maturation is yet 
unexplored. I will investigate the role of physiological Dhh signalling on T cell 
development by using Dhh wild-type, heterogeneous and knockout mice. A direct 
observation of T cell populations in the thymus, spleen and lymph node will 
reveal whether or not Dhh is signalling positively or negatively to T cells during 
their development and maturation (Chapter 4). 
I will investigate the role of physiological Hedgehog signalling on T cell 
development and lineage selection by using two TCR transgenic mice in which T 
cell repertoire selection is biased by expressing rearranged transgenic TCR αβ 
chains, in conjunction with the presence or absence of Hh-signalling components. 
This model will provide information as to whether or not Hh signalling plays a 
role in T cell selection and lineage choice (Chapter 5).  
To further examine the functions of Sonic Hedgehog (Shh) in the thymus during 
selection, I will investigate the differences in differentiation and transition from 
one developmental stage to the next on Shh-treatment. This is done using an in-
vitro system of foetal thymus cultures (FTOCs) taken from two TCR transgenic 
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mice in which T cell repertoire selection is biased by expressing rearranged 
transgenic TCR αβ chains (Chapter 6). 
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Chapter 2  
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Chapter Two: Material and Methods 
 
2.1    Mice 
HY-TCR transgenic mice were as described (Kisielow et al. 1988; Teh et al. 
1988). Marilyn-TCR transgenic mice were as described (Lantz et al. 2000). Dhh
+/−
 
mice were a kind gift from Dr Andrew McMahon (Harvard University, 
Cambridge, MA) (Bitgood et al. 1996). GBS-GFP mice were as described 
(Balaskas et al. 2012). Gli2 transgenic mice, Lck-Gli2ΔN2 (N2, GliA) and Lck-
Gli2ΔC2 (C2, Gli2R) were as described (Rowbotham et al. 2008; Rowbotham, 
Hager-Theodorides, Cebecauer, et al. 2007). HY-Dhh and Marilyn-Gli2ΔC2 
transgenic mice were generated during the course of this PhD, in addition to GBS-
GFP/Gli2ΔC2 transgenic mice. Timed mates were performed by mating male with 
two females and monitoring the females for plugs. The day the plug was found 
was counted as embryonic day 0.5 (E0.5). All adult mice used were between 4-8 
weeks old. The genotypes of adult and embryonic mice were determined by PCR 
(Polymerase Chain Reaction) from genomic DNA as described in Section (2.2). 
Mice were bred and maintained at Institute of Child Health, University College 
London (ICH, UCL, UK) under UK home office regulations.  
 
2.2    DNA extraction and genotyping 
DNA from mice was extracted from 2mm ear biopsies by digesting tissue in 
100μL lysis buffer; 50mM KCI, 1.5 Mm MgCl2, 10Mm Tris-HCI (pH 8.5), 0.01% 
gelatine, 0.45% Nonident P-40, 0.45% Tween 20, and 0.5 μg/ml proteinase K 
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(Sigma-Aldrich, USA) in ultra-pure water (Life Technologies, USA). Samples 
were incubated at 500rpm at 56
0
C overnight for digestion. Samples were then 
spun at 13000rpm in a micro-centrifuge for 5 minutes and 1μL supernatant 
containing the DNA (~1μg) was used as template. Genotypes of mice were 
determined by polymerase chain reaction (PCR) of genomic DNA as described in 
section (2.3). For sex determination of embryo and neonate mice, DNA was 
amplified by PCR for YMT2 / B sequence (a member of the Ssty family present 
on the long arm of Y-chromosome).  
 
2.3     Polymerase chain reaction (PCR) 
Primers used for amplifying the PCR products are listed in table (2.1). Each PCR 
reaction consisted of a 20μL mix composed of 50% GreenTaq DNA Polymerase 
(Sigma-Aldrich, USA) and 1μM of each relevant primer made in ultra pure water 
(Life Technologies, USA). PCR was carried out on a Stratagene Robocycler 
(Stratagene, USA) as follows: 5 minutes at 94
0
C, 38 cycles for 1:30 minute at 
94
0
C, 1 minute at 58
0
C, 1:20 minute at 72
0
C and 10 minutes at 72
0
C. 
 
2.4     Gel Electrophoresis 
PCR products were resolved on a 2% agarose gel (Sigma-Aldrich, USA), 1x Tris-
Borate-EDTA (Life Technologies, USA), stained with GelRed (Biotium, US). A 
1kb marker (Life Technologies, USA) was loaded to estimate band sizes. The 
visualization of the gel was done using ultra-violet light by Herolab gel 
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documentation system (Herolab, Germany), and a photograph taken using Sony 
UP-D897 Digital B/W Printer (A6) (Sony, UK). 
 
2.5     Foetal thymic organ cultures (FTOCs) 
Foetal thymi were cultured on 0.8μm Millipore filters (Millipore, Bedford, MA) 
on 1ml AIM-V serum free medium (Life Technologies, USA) in 24-well plates 
and incubated with 0.05μg/ml recombinant mouse sonic hedgehog protein 
(rmshh) (R&D Systems, UK). Cultures were incubated at 37
0
C and 5% CO2. 
Analysis by flow cytometry was carried out after 7 days. 
 
2.6    Cell suspension and cell counts 
Single cell suspension were obtained by crushing the organ between two pieces of 
ground glass and passing through 70 μm cell strainer (BD Falcon, USA) in AIM-
V medium (Life Technologies, USA). Cell suspensions were then diluted in 1:1 
ratio using same media. Using haemocytometer all viable cells in the specified 
field (25 boxes) were counted and doubled to allow for the AIM-V media dilution. 
This is equal to the number of cells by a factor of 10
4
/mL. Cells were then 
adjusted to 0.5-1x10
6
 cells/mL in FACS buffer; phosphate buffered saline, PBS 
(Sigma-Aldrich, UK), 2% foetal calf serum FCS, .01% sodium azide (Severn 
Biotech, UK). 
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2.7      Antibodies and flow cytometry 
2.7.1   Cell surface staining 
Cell suspensions were stained using combinations of the following directly 
conjugated antibodies supplied by BD Pharminogen (San Diego, CA) and E 
Biosciences (San Diego, USA): anti-CD44FITC, anti-CD44PE, anti-CD25FITC, anti-
CD25PE, anti-CD45CYCHROME, anti-CD4FITC, anti-CD4PE, antiCD4CYCHROME, anti-
CD4APC, anti-CD8FITC, anti-CD8PE, anti-CD8CYCHROME, anti-CD8APC, anti-CD2FITC, 
anti-CD2PE, anti-CD3FITC, anti-CD3PE, anti-CD5FITC, anti-CD5PE, anti-CD69FITC, 
anti-CD69PE, anti-CD62LFITC, anti-Qa2 FITC, anti-CD24PE, anti-CD197, anti-vβ6PE, 
anti-T3.7FITC, anti-T3.7APC. 
Suspensions were stained for 30 minutes on ice in 50μL PBS (Sigma-Aldrich, 
USA) supplemented with 2% FCS and 0.01% sodium azide. Cells were washed in 
this medium between incubations prior to analysis by Accuri C6 (BD 
Biosciences), FACScan and FACSCalibur (BD Biosciences). Minimum events of 
(10
4
) was acquired in list mode using CellQuest (BD Biosciences, USA) and 
analyzed using Flowjo 7.6.4 (Tree Star, USA). 
 
2.7.2   Intracellular staining of Gata3 and Foxp3 
Intracellular staining of Gata3 and Foxp3 was performed using the PE anti-mouse 
Gata3 Staining Set and PE anti-mouse Foxp3 Staining Set (eBiosciences, San 
Diego, CA). Cell surface staining was performed using isolated cell suspensions. 
After washing with PBS, cells were incubated with Fixation/Permeabilization 
working solution for 30 minutes in the dark. Following this, cells were washed 
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twice with permeabilization buffer then stained with anti-Gata3 antibody or anti-
Foxp3 antibody in permeabilization buffer for 30 minutes. After incubation, cells 
were washed twice with permeabilization buffer followed by washing with FACS 
buffer. Samples were analyzed using flow cytometry. 
 
2.7.3   Intracellular staining for Cytokines  
Splenocytes were isolated and cultured in AIM-V medium (Life Technologies, 
USA) supplemented with 50ng/ml PMA (phorbol myristate acetate) (Sigma-
Aldrich, USA), 500ng/ml Ionomycin (Sigma-Aldrich, US) and 3μg/ml Brefeldin 
A (eBiosciences, USA) (Sigma-Aldrich, USA) at a concentration of 5x10
6
 
cells/ml in 12 well plates (Nunc) (Thermo Scientific, USA)  at 37
0
C and 5% CO2. 
Activation was carried out using 0.01μg/ml of anti-CD3 and anti-CD28 (BD 
Pharmingen, USA). Cells were harvested at 4 hours and stained with anti-CD4 
and anti-CD8. Cells were then fixed and permeabilized (Fix and Perm cell 
permeabilization kit, Caltag Laboratories, UK) and stained for intracellular IFN-γ, 
IL-2, IL-4 and IL-17 expression. 
 
2.8    Activation cultures 
Fresh splenocyte suspensions were cultured in AIM-V serum-free medium (Life 
Technologies, USA) at a concentration of 5x10
6
 cells/ml in 12-well plates (Nunc) 
(Thermo Scientific, USA) at 37
0
C and 5% CO2. Activation was induced by 
addition of anti-CD3Ɛ (BD Pharmingen, USA) and anti-CD28 (BD Pharmingen, 
USA) monoclonal antibodies at 0.01μg/ml each. IL-2 was added to some wells at 
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20IU/ml. Cells were harvested at 4 hours for CD69 analysis and 20 hours for 
CD25 analysis using flow cytometry. 
 
2.9      RNA extraction and cDNA synthesis 
Cell suspensions were pelleted and re-suspended in appropriate amounts of lysis 
buffer and β-mercaptoethanol (Stratagene, USA). RNA was extracted using 
Strataprep® total RNA miniprep kit (Stratagene, USA) as per manufacturer’s 
protocol. RNA concentration was measured using Nanodrop 1000 (Thermo 
Scientific, USA). cDNA was synthesized from this RNA using High Capacity 
cDNA Reverse Transcription kit (Applied Biosystems, USA). The reaction mix 
was made up as follows in 13μl HPLC grade water (Life Technologies, USA) and 
incubated at 65
0
C for 5 minutes to denature RNA; 50-100ng RNA, 800μM dNTPs 
(Promega), 500ng random primers (Promega). RNA was placed on ice for 1 
minute, spun briefly and then the following were added; 20% first strand buffer 
(Invitrogen, USA), 10mM DTT (Invitrogen, USA), 200 units superscript III 
reverse transcriptase (Invitrogen, USA). The volume was made to 20μL and 
incubated at 25
0
C for 10 minutes to allow primer binding. Further it was placed 
sequentially at 42
0
C for 50 minutes to allow elongation then at 70
0
C for 15 
minutes to terminate the reaction. RNA was stored at -80
0
C and cDNA was stored 
at -20
0
C. 
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2.10    Cell sorting and microarray 
Thymocytes from adult mice (6-8 weeks) were sorted utilizing ICH/GOSH Flow 
Cytometry Core Facility using a Modular Flow Cytometer (MoFlo XDP; 
Bechman Coulter). Staining with anti-CD4FITC, anti-CD8PE and anti CD-
45CYCHROME allowed sorting of the DP thymic populations. All cells collected fell 
within the forward scatter/side scatter (FCS/SSC) live gate. RNA extracted from 
DP thymocyte populations were sent to UCL Genomics, UCL. GeneChip
®
 Mouse 
Genome MOE430.2 array (Affymetrix, USA) was used for analysis. 
 
2.11      Quantitative reverse transcribed-polymerase chain reaction (qRT-                                                                 
             PCR) 
QRT-PCR was carried out by analysis of cDNA sample in triplicate on an iCycler 
(Bio-Rad) using the iQ
TM
SYBR® Green supermix (Bio-Rad, UK) according to 
manufacturer’s instructions. The housekeeping gene hypoxanthin-guanine 
phosphoribosyltransferase (HPRT) was used to allow quantification of template 
and normalisation for each gene. Amplification of HPRT and Gnb4 (Guanine 
nucleotide-binding protein subunit β-4) was quantitated using a dilution series of 
cDNA prepared from embryo head RNA. Pre-validated primers were used 
(Qiagen QuantiTec
®
 Primer Assay, UK). Primers were selected that span exon-
exon boundaries to prevent the amplification of genomic DNA. Each reaction 
mixture contained the following: approximate 10ng cDNA, 0.3M forward primer, 
0.3M reverse primer, 10μl SYBR Green 2x supermix (containing 100mM KCI, 
40Mm Tris-HCI, PH8.4, 0.4mM of each dNTP (dATP, dCTP, dGTP, dTTP) 
iTaq
TM 
DNA polymerase (50 units/ml), 6mM MgCl2, SYBR Green 1, 20Nm 
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Fuoresein and stabilizers) made up to 20μl with HPLC grade water. RT-PCR was 
performed under the following conditions: for HPRT and Gnb4; 180 minutes at 
95
0
C, then 40 cycles of 30 seconds at 95
0
C followed by 30 seconds. A melt curve 
was also carried out as per the manufacturer’s programme to check the melting 
temperature of the products produced to ensure the product was the size expected 
and not the result of primer-dimers.  
 
2.12     Data analysis 
Statistical analysis using at least three independent experiment was performed 
using Microsoft Excel 2007 (Microsoft Inc, USA) and GraphPad Prism 
(GraphPad Inc, USA). An unpaired two tailed student’s t test was used to test the 
significance of differences observed in WT, Het and KO littermates, unless stated 
otherwise. The microarray data was analyzed by Hemant Sahni using the tools 
and packages available in R and Bioconductor (Bioconductor.org). 
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Table 2.1  Primers used for genotyping of mice by PCR 
 
 
Transcript 
Primer 
Direction 
 
 
Oligonucleotide Sequence (5’>3’) 
Product 
Size (bp) 
YMT2/B 
sequence (Y-
chromosome) 
Forward CTGGAGCTCTACAGTGATGA  
350 
Reverse CAGTTACCAATCAACACATCAC 
HY transgene Forward CACATGGAGGCTGCAGTCAC  
300 
Reverse GTTTCTGCACTGTTATCACC 
Marilyn 
transgene 
Forward GCAGAGGAACCTGGGAGCTGT  
350 
Reverse TGCTGTCTGTACCACCAGAAATAC 
Dhh wild type  
gene  
Forward ATCCACGTATCGGTCAAAGC  
442 
Reverse GGTCCAGGAAGAGCAGCAC 
Dhh mutated 
gene 
 
Forward GGCATGCTGGGGATGCGGTG  
110 
Reverse GGTCCAGGAAGAGCAGCAC 
Gli2ΔC2 
transgene 
Forward AGAACCTGAAGACCACCTGCG  
850 
Reverse AGAACCTGAAGACACACCTGCG 
Gli2ΔN2 
transgene 
 
Forward AAACAAAGCTCCTGTCACG  
600 
Reverse ATGCCTGCTCTTTACTGAAG 
Rag2 wild type 
gene 
 
Forward TTAATTCAACCAGGCTTCTCACTT  
973 
Reverse GCCTGCTTATTGTCTCCTCCTGGTATG 
Rag2 mutated 
gene 
Forward CCAACGCTATGTCCTGATAGCGGT  
1107 
Reverse GCCTGCTTATTGTCTCCTCCTGGTATG 
eGFP transgene Forward TGCAGTGCTTCAGCCGCTAC  
172 
Reverse CCAGCAGGACCATGTGATCG 
 
 
Table 2.2  Primers used for Real-time PCR 
 
 
Transcript 
 
Primer 
Direction 
 
 
Oligonucleotide Sequence (5’>3’) 
Product Size 
(bp) 
 
HPRT 
Forward TGATTATGGACAGGACTGAAAG 
 
 
55 
Reverse GGTCAGCAAAGAACTTATAGCC 
 
 
Gnb4 
Forward 
 
 
Proprietary Qiagen QuantiTec Primer 
Assay 
 
 
300 
Reverse 
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Chapter Three: Hh activation in thymocytes and T cells 
 
3.1       Introduction  
3.1.1    Hh signalling in thymocytes and T cells 
Hedgehog proteins have been found to be essential for differentiation, survival 
and proliferation of thymocyte progenitors, and during the later stages of 
thymocyte development. Thymocyte intrinsic Hh mediated transcription has been 
also found to play a regulatory role in T cell development, suggesting that Hh 
proteins expressed by the epithelial tissue within the thymus signal directly to 
developing thymocytes. 
Our lab has shown that repression of intrinsic Hh-mediated transcription in 
thymocytes increased T cell differentiation and activation from DP to SP 
thymocytes. Our lab has also shown that the DP thymocytes are Hh-responsive 
and that thymocyte-intrinsic Hh-mediated transcription plays a role in modulating 
the production of SP4 and SP8, whereas repression of physiological Hh-mediated 
transcription in thymocytes altered the proportions of DP and SP4 thymocytes 
(Crompton et al. 2007; Rowbotham, Hager-Theodorides, Furmanski, et al. 2007; 
Furmanski et al. 2012). 
 
3.1.2    Chapter objectives 
The purpose of this chapter is to investigate the role of Hh signalling directly to 
thymocytes. For these experiments, two mouse models bearing an in-vivo reporter 
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of Hh signalling (GBS(Gli)-GFP) were used; (1) Lck-driven Gli2ΔC2 (Gli2ΔC2) 
(C2, Gli2R) transgenic mice which express a truncated form of Gli2 which acts as 
a repressor of Hh-dependent transcription. (2) The reciprocal Lck-Gli2ΔN2 
(Gli2ΔN2) (non-TCR-transgenic-Gli2ΔN2) (N2, Gli2A) transgenic mice which 
express a transgene encodes a truncated form of Gli2 that leads to constitutive 
activation of Gli2-dependent transcription in T-lineage cells (Hager-Theodorides 
et al. 2009). Both transgene constructs are otherwise identical in sequence, sharing 
DNA-binding domains.  
Furthermore, we have crossed Lck-Gli2ΔN2 and Lck-Gli2ΔC2 with GBS-GFP 
transgenic mouse. The GBS-GFP transgenic mouse model has eight binding sites 
for Gli transcription factors which regulate GFP expression and serve as a reporter 
for active Hh-induced Gli activity in-vivo (Balaskas et al. 2012). A direct 
observation of T cell populations in the thymus, spleen and lymph node will allow 
us to measure Hh signalling in T cell selection and maturation.  
In addition, to further investigate the consequence of Hh signalling in thymocytes 
on gene expression, Mouse whole genome microarray analysis was performed on 
sorted DP thymocytes extracted from Lck-Gli2ΔC2 and WT mice for comparison. 
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3.2       Results 
3.2.1    Genotyping GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates 
Two strains of mice were generated; the first is GBS-GFP/Gli2ΔN2, created by 
crossing GBS-GFP transgenic mice with Gli2ΔN2 transgenic mice. The result of 
this crossing resulted in two genotypes of mice, the first bearing GBS-GFP 
transgene (GBS-GFP/WT). The second bearing GBS-GFP and Gli2ΔN2 
transgenes (GBS-GFP/Gli2ΔN2+). The second strain used is GBS-GFP/Gli2ΔC2 
mice, created by crossing GBS-GFP transgenic mice with Gli2ΔC2 transgenic 
mice. The result of this crossing resulted in two genotypes of mice, the first 
bearing GBS-GFP transgene (GBS-GFP/WT). The second bearing GBS-GFP and 
Gli2ΔC2 transgenes (GBS-GFP/Gli2ΔC2+). 
Littermates were genotyped for eGFP, Gli2ΔN2 and Gli2ΔC2 transgenes. PCR 
analysis using genomic DNA from ear biopsies was performed in order to identify 
the genotype of littermates, using three sets of primers specific for eGFP, 
Gli2ΔN2 and Gli2ΔC2 transgenes. According to this strategy, eGFP transgene 
should generate a PCR product of 172bp, Gli2ΔN2 transgene should generate a 
PCR product of 600bp, and Gli2ΔC2 transgene should generate a PCR product of 
850bp. 
GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 mutants were identified according to 
the PCR results. Mice with a PCR product positive for eGFP transgene and 
negative for Gli2ΔN2 and Gli2ΔC2 transgenes, were genotyped as (GBS-
GFP/WT). Mice with PCR a product positive for eGFP transgene and positive for 
Gli2ΔN2 transgene, were genotyped as (GBS-GFP/ Gli2ΔN2+). Mice with PCR a 
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product positive for eGFP transgene and positive for Gli2ΔC2 transgene, were 
genotyped as (GBS-GFP/ Gli2ΔC2+) (Figure 3.1). 
3.2.2  Thymocytes and splenocytes in GBS-GFP/Gli2ΔN2+ and GBS-
GFP/Gli2ΔC2+ littermates 
Following anatomical extraction of the thymus and spleen from GBS-GFP/ 
Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates, the thymocytes and splenocytes 
were collected for analysis. In regards to live cell counts in the thymus, we 
observed no significant difference in the mean cell numbers in GBS-GFP/ 
Gli2ΔN2 compared to GBS-GFP/WT control (p>0.05, n=3). On the contrary, we 
observed a significant increase in the mean cell number of thymocytes in GBS-
GFP/ Gli2ΔC2 compared to GBS-GFP/WT control (p≤0.05, n=3) consistent with 
Hh signalling negatively regulating thymocyte numbers (Outram et al. 2000). In 
regards to live cell counts in the spleen, we observed no significant difference 
between the two genotypes of mice compared to their GBS-GFP/WT control 
(p>0.05, n=3) and (p>0.05, n=3) respectively (Figure 3.2). 
 
3.2.3     Role of Hh signalling in thymocyte development during development 
in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ mice 
In order to mesure the proportion of thymocytes transducing Hh signals during 
their development and selection in the thymus, thymocytes from GBS-
GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ and their GBS-GFP/WT littermate mice 
were analyzed for Gli-GFP, CD8 and CD4 cell surface expression (Figure 3.3) 
and (Figure 3.4). According to GFP expression, cells were sub-grouped into two 
main populations, Gli-GFP positive cells (Gli-GFP
+
) and GFP negative cells (Gli-
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GFP
−
). When we measured GFP expression in the major thymocyte populations 
of GBS-GFP/WT littermates, we found GFP
+
 cells in DN, DP, CD8SP and 
CD4SP with highest proportion in the DN population (~9.5%) (Figure 3.3) 
consistent with the role of Hh signalling in DN thymocyte homeostasis and 
differentiation (Outram et al. 2000; Shah et al. 2004). We then examined GFP 
expression in GBS-GFP/Gli2ΔN2 littermates, in which Hh-mediated transcription 
is activate. The proportions of GFP
+
 cells was increased to 16.6% in the DN 
population, consistent with the action of the Gli2ΔN2 transgene on differentiation 
of DN cells (Rowbotham et al. 2009).  
Our data show that over-expression of intrinsic Hh signalling (constitutive Hh-
mediated transcription) altered the proportions of DN, SP8 and SP4 cells that 
expressed GFP. Our analysis revealed that the percentage of SP4 cells was 
significantly increased in the GBS-GFP/Gli2ΔN2+ Compared to the GBS-
GFP/WT (p≤0.05, n=3) (Figure 3.3).  
Interestingly, our data also revealed that intrinsic suppression of Hh signalling in 
thymocytes influenced the proportions of DP, and SP cells expressing GFP in the 
thymus, as our analysis show that the percentage of SP4 cells was significantly 
increased in the GBS-GFP/Gli2ΔC2+ Compared to the GBS-GFP/WT (p≤0.05, 
n=3) (Figure 3.4).  
 
3.2.4    Influence of Hh signalling on the expression of CD3 in GBS-
GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ thymocytes 
In order to assess the potential role of Hh signalling in regulating differentiation 
and TCR signal transduction of GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 
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thymocytes during development and selection, we analyzed the cell surface 
expression of TCR signalling associated molecule (CD3) in DN, DP, SP8 and SP4 
cells in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ in comparison with their 
relative GBS-GFP/WT.
 
Furthermore we compared the mean fluorescence 
intensity (MFI) of staining for CD3 molecule. 
Our data show that active Hh signalling in thymocytes alters the expression of 
CD3 in developing thymocytes. Our analysis revealed that the percentage of CD3 
in SP8 cells was significantly lower in the GBS-GFP/Gli2ΔN2+ compared to the 
GBS-GFP/WT (p≤0.05, n=3). However, the percentage of CD3 in DN, DP and 
SP4 was not different between the three genotypes of mice (p>0.05, n=3). 
Furthermore, CD3 MFI in SP8 and SP4 was significantly increased in the GBS-
GFP/Gli2ΔN2+ compared to the GBS-GFP/WT (p≤0.05, n=3) and (p≤0.005, n=3) 
respectively (p>0.05, n=3) (Figure 3.5). 
Furthermore, our analysis show that suppressing Hh signalling in thymocytes 
alters the expression of CD3 as our data show that the percentage of CD3 in DN, 
SP8 and SP4 cells was significantly increased in the GBS-GFP/Gli2ΔC2+ 
compared to the GBS-GFP/WT (p≤0.005, n=3), (p≤0.05, n=3) and (p≤0.05, n=3) 
respectively. However, the percentage of CD3 in DP was not different between 
the two genotypes of mice (p>0.05, n=3). Additionally, CD3 MFI in SP8 was 
significantly increased in GBS-GFP/Gli2ΔC2+ compared to GBS-GFP/WT 
((p≤0.03, n=3), (p≤0.02, n=3)) respectively (Figure 3.6). 
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3.2.5     Role of Hh signalling in Foxp3 expression in thymocytes during 
development and selection in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ 
mice 
In order to assess the role of Hh signalling in the expression of Foxp3 during 
thymocyte development and selection, thymocytes were analyzed for Foxp3 
expression within the GFP
+
 SP4 cells.  
Our data show that in Hh active thymocytes, Hh signalling influences the 
phenotype of SP4 cells by promoting the expression of Foxp3, which is the 
transcription factor believed to be master regulator of the Treg lineage. Our 
analysis revealed that the percentage of Foxp3 in SP4 cells was significantly 
higher in the GBS-GFP/Gli2ΔN2+ Compared to the GBS-GFP/WT (p≤0.05, n=3) 
(Figure 3.7). 
 
3.2.6     Role of Hh signalling in thymocyte maturation during development 
and selection in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ mice 
In order to assess the role of Hh signalling in influencing cell maturation of the 
single positive populations during thymocyte development and selection, 
thymocytes from GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ in addition to 
their relative GBS-GFP/WT were analyzed for HSA expression in DP, SP8 and 
SP4 cells. 
Our data show that over-expression of Hh in thymocytes does not alter the 
maturation status of developing thymocytes, as our analysis revealed no 
100 
 
difference in the percentage of HSA on GFP
+
 thymocytes between the two 
genotypes of mice (p>0.05, n=3) (Figure 3.8). 
Similarly, our data show that suppressing Hh signalling in thymocytes dose not 
influence thymocyte maturation in Gli active cells. Our analysis revealed no 
difference in the percentage of HSA in GFP
+ 
thymocytes between the two 
genotypes of mice (p>0.05, n=3) (Figure 3.9). 
 
3.2.7     Influence of Hh signalling in spleen T cells of GBS-GFP/Gli2ΔN2+ and 
GBS-GFP/Gli2ΔC2+ mice  
In order to visulize Hh signalling ex-vivo in spleen T cells in the periphery, 
splenocytes from GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ in addition to 
their relative GBS-GFP/WT littermates were analyzed for Gli-GFP, CD8 and 
CD4 cell surface expression. According to GFP expression, cells were sub-
grouped into two main populations, Gli-GFP positive cells (Gli-GFP
+
) and GFP 
negative cells (Gli-GFP
−
). Within the Gli-GFP positive compartment, cells were 
sub-grouped according to the cell surface expression of CD8 and CD4 into three 
main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4).  
Our data show that active Hh signalling has no influence on mature splenocytes in 
the spleen as our analysis revealed that the percentage of splenocytes between the 
two genotypes of mice was not statistically different (p>0.05, n=3) (Figure 3.10). 
Furthermore, our analysis from the spleen show that suppressing Hh signalling 
has no influence on mature splnocytes, as our data show that the percentage of 
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splenocytes between the two genotypes of mice was not statistically different 
(p>0.05, n=3) (Figure 3.11). 
 
3.2.8    Influence of Hh signalling on the expression of CD3 in GBS-
GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ splenocytes 
In order to assess the potential role of Hh signalling in regulating differentiation 
and TCR signal transduction in splenocytes, we analyzed the cell surface 
expression of TCR associated signalling molecule (CD3) in DN, DP, SP8 and SP4 
cells in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔN2+ in addition to their relative 
GBS-GFP/WT. Furthermore we compared the mean fluorescence intensity (MFI) 
of staining for CD3 molecule. 
Our data show that increased Hh signalling does not alter the expression of CD3 
in the spleen as our analysis revealed that the percentage of CD3 in splenocytes 
was not statistically different between the two genotypes of mice (p>0.05, n=3). 
Similarly, CD3 MFI was not different in splenocytes between the two genotypes 
of mice (p>0.05, n=3) (Figure 3.12). 
Furthermore, our analysis from the spleen shows that suppressing Hh signalling in 
splenocytes alters the expression of CD3. Our data show that the percentage of 
CD3 in SP8 and SP4 was significantly lower in the GBS-GFP/Gli2ΔC2+ 
compared to the WT ((p>0.05, n=3), (p>0.05, n=3)) respectively. In addition, we 
measured the CD3 MFI in splenocytes and our analysis reveals that CD3 MFI was 
not different between the two genotypes of mice (p>0.05, n=3) (Figure 3.13). 
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3.2.9     Role of Hh signalling in Foxp3 expression in splnocytes during 
development and selection in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ 
mice 
In order to assess the role of Hh signalling in the expression of Foxp3 in the 
spleen, splenocytes were analyzed for Foxp3 expression within the SP4 cells. 
Foxp3 is the transcription factor believed to be master regulator of the Treg 
lineage. 
Our data from Foxp3 in the spleen confirmed our observation in that increased Hh 
signalling influence the phenotype of SP4 cells, as our data from the spleen show 
that the percentage of Foxp3 in SP4 cells was significantly higher in the GBS-
GFP/Gli2ΔN2+ Compared to the GBS-GFP/WT (p≤0.05, n=3) (Figure 3.14). 
Furthermore, inhibition of Hh signalling in thymoctes had no influence on the 
expression of Foxp3. Our analysis revealed that the percentage of Foxp3 in SP4 
cells was not statistically different in the GBS-GFP/Gli2ΔC2+ Compared to the 
GBS-GFP/WT (p>0.05, n=3) (Figure 3.14). 
 
3.2.10     Influence of Hh signalling in lymph node T cells of GBS-
GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ mice  
In order to assess the influence of Hh signalling in lymph node T cells in the 
periphery, cells from GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ in addition to 
their relative GBS-GFP/WT were analyzed for Gli-GFP, CD8 and CD4 cell 
surface expression. According to GFP expression, cells were sub-grouped into 
two main populations, Gli-GFP positive cells (Gli-GFP
+
) and GFP negative cells 
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(Gli-GFP
−
). Within the Gli positive compartment, cells were sub-grouped 
according to the cell surface expression of CD8 and CD4 into three main 
populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4).  
Our data analysis from the lymph node show that Hh expression has no influence 
on T cells in the lymph node. Our data show that the percentage of cells was not 
different (Figure 3.15). Similarly,  Hh suppression in T cells has no influence in 
the proportion of cells during as our analysis show that the percentage of T cell 
population was not different between the two genotypes of mice (p>0.05, n=3) 
(Figure 3.16). 
 
3.2.11    Influence of Hh signalling on the expression of CD3 in GBS-
GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ lymph node T cells 
In order to assess the potential role of Hh signalling in regulating differentiation 
and TCR signal transduction in lymph node T cells, we analyzed the cell surface 
expression of TCR associated signalling molecule (CD3) in CD8
−
CD4
−
, SP8 and 
SP4 cells in GBS-GFP/Gli2ΔN2+ and GBS-GFP/Gli2ΔC2+ in addition to their 
relative GBS-GFP/WT. Furthermore we compared the mean fluorescence 
intensity (MFI) of staining for CD3 molecule. 
As in the thymus, our data revealed that Hh signalling alters the expression of 
CD3 in T cells, as our analysis revealed that the percentage of CD3 in SP8 was 
significantly higher in the GBS-GFP/Gli2ΔN2+ compared to the GBS-GFP/WT 
(p≤0.005, n=3). Additionally, CD3 MFI was not different in lymph node T cells 
between the two genotypes of mice (p>0.05, n=3) (Figure 3.17). 
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Furthermore, our data from the lymph node revealed that suppression of Hh 
signalling in T cells influence the expression of CD3. Our analysis show that the 
percentage of CD3 in CD4
−
CD8
−
, SP8 and SP4 cells was significantly higher in 
the GBS-GFP/Gli2ΔC2+ compared to the GBS-GFP/WT (p≤0.05, n=3). 
Furthermore, CD3 MFI in SP8 and SP4 was significantly decreased in the GBS-
GFP/Gli2ΔC2+ compared to the GBS-GFP/WT ((p≤0.005, n=3), (p≤0.05, n=3)) 
respectively (Figure 3.18). 
 
3.2.12     Role of Hh signalling in Foxp3 expression in lymph node T cells 
during development and selection in GBS-GFP/Gli2ΔN2+ and GBS-
GFP/Gli2ΔC2+ mice 
In order to assess the role of Hh signalling in the expression of Foxp3 in the 
lymph node, T cells were analyzed for Foxp3 expression within the SP4 cells. 
Foxp3 is the transcription factor believed to be master regulator of the Treg 
lineage. 
Our data from the lymph node shows that the percentage of Foxp3 in SP4 cells 
was not significantly different between the two genotypes of mice (p>0.05, n=3) 
(Figure 3.19). Similarly, our data from Hh-suppressed cells in the lymph node 
revealed that the percentage of Foxp3 in SP4 cells was not statistically different 
between the two genotypes of mice (p>0.05, n=3) (Figure 3.19). 
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3.2.13     Hh signalling and gene expression  
To further investigate the consequence of Hh signalling in thymocytes on gene 
expression, we extracted DP thymocytes for whole genome expression analysis 
from Hh-suppressed, Hh-activated mouse models and WT mice for comparison. 
We used Lck-driven Gli2ΔC2 (ΔC2) (C2, Gli2R) transgenic mice which express a 
truncated form of Gli2 which acts as a repressor of Hh-dependent transcription. 
The reciprocal Lck- Gli2ΔN2 (ΔN2) (non-TCR-transgenic-Gli2ΔN2) (N2, Gli2A) 
transgene also encodes a truncated form of Gli2 that leads to constitutive 
activation of Gli2-dependent transcription in T-lineage cells. Both transgene 
constructs are otherwise identical in sequence, sharing DNA-binding domains. 
Microarray data analysis showed an increase by at least 2-folds in the expression 
of 35 genes in WT compared to Lck-Gli2ΔC2 (Table 3.1). Furthermore, Glioma-
associated oncogene (Gli-2), Guanine nucleotide binding protein β-subunit 
(Gnb4) and chemokine ligand-19 (Ccl-19) showed increased expression by at 
least 2-folds in Lck-Gli2ΔC2 compared to WT (Table 3.2) (Figure 3.20).  
Following this observation quantitative qRT-PCR was carried out to study the 
expression of Gnb4 in DP thymocytes from Lck-Gli2ΔN2, Lck-Gli2ΔC2 and WT. 
We showed that Gnb4 was highly expressed in Lck-Gli2ΔC2 DP thymocytes with 
a 2.6-fold change compared to DP thymocytes from Lck-Gli2ΔN2 mice (p≤0.05, 
n=3) (Figure 3.21).  
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Genes 
Higher expression in WT 
 
Description 
B930036n10rik 
 
Unclassified gene 
9430008c03Rik 
 
LincRNA gene 
Wfdc17 Cellular component 
Snora2b, Snora3, Snora21, Snora28, 
Snora33, Snora44 & Snora69         
 
Small nuclear RNA 
 
Rnu3a, Rnu1b1 & Rnu12 
 
Small nuclear RNA 
Vaultrc5 
 
Unclassified RNA coding gene 
Snord22, Snord33 & Snord118 
 
Small nucleolar RNA 
Snhg8 
 
Small nucleolar RNA (non-coding) 
Scarna8 
 
Small cajal body-specific RNA 
Rny1 & Rny3 RNA, Y small cytoplasmic (associated with Ro 
protein) 
Rn4.5s 
 
rRNA gene 
Hist1h2bg, Hist1h2ac, Hist1h3g & 
Hist2h3c2-ps 
 
Histone cluster 
Eif2s3y (Eukaryotic translation initiation 
factor-2 subunit-3) 
 
Structural gene Y-linked 
 
Top2a (topoisomerase (DNA) II alpha) 
 
Ubiquitously expressed enzymes  
Ndufb4 (NADH dehydrogenase (ubiquitin) 
1 beta subcomplex-4) 
 
Accessory subunit of the mitochondrial 
membrane respiratory chain NADH 
dehydrogenase (Complex-I) 
Kdm5d 
 
Lysine (K)-specific demethylase 5D 
Vmn2r42 (Vomeronasal 2, receptor 42) 
 
G-protein coupled receptor  
Hbb-b1 
 
Haemoglobin, beta adult major chain 
Uty Ubiquitously transcribed tetratricopeptide repeat 
gene, Y-linked 
Ddx3y 
 
Probable ATP-dependent RNA helicase 
Srsy 
 
Sex determining region Y 
 
Table 3.1 
Gene expression higher in WT 
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Genes  
Higher expression in Lck-Gli2ΔC2 
 
Description 
Gli2 (Gliomma-associated oncogene-2) Transcription activator 
 
Gnb4 (Guanine nucleotide binding 
protein (G protein) beta-4 subunit) 
 
Modulator or transducer in various 
transmembrane signalling systems 
 
Ccl19 (Chemokine (C-C motif) ligand-
19) 
Cellular trafficking and migration  
 
Table 3.2 
Gene expression higher in Lck-Gli2ΔC2 
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Figure 3.1 
Genotyping of GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates. GBS-GFP/Gli2ΔN2 
and GBS-GFP/Gli2ΔC2 mutants were identified according to the PCR results. The presence of the 
Gli2ΔN2 transgene generated a PCR product of 600bp. The presence of the Gli2ΔC2 transgene 
generated a PCR product of 850bp. The presence of the eGFP transgene generated a PCR product 
of 172bp. Mice with PCR a product positive for eGFP transgene and negative for Gli2ΔN2 and 
Gli2ΔC2 transgene, were genotyped as (GBS-GFP/WT). Mice with PCR a product positive for 
eGFP transgene and positive for Gli2ΔN2 transgene, were genotyped as (GBS-GFP/Gli2ΔN2+). 
Mice with PCR a product positive for eGFP transgene and positive for Gli2ΔC2 transgene, were 
genotyped as (GBS-GFP/ Gli2ΔC2+). 
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Figure 3.2 
Thymus and spleen live cell counts in male GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 
littermates. Thymocyte and splenocyte total counts from adult GBS-GFP/Gli2ΔN2, GBS-
GFP/Gli2ΔC2 and GBS-GFP/WT littermates. (A) Live thymocyte counts in GBS-GFP/Gli2ΔN2. 
(B) Live splenocyte counts in GBS-GFP/Gli2ΔN2. (C) Live thymocyte counts in GBS-
GFP/Gli2ΔC2. (D) Live splenocyte counts in GBS-GFP/Gli2ΔC2. Mean and standard deviation of 
each population are given. Bars represent mean ± standard deviations. Thymocyte counts; GBS-
GFP/Gli2ΔN2 (p=0.8, n=3). GBS-GFP/Gli2ΔC2 (p=0.05, n=3). Splenocyte counts; GBS-
GFP/Gli2ΔN2 splenocytes; (p=0.3, n=3). GBS-GFP/Gli2ΔC2 splenocytes; (p=0.4, n=3). 
*represents p≤0.05. 
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 Figure 3.3 
Major thymocyte populations in GBS-GFP/Gli2ΔN2. Percentage of thymocyte populations 
from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. Thymocytes were stained for anti-
CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) 
Representative dot plot of thymocyte populations gated on GLI-GFP
+
 and Gli-GFP
−
 for DN, DP, 
SP8 and SP4 cells. (B) Representative dot plot of thymocyte populations gated on total and GLI-
GFP
+
 cells. (C) Representative histogram of GLI-GFP
+
 DN, DP, SP8 and SP4 cells. (D) 
Representative bar graph of GLI-GFP
+
 percentages in DN, DP, SP8 and SP4 cells. (E) 
Representative bar graph of CD4:CD8 ratio from GLI-GFP
+
 cells. (F) Representative bar graph of 
GLI-GFP
+
 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 3 independent sets of 
GBS-GFP/Gli2ΔN2 littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. Thymocyte percentages; DN (p= 0.4, n=3). DP (p= 0.5, 
n=3). SP8 (p= 0.5, n=3). SP4 (p=0.04, n=3).  GLI-GFP MFI; DN (p= 0.3, n=3). DP (p= 0.6, 
n=3). SP8 (p= 0.6, n=3). SP4 (p=0.9, n=3). *represents p≤0.05. 
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 Figure 3.4 
Major thymocyte populations in GBS-GFP/Gli2ΔC2. Percentage of thymocyte populations 
from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. Thymocytes were stained for anti-
CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) 
Representative dot plot of thymocyte populations gated on GLI-GFP
+
 and Gli-GFP
−
 for DN, DP, 
SP8 and SP4 cells. (B) Representative dot plot of thymocyte populations gated on total and GLI-
GFP
+
 cells. (C) Representative histogram of GLI-GFP
+
 DN, DP, SP8 and SP4 cells. (D) 
Representative bar graph of GLI-GFP
+
 percentages in DN, DP, SP8 and SP4 cells. (E) 
Representative bar graph of CD4:CD8 ratio from GLI-GFP
+
 cells. (F) Representative bar graph of 
GLI-GFP
+
 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 3 independent sets of 
GBS-GFP/Gli2ΔN2 littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. Thymocyte percentages; DN (p= 0.2, n=3). DP (p= 0.1, 
n=3). SP8 (p= 0.3, n=3). SP4 (p=0.01, n=3). GLI-GFP MFI; DN (p= 0.4, n=3). DP (p= 0.7, n=3). 
SP8 (p= 0.3, n=3). SP4 (p=0.7, n=3). *represents p≤0.05. 
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Figure 3.5 
 
Expression of CD3 in GBS-GFP/Gli2ΔN2 thymocytes. Expression of CD3 in DN, DP, SP8 and 
SP4 cells from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. Thymocytes were stained 
for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells.  (D) Representative histogram of GLI-GFP 
in CD3 from DN, DP, SP8 and SP4 cells. (E) Representative bar graph of GLI-GFP percentages in 
CD3 from DN, DP, SP8 and SP4 cells. (F) Representative histogram and dot plot of CD3-high 
expression then gated on CD8 and CD4. Figures are representative of 3 independent sets of GBS-
GFP/Gli2ΔN2 littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. CD3 percentages; DN (p= 0.5, n=3). DP (p= 0.4, n=3). 
SP8 (p= 0.01, n=3). SP4 (p= 0.3, n=3). CD3 MFI; DN (p= 0.2, n=3). DP (p= 0.8, n=3). SP8 (p= 
0.01, n=3). SP4 (p= 0.004, n=3). GLI GFP MFI; DN (p= 0.5, n=3). DP (p= 0.4, n=3). SP8 (p= 
0.2, n=3). SP4 (p= 0.8, n=3).*represents p≤0.05, **represents p≤0.005. 
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Figure 3.6 
 
Expression of CD3 in GBS-GFP/Gli2ΔC2 thymocytes. Expression of CD3 in DN, DP, SP8 and 
SP4 cells from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. Thymocytes were stained 
for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells.  (D) Representative histogram of GLI-GFP 
in CD3 from DN, DP, SP8 and SP4 cells. (E) Representative bar graph of GLI-GFP MFI in CD3 
from DN, DP, SP8 and SP4 cells. (F) Representative histogram and dot plot of CD3-high 
expression then gated on CD8 and CD4. Figures are representative of 3 independent sets of GBS-
GFP/Gli2ΔC2 littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. CD3 percentages; DN (p= 0.005, n=3). DP (p= 0.1, n=3). 
SP8 (p= 0.02, n=3). SP4 (p= 0.008, n=3). CD3 MFI; DN (p= 0.3, n=3). DP (p= 0.4, n=3). SP8 
(p= 0.04, n=3). SP4 (p= 0.07, n=3). GLI-GFP MFI; DN (p= 0.2, n=3). DP (p= 0.6, n=3). SP8 (p= 
0.1, n=3). SP4 (p= 0.3, n=3).*represents p≤0.05, **represents p≤0.005. 
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Figure 3.7 
 
Expression of Foxp3 in GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 SP4 thymocytes. 
Expression of Foxp3 in SP4 cells from adult GBS-GFP/Gli2ΔN2, GBS-GFP/Gli2ΔC2 and GBS-
GFP/WT littermates. Thymocytes were stained for anti-Foxp3, anti-CD25, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) Representative 
histogram of Foxp3 expression in GBS-GFP/Gli2ΔN2 SP4 cells. (B) Representative histogram of 
Foxp3 expression in GBS-GFP/Gli2ΔC2 SP4 cells. (C) Representative bar graph of Foxp3 
percentages in GBS-GFP/Gli2ΔN2 SP4 cells. (D) Representative bar graph of Foxp3 percentages 
in GBS-GFP/Gli2ΔC2 SP4 cells. (E) Representative histogram of GLI-GFP expression in Foxp3 
from GBS-GFP/Gli2ΔN2 SP4 cells. (F) Representative histogram of GLI-GFP expression in 
Foxp3 from GBS-GFP/Gli2ΔC2 SP4 cells. (G) Representative bar graph of GLI-GFP MFI in 
Foxp3 from GBS-GFP/Gli2ΔN2 SP4 cells. (H) Representative bar graph of GLI-GFP MFI in 
Foxp3 from GBS-GFP/Gli2ΔC2 SP4 cells. Figures are representative of 3 independent sets of 
GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. GBS-GFP/Gli2ΔN2 Foxp3 
percentage; SP4 (p= 0.006, n=3). GBS-GFP/Gli2ΔC2 Foxp3 percentage; SP4 (p= 0.1, n=3). 
GBS-GFP/Gli2ΔN2 GLI-GFP MFI; SP4 (p= 0.3, n=3). GBS-GFP/Gli2ΔC2 GLI-GFP MFI; 
SP4 (p= 0.9, n=3).*represents p≤0.05. 
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Figure 3.8 
Expression of HSA in GBS-GFP/Gli2ΔN2 thymocytes. Expression of HSA in DP, SP8 and SP4 
cells from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. Thymocytes were stained for 
anti-CD24, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative histogram of HSA expression in DP, SP8 and SP4 cells. (B) 
Representative bar graph of HSA percentages in DP, SP8 and SP4 cells. (C) Representative 
histogram of GLI-GFP expression in HSA for DP, SP8 and SP4 cells. (D) Representative bar 
graph of GLI GFP MFI in HSA from DP, SP8 and SP4 cells. Figures are representative of 3 
independent sets of GBS-GFP/Gli2ΔN2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. HSA percentages; DP (p= 0.1, 
n=3). SP8 (p= 0.5, n=3). SP4 (p= 0.09, n=3). GLI-GFP MFI; DP (p= 0.2, n=3). SP8 (p= 0.1, 
n=3). SP4 (p= 0.4, n=3).  
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Figure 3.9 
Expression of HSA in GBS-GFP/Gli2ΔC2 thymocytes. Expression of HSA in DP, SP8 and SP4 
cells from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. Thymocytes were stained for 
anti-CD24, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative histogram of HSA expression in DP, SP8 and SP4 cells. (B) 
Representative bar graph of HSA percentages in DP, SP8 and SP4 cells. (C) Representative 
histogram of GLI-GFP expression in HSA from DP, SP8 and SP4 cells. (D) Representative bar 
graph of GLI-GFP MFI in HSA from DP, SP8 and SP4 cells. Figures are representative of 3 
independent sets of GBS-GFP/Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. HSA percentages; DP (p= 0.3, 
n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.2, n=3). GLI-GFP-MFI; DP (p= 0.4, n=3). SP8 (p= 0.1, n=3). 
SP4 (p= 0.3, n=3).  
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Figure 3.10 
Major splenocyte populations in GBS-GFP/Gli2ΔN2 mice. Percentage of splenocyte 
populations from adult male GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. Splenocytes were 
stained for anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative dot plot of splenocyte populations gated on GLI-GFP
+
 and Gli-
GFP
−
 for CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative dot plot of splenocyte populations 
gated on total and GLI-GFP
+
 cells. (C) Representative histogram of GLI-GFP
+
 in CD4
−
CD8
−
, SP8 
and SP4 cells. (D) Representative bar graph of GLI-GFP
+
 percentages in CD4
−
CD8
−
, SP8 and SP4 
cells. (E) Representative bar graph of GLI-GFP
+
 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures 
are representative of 3 independent sets of GBS-GFP/Gli2ΔN2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. Splenocyte 
percentages; CD4
−
CD8
−
 (p= 0.5, n=3). SP8 (p= 0.5, n=3). SP4 (p= 0.6, n=3). Gli-GFP MFI 
percentages; CD4
−
CD8
−
 (p= 0.6, n=3). SP8 (p= 0.7, n=3). SP4 (p= 0.3, n=3).  
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 Figure 3.11 
Major splenocyte populations in GBS-GFP/Gli2ΔC2 mice. Percentage of splenocyte 
populations from adult male GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. Splenocytes were 
stained for anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-
GFP
+
 cells. (A) Representative dot plot of splenocyte populations gated on GLI-GFP
+
 and Gli-
GFP
−
 for CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative dot plot of splenocyte populations 
gated on total and GLI-GFP
+
 cells. (C) Representative histogram of GLI-GFP
+
 CD4
−
CD8
−
, SP8 
and SP4 cells. (D) Representative bar graph of GLI-GFP
+
 percentages in CD4
−
CD8
−
, SP8 and SP4 
cells. (E) Representative bar graph of GLI-GFP
+
 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures 
are representative of 3 independent sets of GBS-GFP/Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. Splenocyte 
percentages; CD4
−
CD8
−
 (p= 0.4, n=3). SP8 (p= 0.3, n=3). SP4 (p= 0.1, n=3). GLI-GFP MFI 
(p= 0.3, n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.6, n=3).  
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Figure 3.12 
 
Expression of CD3 in GBS-GFP/Gli2ΔN2 splenocytes. Expression of CD3 in CD4−CD8−, SP8 
and SP4 cells from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. Splenocytes were 
stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated 
on Gli-GFP
+
 cells. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 
cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. (D) Representative 
histogram of GLI-GFP expression in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (E) Representative 
bar graph of GLI-GFP MFI in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (F) Representative 
histogram and dot plot of CD3-high expression then gated on CD8 and CD4. Figures are 
representative of 3 independent sets of GBS-GFP/Gli2ΔN2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.5, n=3). SP4 (p= 0.6, n=3). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.6, n=3). SP8 (p= 0.2, n=3). SP4 (p= 0.5, n=3). GLI-GFP MFI; CD4
−
CD8
−
 (p= 
0.2, n=3). SP8 (p= 0.7, n=3). SP4 (p= 0.4, n=3).  
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Figure 3.13 
 
Expression of CD3 in GBS-GFP/Gli2ΔC2 splenocytes. Expression of CD3 in CD4−CD8−, SP8 
and SP4 cells from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. Splenocytes were 
stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated 
on Gli-GFP
+
 cells. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 
cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. (D) Representative 
histogram of GLI-GFP expression in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (E) Representative 
bar graph of GLI-GFP MFI in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (F) Representative 
histogram and dot plot of CD3-high expression then gated on CD8 and CD4. Figures are 
representative of 3 independent sets of GBS-GFP/Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.02, n=3). SP4 (p= 0.03, n=3). GLI-GFP MFI; 
CD4
−
CD8
−
 (p= 0.3, n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.7, n=3). *represents p≤0.05. 
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Figure 3.14 
Expression of Foxp3 in GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 SP4 splenocytes. 
Expression of Foxp3 in SP4 cells from adult GBS-GFP/Gli2ΔN2, GBS-GFP/Gli2ΔC2 and GBS-
GFP/WT littermates. Splenocytes were stained for anti-Foxp3, anti-CD25, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) Representative 
histogram of Foxp3 expression in GBS-GFP/Gli2ΔN2 SP4 cells. (B) Representative histogram of 
Foxp3 expression in GBS-GFP/Gli2ΔC2 SP4 cells. (C) Representative bar graph of Foxp3 
percentages in GBS-GFP/Gli2ΔN2 SP4 cells. (D) Representative bar graph of Foxp3 percentages 
in GBS-GFP/Gli2ΔC2 SP4 cells. (E) Representative histogram of GLI-GFP expression in Foxp3 
from GBS-GFP/Gli2ΔN2 SP4 cells. (F) Representative histogram of GLI-GFP expression in 
Foxp3 from GBS-GFP/Gli2ΔC2 SP4 cells. (G) Representative bar graph of GLI-GFP MFI in 
Foxp3 from GBS-GFP/Gli2ΔN2 SP4 cells. (H) Representative bar graph of GLI-GFP MFI in 
Foxp3 from GBS-GFP/Gli2ΔC2 SP4 cells. Figures are representative of 3 independent sets of 
GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. GBS-GFP/Gli2ΔN2 Foxp3 
percentage; SP4 (p= 0.02, n=3). GBS-GFP/Gli2ΔC2 Foxp3 percentage; SP4 (p= 0.08, n=3). 
GBS-GFP/Gli2ΔN2 GLI-GFP MFI; SP4 (p= 0.05, n=3). GBS-GFP/Gli2ΔC2 GLI-GFP MFI; 
SP4 (p= 0.3, n=3). *represents p≤0.05. 
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Figure 3.15 
Major T cell populations in the lymph node of GBS-GFP/Gli2ΔN2 mice. Percentage of T cell 
populations from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT  littermates. Cells were stained for 
anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) 
Representative dot plot of T cell populations gated on GLI-GFP
+
 and Gli-GFP
−
 for CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative dot plot of T cell populations gated on total and GLI-GFP
+
 
cells. (C) Representative histogram of GLI-GFP
+
 CD4
−
CD8
−
, SP8 and SP4 cells. (D) 
Representative bar graph of GLI-GFP
+
 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (E) 
Representative bar graph of GLI-GFP
+
 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of male Marilyn-Gli2ΔN2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. T cell 
percentages; CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.2, n=3). SP4 (p= 0.08, n=3). GLI-GFP MFI; 
CD4
−
CD8
−
 (p= 0.4, n=3). SP8 (p= 0.1, n=3). SP4 (p= 0.3, n=3). 
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Figure 3.16 
Major T cell populations in the lymph node of GBS-GFP/Gli2ΔC2 mice. Percentage of T cell 
populations from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT  littermates. Cells were stained for 
anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) 
Representative dot plot of T cell populations gated on GLI-GFP
+
 and Gli-GFP
−
 for CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative dot plot of T cell populations gated on total and GLI-GFP
+
 
cells. (C) Representative histogram of GLI-GFP
+
 CD4
−
CD8
−
, SP8 and SP4 cells. (D) 
Representative bar graph of GLI-GFP
+
 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (E) 
Representative bar graph of GLI-GFP
+
 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of male GBS-GFP/Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. T cell 
percentages; CD4
−
CD8
−
 (p= 0.3, n=3). SP8 (p= 0.2, n=3). SP4 (p= 0.09, n=3). GLI-GFP MFI; 
CD4
−
CD8
−
 (p= 0.2, n=3). SP8 (p= 0.1, n=3). SP4 (p= 0.4, n=3). 
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Figure 3.17 
 
Expression of CD3 in GBS-GFP/Gli2ΔN2 lymph node T cells. Expression of CD3 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult GBS-GFP/Gli2ΔN2 and GBS-GFP/WT littermates. 
Cells were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells 
were gated on Gli-GFP
+
 cells. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. (D) 
Representative histogram of GLI-GFP expression in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (E) 
Representative bar graph of GLI-GFP MFI in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (F) 
Representative histogram and dot plot of CD3-high expression then gated on CD8 and CD4. 
Figures are representative of 3 independent sets of male GBS-GFP/Gli2ΔN2 littermates. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.001, n=3). SP4 (p= 0.07, n=3). GBS-
GFP/Gli2ΔN2 CD3 MFI; CD4−CD8− (p= 0.3, n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.09, n=5). 
GLI-GFP MFI; CD4
−
CD8
−
 (p= 0.3, n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.2, n=3). **represents 
p≤0.005. 
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Figure 3.18 
 
Expression of CD3 in GBS-GFP/Gli2ΔC2 lymph node T cells. Expression of CD3 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult GBS-GFP/Gli2ΔC2 and GBS-GFP/WT littermates. 
Cells were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. Cells 
were gated on Gli-GFP
+
 cells. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. (D) 
Representative histogram of GLI-GFP expression in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (E) 
Representative bar graph of GLI-GFP MFI in CD3 from CD4
−
CD8
−
, SP8 and SP4 cells. (F) 
Representative histogram and dot plot of CD3-high expression then gated on CD8 and CD4. 
Figures are representative of 3 independent sets of male GBS-GFP/Gli2ΔC2 littermates. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.009, n=3). SP8 (p= 0.01, n=3). SP4 (p= 0.02, n=3). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.4, n=3). SP8 (p= 0.003, n=3). SP4 (p= 0.02, n=5). GLI-GFP MFI; CD4
−
CD8
−
 
(p= 0.2, n=3). SP8 (p= 0.3, n=3). SP4 (p= 0.2, n=5).*represents p≤0.05, **represents p≤0.005. 
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Figure 3.19 
Expression of Foxp3 in GBS-GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 SP4 lymph node T cells. 
Expression of Foxp3 in SP4 cells from adult GBS-GFP/Gli2ΔN2, GBS-GFP/Gli2ΔC2 and GBS-
GFP/WT littermates. Cells were stained for anti-Foxp3, anti-CD25, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Cells were gated on Gli-GFP
+
 cells. (A) Representative histogram of 
Foxp3 expression in GBS-GFP/Gli2ΔN2 SP4 cells. (B) Representative histogram of Foxp3 
expression in GBS-GFP/Gli2ΔC2 SP4 cells. (C) Representative bar graph of Foxp3 percentages in 
GBS-GFP/Gli2ΔN2 SP4 cells. (D) Representative bar graph of Foxp3 percentages in GBS-
GFP/Gli2ΔC2 SP4 cells. (E) Representative histogram of GLI-GFP expression in Foxp3 from 
GBS-GFP/Gli2ΔN2 SP4 cells. (F) Representative histogram of GLI-GFP expression in Foxp3 
from GBS-GFP/Gli2ΔC2 SP4 cells. (G) Representative bar graph of GLI-GFP MFI in Foxp3 from 
GBS-GFP/Gli2ΔN2 SP4 cells. (H) Representative bar graph of GLI-GFP MFI in Foxp3 from 
GBS-GFP/Gli2ΔC2 SP4 cells. Figures are representative of 3 independent sets of GBS-
GFP/Gli2ΔN2 and GBS-GFP/Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. GBS-GFP/Gli2ΔN2 Foxp3 
percentage; SP4 (p= 0.3, n=3). GBS-GFP/Gli2ΔC2 Foxp3 percentage; SP4 (p= 0.06, n=3). 
GBS-GFP/Gli2ΔN2 GLI-GFP MFI; SP4 (p= 0.2, n=3). GBS-GFP/Gli2ΔC2 GLI-GFP MFI; 
SP4 (p= 0.6, n=3).  
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Figure 3.20 
Mouse whole genome microarray data. (A) Microarray heat map represent 1000 gene 
expression clusters in two WT mice and two Lck-Gli2ΔC2 mice. Expression values from low, 
middle and high indicated by colors; blue, green, and yellow respectively. (B) Fold change data 
analysis of mouse whole genome expression performed for 2 Lck-Gli2ΔC2 and 2 WT mice. Fold 
change represent clusters of gene expressions higher or lower in Lck-Gli2ΔC2 compared to WT. 
The middle cluster of gene expressions, represent a similar expression of genes in both sets. 
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Figure 3.21 
Gnb4 expression. Relative mean expression of Gnb4 in DP thymocytes from Lck-Gli2 ΔN2,  Lck-
Gli2ΔC2, and WT mice. GBS-GFP/Gli2ΔC2 expression; (p= 0.04, n=3). *represents p≤0.05. 
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3.3       Discussion 
Our data revealed that both, intrinsic inhibition and activation of Hh signalling in 
thymocytes altered the proportions of SP4 cells that express GFP, suggesting a 
regulatory role of Gli in SP4 thymocytes. Hh signalling promotes target gene 
transcription through the activation of glioblastoma-associated Gli family of 
transcription factors, Gli1, Gli2 and Gli3. Both Gli1 and Gli2 are transcription 
activators dependent on Hh signalling, however, Gli3 functions as a 
transcriptional regulator independent of Hh signalling (Wang et al. 2000; Pan et 
al. 2006; Bai et al. 2002). Gli3 has been previously shown to control thymocyte 
negative selection and TCR signal strength through Hh-dependent and 
independent mechanisms, moreover, it has been shown that defective Gli3 
expression resulted in an inappropriate production of MHC class I-selected CD4 
cells (Hager-Theodorides et al. 2009). This is consistent with our finding as the 
proportions of SP4 cells expressing GFP were increased in both Hh-suppressed 
and Hh-activated mouse models. Moreover, CD3 expression was reduced in SP 
cells when Hh-signalling was active and increased when Hh-signalling was 
inhibited, indicating a regulatory role of Hh in TCR signal transduction through 
the expression of CD3 molecule. 
We have undertaken further characterization of SP4 cells through examining the 
expression of the master regulator of Treg lineage, Foxp3. Our data have shown 
that Hh-signalling influences the phenotype of SP4 cells in the thymus and spleen. 
In contrast, suppression of Hh-signalling in T cells reduced the expression of 
Foxp3 in SP4 cells suggesting a Hh-dependent regulatory role on these cells. 
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We investigated Hh-signalling and gene expressions by microarray analysis and 
our data have shown that Hh-signalling is attenuating gene transcription of 
various genes that may have a direct effect on T cell development and selection 
within the thymus.  Several genes were found to be differentially expressed in DP 
thymocytes from mouse model where the physiological Hh-signalling is 
suppressed. Such a differential expression pattern of these genes in developing 
thymocytes led us to ask if they play a role in T cell development and maturation 
within the thymus and the role of Hh signalling in their expression and regulation. 
Our data have shown that the expression of Gli2 (glioma-asssociated oncogene-2), 
was upregulted when Hh-signalling was suppressed by at least 2-folds compared 
to WT. This increase is probably due to the very design of these mice model, 
where it expresses a truncated form of Gli2 which acts as a repressor of Hh-
dependent transcription, so the microarray is picking up the transgenic transcript. 
Our microarray data analysis revealed that Gnb4 (Heterotrimeric Guanine 
nucleotide binding protein β-4 subunit) was upregulated by 2.6 folds when Hh-
signalling was suppressed compared to WT and its expression was validated using 
qRT-PCR.  Gnb4 play a key role in the signal transduction from membrane 
receptors to intracellular receptors. Activated G-protein coupled receptors result in 
the activation of many signal transduction cascades via the α-subunit and βγ-
dimmers. The effect of βγ -mediated signalling involve the regulation of cell 
growth and proliferation via Ras activation and it has been found that genetic 
variations in genes encoding G-protein subunit β4  have been associated with 
cancer (Riemann et al. 2009; Schwindinger & Robishaw 2001).  
131 
 
Our microarray data also showed an increase in the expression of Ccl-19 
(chemokine ligand-19) when Hh is suppressed by at least 2 folds compared to 
WT. Ccl-19 plays a role in lymphocyte recirculation and homing. It involves in T 
cell trafficking in the thymus and migration to lymphoid organs. It is possible that 
Hh-signalling play a role in regulating the expression of Ccl-19 for thymocytes 
during their development and selection as they constantly travel along the 
different compartments of the thymus.   
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3.4       Conclusion 
Our data revealed that both, intrinsic inhibition and activation of Hh signalling in 
thymocytes altered the proportions of SP4 cells that express GFP. Moreover, CD3 
expression was reduced in SP cells when Hh-signalling was active and increased 
when Hh-signalling was inhibited, indicating a regulatory role of Hh in TCR 
signal transduction through the expression of CD3 molecule. Further 
characterization of SP4 cells through detecting the expression of the Foxp3 show 
that Hh-signalling influences the phenotype of SP4 cells in both, the thymus and 
spleen.  
Furthermore, our data have shown that Hh-signalling is attenuating gene 
transcription of various genes that may have a direct effect on T cell development 
and selection within the thymus.  Such a differential expression pattern of these 
genes in developing thymocytes suggest a role of Hh signalling directly to T cells 
during the development and maturation within the thymus.  
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Chapter Four: Role of Dhh in T cell development 
 
4.1       Introduction  
4.1.1    Dhh in T cell development 
The role of Dhh in T cell development and maturation is as yet unexplored. Dhh 
has been shown to be produced by thymic epithelial cells distributed throughout 
the thymus indicating a possible role of Dhh in thymocyte development and 
differentiation (Sacedón et al. 2003). It has been found that thymocytes do not 
express Dhh, however, their development in the thymus requires a direct 
interaction with thymic epithelial cells which is essential for their development 
and maturation (Sacedón et al. 2003).  
T cell activation, clonal expansion and peripheral maintenance of tolerance take 
place in the peripheral lymphoid organs, including the spleen and lymph nodes. 
Dhh is known to be expressed by stromal tissues in these organs, specifically in 
the spleen, indicating a possible role of Dhh in peripheral T cell differentiation 
and maturation (Perry et al. 2009; Lau et al. 2012).  Furthermore, as T cell 
progenitors are liver-derived during embryogenesis and bone marrow-derived 
postnatally and in adults, it is possible that Dhh may also play a role in signalling 
to early T cell progenitors, since Dhh is expressed in foetal liver and adult bone 
marrow (Lau et al. 2012). 
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4.1.2    Chapter objectives 
The purpose of this chapter is to understand the role of Dhh in T cell development 
in the thymus and its function in the periphery. Studying the functions of Dhh in 
the Dhh-knockout thymus makes it possible to detect differences in differentiation 
and transition from one developmental stage to the next. T cell functions in the 
periphery are also investigated through in-vitro induced activation to assess the 
role of Dhh in T cell differentiation activation and expansion.  
To investigate the role of physiological Dhh signalling on T cell development, I 
have generated Dhh-KO and Dhh-WT mice from crossing Dhh
+/−
 male and female 
mice. A direct observation of T cell populations in the thymus, spleen and lymph 
node will reveal whether or not Dhh is signalling positively or negatively to T 
cells during their development and maturation.  
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4.2       Results 
4.2.1 Genotyping Dhh littermates 
Three genotypes of mice were utilized, the first is wild type (WT) bearing the 
normal complete Dhh gene. The second is a knockout (Dhh-KO) where the 
expression of Dhh is completely lost through a mutated gene on both alleles. The 
third is heterozygous (Dhh-Het) with partial expression of Dhh (one normal allele 
and one mutated allele). Dhh-KO and Dhh-WT mice were generated from 
crossing Dhh-Heterozygous male and female mice.  
The genotypes of Dhh mice cannot be distinguished visually as Dhh-KO and Dhh-
Het mice appear similar to WT. Each littermate was genotyped for both Dhh-WT 
and Dhh mutant alleles. PCR analysis using genomic DNA from ear biopsies was 
performed in order to identify the genotype of Dhh littermates. PCR analysis of 
the three littermates was performed using two sets of primers specific for Dhh-
WT and mutant alleles. According to this strategy, WT allele should generate a 
PCR product of 442bp, while mutant alleles should generate a PCR product of 
110bp. 
Dhh mutants were identified according to the PCR results. Mice with a PCR 
product positive for the WT gene and negative for the mutant gene were 
genotyped as (+/+). Mice with a PCR product negative for WT gene and positive 
for the mutant gene were genotyped as (−/−). Mice with a PCR product positive 
for both WT and mutant genes were genotyped as (+/−) (Figure 4.1). 
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4.2.2    Differences in organ size of Dhh KO and Heterozygous 
Thymus and spleen of Dhh-WT, KO and Het were compared following 
anatomical dissection in order to assess their differences and similarities. All 
observations were carried out on Dhh littermates. Size comparison was carried out 
by visual comparison and measuring the horizontal width and vertical length of 
extracted organs. Thymus extracted from Dhh-KO appeared larger in size 
compared to both Dhh-WT and Dhh-Het. Thymus extracted from Dhh-Het was 
also larger than thymus extracted from Dhh-WT but smaller than Dhh-KO (Figure 
4.2). The spleen of Dhh-KO was larger compared to Dhh-WT but smaller than 
Dhh-Het. Surprisingly, the spleen of Dhh-Het appeared larger than both Dhh-WT 
and Dhh-KO (Figure 4.2). 
 
4.2.3    Thymocytes and splenocytes in Dhh littermates 
Following anatomical extraction of the thymus and spleen from Dhh littermates, 
the thymocytes were collected for analysis. Live cell counts in the thymus was 
significantly increased in Dhh-KO by at least 6% compared to Dhh-WT (p≤0.05, 
n=6), whereas there was no significant difference between Het and WT. Thus, we 
found that Dhh influences thymocyte numbers (Figure 4.3). 
Similarly in the spleen, our data have shown that Dhh also regulates splenocyte 
numbers (Lau et al. 2012). We observed a significant increase in live splenocyte 
counts in Dhh-KO of at least 5% compared to Dhh-WT (p≤0.05, n=6). In Dhh-Het 
we observed a significant increase of at least 7% compared to Dhh-WT (p≤0.05, 
n=6) (Figure 4.3). 
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4.2.4     Role of Dhh during the early stages of thymocyte development 
In order to assess the role of Dhh during the early stages of thymocyte 
development and differentiation, thymocytes from Dhh-WT, Het and KO were 
analyzed for CD44 and CD25 and sub-grouped according to their expression into 
the four main DN populations, the CD44
+
CD25
−
 (DN1), CD44
+
CD25
+ 
(DN2), 
CD44
−
CD25
+
 (DN3) and CD44
−
CD25
− 
(DN4).  
We observed differences in the proportion of DN1, DN3 and DN4 cells indicating 
a possible role of Dhh in accelerating the transition of immature thymocytes from 
DN1 through DN3 stage, and eventually arresting cells at the DN4 stage. 
Surprisingly, Dhh-Het seems to display a different phenotype compared to Dhh-
WT. Our data show that the percentage of DN1 cells in Dhh-KO was significantly 
lower than in the Dhh-WT (p≤0.05, n=6), and significantly lower than in the Dhh-
Het (p≤0.005, n=6). The percentage of DN3 cells in the Dhh-KO, was 
significantly lower than in the Dhh-Het (p≤0.05, n=6). The percentage of DN4 
cells in the Dhh-KO was significantly higher than in the Dhh-Het (p≤0.05, n=6) 
(Figure 4.4).  
These data indicate that Dhh influences the homeostasis and differentiation of DN 
subsets in a dose-dependent manner. The observation that Dhh and Dhh
+/−
 show 
opposing phenotype is consistent with Dhh’s function as a morphogen, and has 
previously been observed in the Ihh-mutant thymus (Outram et al. 2009). 
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4.2.5     Role of Dhh in thymocyte development  
In order to assess the role of Dhh in later stages of thymocyte development and 
differentiation, thymocytes from Dhh-WT, Het and KO were analyzed for CD4 
and CD8 cell surface expression and sub-grouped according to their expression 
into four main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
+ 
(DP), CD8
+
CD4
−
 
(SP8) and CD8
−
CD4
+ 
(SP4). Our data have shown that Dhh negatively regulate 
DP and SP8 populations during their development in the thymus.  
The percentage of DP cells in the Dhh-KO thymus was significantly lower 
compared to the Dhh-WT (p≤0.05, n=6). The percentage of SP8 cells in Dhh-KO 
was significantly higher than in the Dhh-WT (p≤0.05, n=6) (Figure 4.5). The 
decrease in DP and increase in SP8 cells we observed in Dhh-mutant mice 
indicated that Dhh negatively regulates the transition from DP to SP8. 
Additionally, our data have shown no difference in the proportion of DN and SP4 
cells between the three genotypes of Dhh mice (p>0.05, n=6) (Figure 4.5). 
 
4.2.6    Influence of Dhh on expression of CD2, CD3 and CD5 in thymocytes 
In order to assess the potential role of Dhh in regulating differentiation and TCR 
signal transduction during thymocyte development, we analyzed the cell surface 
expression of molecules associated with TCR signalling (CD2, CD3 and CD5) 
within the DN, DP, SP8 and SP4 cells in Dhh-WT, Het and KO. Furthermore we 
compared the mean fluorescence intensity (MFI) of staining for these molecules, 
as high CD5 expression is associated with high TCR signal strength. 
140 
 
We found that Dhh has no influence on the expression of CD2 in thymocytes 
during their development in the thymus, as we observed no difference in the 
expression of CD2 or its MFI in thymocytes between the three genotypes of mice 
(p>0.05, n=6) (Figure 4.6).  
The influence of Dhh on CD3 expression in thymocytes seems to be restricted to 
the SP8 cells, as our data have shown that the percentage of DN, DP and SP4 cells 
expressing CD3 between the three genotypes was not statistically significant 
(p>0.05, n=6). The percentage of SP8 cells expressing CD3 in the Dhh-KO was 
found significantly lower than in the Dhh-WT (p≤0.05, n=6). In the Dhh-Het, the 
percentage of SP8 cells expressing CD3 was also significantly lower than in the 
Dhh-WT (p≤0.05, n=6). The reduced percentage of CD8SP that express high 
levels of cell surface CD3 is consistent with an increase in the CD8 ISP 
population. This ISP CD8 population might account for the increase in CD8SP 
cells observed in (Figure 4.5). To test if this is the case, we gated on CD3 high 
cells and examined CD4 and CD8 expression. We also observed no difference in 
CD3 MFI in thymocyte populations between the three genotypes (p>0.05, n=6) 
(Figure 4.7). In addition, we measured the expression of cell surface CD5 and its 
MFI. Our data showed no difference between the three genotypes of Dhh 
littermates (p>0.05, n=6) (Figure 4.8). 
 
4.2.7     Role of Dhh in thymocyte interactions 
In order to assess further the role of Dhh in influencing thymocyte development, 
thymocytes from Dhh-WT, Het and KO were analyzed for CD69 expression 
within the DN, DP, SP8 and SP4 cells (Figure 4.9). CD69 correlates with positive 
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selection (TCR ligation) in DP and SP populations, and is believed to be 
associated with cell death in the DN population. 
Our data indicated that Dhh negatively regulated the expression of CD69 during 
the DN and SP4 cells. The percentage of DN cells expressing CD69 in the Dhh-
KO was significantly higher than in the Dhh-WT (p≤0.05, n=4). The differences 
in the percentage of DP and SP8 cells expressing CD69 between the three 
genotypes of mice were not statistically significant (p>0.05, n=4). The percentage 
of SP4 cells expressing CD69 in the Dhh-KO was significantly higher compared 
to the Dhh-WT (p≤0.05, n=4) (Figure 4.9). The increase in CD69 expression in 
the DN compartment in the Dhh-KO is consistent with increased cell death, and 
suggests that like Shh (Shah et al. 2004), Dhh might provide a survival signal to 
these cells. The decrease in CD69 expression in the CD4SP population in the 
Dhh-KO is consistent with a reduction in positive selection to this lineage and 
increase in differentiation to the CD8SP lineage. 
Additionally we measured the expression of CD62L on DN cells and found that 
Dhh negatively regulates CD62L expression in DN cells. We found that the 
percentage of DN cells expressing CD62L in the Dhh-KO was significantly 
higher than in the Dhh-WT (p≤0.05, n=4) (Figure 4.9). Interestingly, CD62L has 
recently been shown to be regulated by the Hedgehog signalling pathway in CD4+ 
T cells from the spleen (Furmanski et al 2015). 
 
4.2.8     Role of Dhh in thymocyte maturation 
In order to assess the role of Dhh in influencing SP cell maturation and positive 
selection during thymocyte development, thymocytes from Dhh-WT, Het and KO 
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were analyzed for Qa2 and HSA expression within the DP, SP8 and SP4 cells. 
Expression of Qa2 and HSA allows dissection of the SP compartment by 
maturity: HSA
+
 to HSA
+
Qa2
+
, to Qa2
+
. 
The percentage of Qa2 in DP cells was significantly increased in the Dhh-KO 
compared to the Dhh-WT (p≤0.05, n=3), and significantly higher than in the Dhh-
Het (p≤0.05, n=3). The percentage of Qa2+HSA+ in DP cells was significantly 
higher in the Dhh-KO compared to the Dhh-WT (p≤0.05, n=3), and significantly 
higher than in the Dhh-Het (p≤0.05, n=3). The percentage of Qa2+HSA+  in SP8 
cells showed the opposite finding to the DP cells, where the percentage of 
Qa2
+
HSA
+
 in SP8 cells was significantly lower in the Dhh-KO compared to the 
Dhh-WT, and significantly lower than in the Dhh-Het (p≤0.05, n=3). The 
percentage of HSA in SP4 cells was significantly increased in the Dhh-KO 
compared to the Dhh-WT, indicating that the CD4SP compartment contains more 
immature cells in the Dhh-KO than in the WT. Interestingly, in the Dhh-Het we 
also observed a significant increase in the expression of HSA in SP4 cells 
compared to the Dhh-WT (p≤0.05, n=3) (Figure 4.10). 
 
4.2.9     Role of Dhh in spleen T cells  
In order to assess the influence of Dhh on spleen T cells in the periphery, 
splenocytes from Dhh-WT, Het and KO were analyzed for CD4 and CD8 cell 
surface expression and sub-grouped according to their expression into three main 
populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4). 
Our data show that Dhh regulates SP8 splenocytes, as the percentage of SP8 cells 
was significantly increased in the Dhh-KO compared to both the Dhh-WT and the 
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Dhh-Het ((p≤0.05, n=5), (p≤0.005, n=5)) respectively. In the Dhh-Het we 
observed no significant difference compared to the Dhh-WT (p>0.05, n=5). As for 
the DN and SP4 cells, Dhh seemed to have no significant influence between the 
three genotypes of Dhh littermates (Figure 4.11). The influence of Dhh-deficiency 
on the CD8
+
 T cell population in the spleen is consistent with its effect in the 
thymus. 
 
4.2.10    Influence of Dhh on expression of CD2, CD5 and CD3 in splenocytes 
In order to assess the potential influence of Dhh on TCR signal transduction in the 
periphery, splenocytes from Dhh-WT, Het and KO were analyzed for CD2, CD3, 
and CD5 expression within the CD4
−
CD8
−
, SP8 and SP4 cells.  Furthermore, we 
calculated the mean fluorescence intensity (MFI) for each of these molecules to 
estimate TCR signal strength. 
Our data show that Dhh has no influence on the expression of CD2 in splenocytes 
between the three genotypes of Dhh littermates. Similarly, we observed no 
significant difference in CD2 MFI in splenocytes between the three genotypes of 
mice (Figure 4.12). We also found that Dhh has no influence on the expression of 
CD3 in splenocytes, as our data did not show a significant difference between the 
three genotypes of Dhh littermates. Similarly, our data show no significant 
difference in CD3 MFI between the three genotypes of mice (Figure 4.13). In 
addition, our data have shown that Dhh has no influence on the expression of CD5 
in splenocytes as we observed no significant difference between the three 
genotypes of mice. Our data from CD5 MFI also showed no significant difference 
between the three genotypes of Dhh mice (Figure 4.14). 
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4.2.11    Further characterization of splenocyte population 
In order to assess further the role of Dhh in influencing T cells in the spleen, 
splenocytes from Dhh-WT, Het and KO were analyzed for CD69 and CD62L 
expression within the SP8 and SP4 cells. CD69 is an early activation marker, 
whereas CD62L cell surface expression is late on activation of naïve T cells. 
Our data showed that Dhh influenced the expression of CD69 in SP4 splenocytes 
as we observed a significant decrease in the percentage of CD69 in Dhh-Het 
compared to Dhh-WT, and Dhh-KO ((p≤0.05, n=4), (p≤0.05, n=4)) respectively 
(Figure 4.15). Additionally, we examined the expression of CD62L in splenocytes 
and our data showed that Dhh regulates its cell surface expression in SP4 cells. 
Our analysis showed that the percentage of CD62L in SP4 cells was significantly 
reduced in the Dhh-Het compared to the Dhh-WT (p≤0.05, n=4) (Figure 4.15). 
The reduction in cell surface CD62L expression in the Dhh-Het suggested that 
fewer cells were naïve in those mice. 
 
4.2.12     Influence of Dhh on lymph node T cells  
In order to assess the influence of Dhh on T cells in the lymph node, cells from 
Dhh-WT, Het and KO were analyzed for CD4 and CD8 cell surface expression 
and sub-grouped according to their expression into three main populations, the 
CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4). 
Our data have shown that Dhh influences T cells in the spleen. However, its 
regulation of SP4 cells in the lymph node is interesting as the difference we 
observed was between the Dhh-KO and Dhh-Het, suggesting a dual role of Dhh 
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on T cells in the lymph node. Our analysis show that the percentage of SP4 cells 
was significantly increased in the Dhh-KO compared to the Dhh-Het (p≤0.05, 
n=4). In regards to SP8 cells, we observed no difference between the three 
genotypes of Dhh littermates (p>0.05, n=4) (Figure 4.16). 
 
4.2.13    Influence of Dhh on expression of CD2, CD5 and CD3 in lymph node 
T cells 
In order to assess the potential influence of Dhh on TCR signal transduction in the 
lymph node, cells from Dhh WT, Het and KO were analyzed for CD2, CD3, and 
CD5 expression within the CD4
−
CD8
−
, SP8 and SP4 cells.  Furthermore, we have 
calculated the mean fluorescence intensity (MFI) for each of these molecules as 
intensity of CD5 staining correlates with TCR signal strength. 
Our data showed that Dhh regulates CD2 expression on SP8 cells, as our analysis 
show that the percentage SP8 cells expressing CD2 is significantly higher in the 
Dhh-KO compared to the Dhh-WT (p≤0.05, n=3), and higher compared to the 
Dhh-Het, but this increase was not significant (p>0.05, n=3). In the Dhh-Het, the 
percentage of SP8 cells expressing CD2 was higher compared to the Dhh-WT, but 
this difference was not significant (p>0.05, n=3). Additionally the percentage of 
CD2 in CD4
−
CD8
−
 and SP4 cells was not different between the three genotypes of 
Dhh mice (p>0.05, n=3). Similarly, CD2 MFI was not different between the three 
genotypes of Dhh mice (p>0.05, n=3) (Figure 4.17). 
In addition, we examined CD3 percentage in T cells in the lymph node, and our 
data show that Dhh has no influence on its expression. Our analysis show no 
difference in the expression of CD3 in T cells between the three genotypes of 
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mice (p>0.05, n=4). Similarly CD3 MFI was not different between the three Dhh 
littermates (p>0.05, n=4) (Figure 4.18). 
Furthermore, our data show that Dhh has no influence on the expression of CD5 
as well, as our analysis show no difference in the percentage of CD5 in T cells 
between the three genotypes of Dhh mice (p>0.05, n=4). Similarly, CD5 MFI was 
not different between the three genotypes of Dhh littermates (p>0.05, n=4) 
(Figure 4.19). 
 
4.2.14   Influence of Dhh on the phenotype of lymph node SP8 and SP4 cells  
In order to assess further the role of Dhh on phenotype of lymph node T cells, 
cells from Dhh-WT, Het and KO were analyzed for CD69 and CD62L expression 
within the SP8 and SP4 cells. 
Our data show that Dhh has no influence on the expression of CD69 in T cells, as 
our analysis show that the percentage of CD69 in T cells between the three 
genotypes of mice was not different (p>0.05, n=3) (Figure 4.20). Similarly, our 
data also show that Dhh has no influence on the expression of CD62L in T cells, 
as our analysis show no difference in the percentage of CD62L between the three 
genotypes of Dhh littermates (p>0.05, n=3) (Figure 4.20). 
 
4.2.15   Role of Dhh in T cell activation 
In order to assess the role of Dhh in T cell activation, splenocytes from Dhh-WT, 
Het and KO were stimulated with anti-CD3 and anti-CD28 antibodies with or 
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without the addition of IL-2 in culture, and analyzed by flow cytometry at 4 hours 
after treatment for cell surface expression of the early activation marker CD69, 
and at 18 hours after treatment for the expression of the later activation marker 
CD25. 
We examined the expression of CD69 on activation of SP4 and SP8 cells, and our 
data show that Dhh influence CD69 expression in activated SP8 and SP4 cells. 
Our analysis show that the percentage of CD69 in both, SP8 and SP4 cells was 
significantly higher in the Dhh-KO compared to the Dhh-WT ((p≤0.05, n=3), 
(p>0.005, n=3)) respectively. Additionally, in the Dhh-Het, the percentage of 
CD69 in activated SP4 was significantly lower than in the Dhh-KO (p≤0.05, n=3). 
With IL2 addition, we observed the same difference as our data show that the 
percentage CD69 in SP8 and SP4 cells was significantly higher in the Dhh-KO 
compared to the Dhh-WT ((p≤0.05, n=3), (p>0.05, n=3)) respectively (Figure 
4.21). 
Additionally, our data show that Dhh regulates the expression of CD25 in 
activated SP8 and SP4 cells, as our analysis show that the percentage of CD25 in 
both, SP8 and SP4 cells was significantly higher in the Dhh-KO compared to the 
Dhh-WT ((p≤0.05, n=3), (p≤0.005, n=3)) respectively. In the Dhh-Het, the 
percentage of CD25 in activated SP4 was significantly lower than in the Dhh-KO 
(p≤0.05, n=3). With IL2 addition, we observed the same difference as our data 
show that the percentage CD25 in SP8 cells was significantly higher in the Dhh-
KO compared to the Dhh-WT (p≤0.05, n=3). However, our data did not show 
difference in the expression of CD25 in activated SP4 cells with IL2 addition 
between the three genotypes of mice (p≤0.05, n=3) (Figure 4.21). 
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4.2.16   Intracellular cytokine staining of splenocytes  
In order to assess the role of Dhh in influencing production of cytokines by SP8 
and SP4 cells, splenocytes from Dhh-WT, Het and KO were cultured with PMA, 
ionomycin and bredfeldin-A for 4 hours followed by intracellular staining for 
IFNγ and IL-2 within the SP8 cells, and for IFNγ, IL-2, IL-4 and IL-17 for SP4 
cells.  
Our data show that Dhh influenced cytokine production in activated SP8 cells. 
Interestingly, the difference we observed was in the percentage of IL2 in SP8 cells 
from Dhh-Het. Our analysis show that the percentage of IL2 was significantly 
increased in the Dhh-Het compared to Dhh-WT (p≤0.05, n=3), and was higher 
compared to Dhh-KO, but this difference was not significant (p>0.05, n=3). In the 
Dhh-KO, the percentage of IL2 was higher compared to the Dhh-WT, but this 
difference was not significant (p>0.05, n=3). Additionally, we examined the 
percentage of IFNγ in activated SP8 cells and our data show no difference in its 
production in SP8 between the three genotypes of Dhh littermates (p>0.05, n=3) 
(Figure 4.16).  
Furthermore, we examined the production of IL2, IL4, IL17 in activated SP4 
cells, and our data show no difference between the three genotypes of Dhh mice 
(p>0.05, n=3). However, the percentage of IFNγ+ in SP4 cells was significantly 
lower in the Dhh-KO compared to the Dhh-WT (p≤0.05, n=3). In Dhh-Het, the 
percentage of IFNγ in SP4 was significantly lower compared to the Dhh-WT 
(p≤0.05, n=3) (Figure 4.22). 
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Figure 4.1 
 
Genotyping of Dhh littermates. The genotyping of Dhh littermates by PCR using genomic DNA 
extracted from ear biopsies. The presence of a wild type (Dhh-WT) allele generated a PCR product 
of 442bp, while the presence of a mutated allele (Dhh-KO) generated a PCR product of 110bp. 
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Figure 4.2 
 
Thymus and spleen of Dhh littermates. Freshly isolated (A) thymus and (B) spleen from 5-
weeks old Dhh-WT (left), Dhh-KO (middle) and Dhh-Het (right). 
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Figure 4.3 
 
Dhh thymus and spleen live cell counts. Thymocyte and splenocyte total counts from adult Dhh-
WT, Het and KO littermates. (A) Live thymocyte counts. (B) Live splenocyte counts. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. 
Thymocytes; (p=0.06 (WT/Het), 0.04 (WT/KO), 0.01 (Het/KO), n=6). Splenocytes; (p=0.01 
(WT/Het), 0.02 (WT/KO), 0.2 (Het/KO), n=6). *represents p≤0.05.  
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Figure 4.4 
Major DN subsets in Dhh littermates. DN thymocyte populations from adult Dhh-WT, Het and 
KO littermates. Thymocytes were stained for anti-CD44, anti-CD25, anti-CD8, anti-CD4, anti-
CD3, anti-B220 and CD4
+
CD8
+
CD3
+
B220
+
 cells were excluded. Cells were analyzed by flow 
cytometry. (A) Representative dot plot of thymocyte DN populations. (B) Representative bar 
graph of DN1, DN2, DN3 and DN4 percentages. Figures are representative of 6 independent sets 
of Dhh littermates. Mean and standard deviation of each population are given. Bars represent mean 
± standard deviations. DN1 (p= 0.08 (WT/Het), 0.04 (WT/KO), 0.0007 (Het/KO), n=6). DN2 (p= 
0.3 (WT/Het), 0.7 (WT/KO), 0.2 (Het/KO), n=6). DN3 (p= 0.04 (WT/Het), 0.6 (WT/KO), 0.03 
(Het/KO), n=6). DN4 (p= 0.2 (WT/Het), 0.1 (WT/KO), 0.01 (Het/KO), n=6). *represents p≤0.05, 
**represents p≤0.005.  
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Figure 4.5 
Major thymocyte populations in Dhh littermates. Thymocyte populations from adult Dhh-WT, 
Het and KO littermates. Thymocytes were stained for anti-CD8 and anti-CD4, and analyzed by 
flow cytometry. (A) Representative dot plot of thymocyte populations. (B) Representative bar 
graph of DN, DP, SP8 and SP4 percentages. Figures are representative of 6 independent sets of 
Dhh littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. DN (p= 0.5 (WT/Het), 0.2 (WT/KO), 0.1 (Het/KO), n=6). DP (p= 0.1 
(WT/Het), 0.01 (WT/KO), 0.3 (Het/KO), n=6). SP8 (p= 0.07 (WT/Het), 0.05 (WT/KO), 0.4 
(Het/KO), n=6). SP4 (p= 0.5 (WT/Het), 0.4 (WT/KO), 0.7 (Het/KO), n=6). *represents p≤0.05.  
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Figure 4.6 
Expression of CD2 in Dhh thymocytes. Expression of CD2 in thymocytes from adult Dhh-WT, 
Het and KO littermates. Thymocytes were stained for anti-CD2, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD2 expression in DN, DP, SP8 and 
SP4 cells. (B) Representative bar graph of CD2 percentages in DN, DP, SP8 and SP4 cells. (C) 
Representative scatter plot of CD2 MFI in DN, DP, SP8 and SP4 cells. Figures are representative 
of 6 independent sets of Dhh littermates. Mean and standard deviation of each population are 
given. Bars represent mean ± standard deviations. CD2 percentages; DN (p= 0.4 (WT/Het), 0.6 
(WT/KO), 0.7 (Het/KO), n=6). DP (p= 0.7 (WT/Het), 0.4 (WT/KO), 0.1 (Het/KO), n=6). SP8 (p= 
0.5 (WT/Het), 0.6 (WT/KO), 0.2 (Het/KO), n=6). SP4 (p= 0.7 (WT/Het), 0.2 (WT/KO), 0.3 
(Het/KO), n=6). CD2 MFI; DN (p= 0.07 (WT/Het), 0.08 (WT/KO), 0.06 (Het/KO), n=6). DP (p= 
0.09 (WT/Het), 0.1 (WT/KO), 0.07 (Het/KO), n=6). SP8 (p= 0.08 (WT/Het), 0.09 (WT/KO), 0.06 
(Het/KO), n=6). SP4 (p= 0.3 (WT/Het), 0.08 (WT/KO), 0.4 (Het/KO), n=6).  
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Figure 4.7 
Expression of CD3 in Dhh thymocytes. Expression of CD3 in thymocytes from adult Dhh-WT, 
Het and KO littermates. Thymocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD3 expression in DN, DP, SP8 and 
SP4 cells. (B) Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are representative 
of 6 independent sets of Dhh littermates. Mean and standard deviation of each population are 
given. Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.7 (WT/Het), 0.4 
(WT/KO), 0.6 (Het/KO), n=6). DP (p= 0.9 (WT/Het), 0.5 (WT/KO), 0.6 (Het/KO), n=6). SP8 (p= 
0.02 (WT/Het), 0.01 (WT/KO), 0.3 (Het/KO), n=6). SP4 (p= 0.6 (WT/Het), 0.3 (WT/KO), 0.7 
(Het/KO), n=6). CD3 MFI; DN (p= 0.9 (WT/Het), 0.08 (WT/KO), 0.3 (Het/KO), n=6). DP (p= 
0.2 (WT/Het), 0.1 (WT/KO), 0.6 (Het/KO), n=6). SP8 (p= 0.4 (WT/Het), 0.7 (WT/KO), 0.2 
(Het/KO), n=6). SP4 (p= 0.1 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=6). *represents p≤0.05. 
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Figure 4.8 
Expression of CD5 in Dhh thymocytes. Expression of CD5 in thymocytes from adult Dhh-WT, 
Het and KO littermates. Thymocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD5 expression in DN, DP, SP8 and 
SP4 cells. (B) Representative bar graph of CD5 percentages in DN, DP, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are representative 
of 6 independent sets of Dhh littermates. Mean and standard deviation of each population are 
given. Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.6 (WT/Het), 0.1 
(WT/KO), 0.2 (Het/KO), n=6). DP (p= 0.5 (WT/Het), 0.2 (WT/KO), 0.4 (Het/KO), n=6). SP8 (p= 
0.6 (WT/Het), 0.3 (WT/KO), 0.5 (Het/KO), n=6). SP4 (p= 0.6 (WT/Het), 0.3 (WT/KO), 0.6 
(Het/KO), n=6). CD5 MFI; DN (p= 0.06 (WT/Het), 0.8 (WT/KO), 0.9 (Het/KO), n=6). DP (p= 
0.1 (WT/Het), 0.3 (WT/KO), 0.3 (Het/KO), n=6). SP8 (p= 0.4 (WT/Het), 0.07 (WT/KO), 0.08 
(Het/KO), n=6). SP4 (p= 0.2 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=6).  
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Figure 4.9 
Expression of CD69 and CD62L in Dhh thymocytes. Expression of CD69 and CD62L in 
thymocytes from adult Dhh-WT, Het and KO littermates. Thymocytes were stained for anti-CD69, 
anti-CD62L, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
histogram of CD69 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of 
CD69 percentages in DN, DP, SP8 and SP4 cells. (C) Representative histogram of CD62L 
expression in DN cells. (D) Representative bar graph of CD62L percentage in DN cells. Figures 
are representative of 4 and 6 independent sets of Dhh littermates respectively. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD69 
percentages; DN (p= 0.3 (WT/Het), 0.02 (WT/KO), 0.3 (Het/KO), n=4). DP (p= 0.4 (WT/Het), 
0.2 (WT/KO), 0.5 (Het/KO), n=4). SP8 (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=6). SP4 
(p= 0.1 (WT/Het), 0.03 (WT/KO), 0.2 (Het/KO), n=6). CD62L percentage; DN (p= 0.01 
(WT/Het), 0.01 (WT/KO), 0.05 (Het/KO), n=4). *represents p≤0.05. 
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Figure 4.10 
Expression of Qa2 and HSA in Dhh thymocytes. Expression of Qa2 and HSA in DP, SP8 and 
SP4 cells from adult Dhh-WT, Het and KO littermates. Thymocytes were stained for anti-Qa2, 
anti-CD24, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative dot plot 
of Qa2 and HSA expression in DP, SP8 and SP4 cells. (B) Representative bar graph of Qa2 and 
HSA percentages in DP, SP8 and SP4 cells. Figures are representative of 3 independent sets of 
Dhh littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. Qa2 percentages; DP (p= 0.06 (WT/Het), 0.04 (WT/KO), 0.04 (Het/KO), 
n=3). SP8 (p= 0.5 (WT/Het), 0.3 (WT/KO), 0.7 (Het/KO), n=3). SP4 (p= 0.3 (WT/Het), 0.5 
(WT/KO), 0.6 (Het/KO), n=3). Qa2
+
HSA
+
 percentages; DP (p= 0.02 (WT/Het), 0.01 (WT/KO), 
0.03 (Het/KO), n=3). SP8 (p= 0.05 (WT/Het), 0.03 (WT/KO), 0.05 (Het/KO), n=3). SP4 (p= 0.3 
(WT/Het), 0.6 (WT/KO), 0.1 (Het/KO), n=3). HSA percentages; DP (p= 0.5 (WT/Het), 0.8 
(WT/KO), 0.6 (Het/KO), n=3). SP8 (p= 0.4 (WT/Het), 0.2 (WT/KO), 0.5 (Het/KO), n=3). SP4 (p= 
0.006 (WT/Het), 0.01 (WT/KO), 0.07 (Het/KO), n=3). *represents p≤0.05. 
 
 
159 
 
 
Figure 4.11 
Major splenocyte, T cell populations in Dhh littermates. Splenocyte, T cell populations from 
adult Dhh-WT, Het and KO littermates. Cells were stained for anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative dot plot of splenocyte populations. (B) 
Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 5 
independent sets of Dhh littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD4
−
CD8
−
 (p= 0.6 (WT/Het), 0.2 (WT/KO), 0.5 
(Het/KO), n=5). SP8 (p= 0.2 (WT/Het), 0.01 (WT/KO), 0.003 (Het/KO), n=5). SP4 (p= 0.8 
(WT/Het), 0.6 (WT/KO), 0.3 (Het/KO), n=5). *represents p≤0.05, **represents p≤0.005. 
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Figure 4.12 
Expression of CD2 in Dhh splenocytes. Splenocytes from adult Dhh-WT, Het and KO 
littermates. Splenocytes were stained for anti-CD2, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD2 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD2 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD2 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD2 percentages; CD4
−
CD8
−
 
(p= 0.06 (WT/Het), 0.7 (WT/KO), 0.06 (Het/KO), n=3). SP8 (p= 0.7 (WT/Het), 0.5 (WT/KO), 0.6 
(Het/KO), n=3). SP4 (p= 0.5 (WT/Het), 0.4 (WT/KO), 0.9 (Het/KO), n=3). CD2 MFI; 
CD4
−
CD8
−
 (p= 0.7 (WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), n=3). SP8 (p= 0.5 (WT/Het), 0.7 
(WT/KO), 0.8 (Het/KO), n=3). SP4 (p= 0.5 (WT/Het), 0.6 (WT/KO), 0.9 (Het/KO), n=3).  
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Figure 4.13 
Expression of CD3 in Dhh splenocytes. Splenocytes from adult Dhh-WT, Het and KO 
littermates. Splenocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD3 percentages; CD4
−
CD8
−
 
(p= 0.8 (WT/Het), 0.5 (WT/KO), 0.7 (Het/KO), n=3). SP8 (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.3 
(Het/KO), n=3). SP4 (p= 0.5 (WT/Het), 0.2 (WT/KO), 0.5 (Het/KO), n=3). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.3 (WT/Het), 0.7 (WT/KO), 0.7 (Het/KO), n=3). SP8 (p= 0.3 (WT/Het), 0.4 
(WT/KO), 0.8 (Het/KO), n=3). SP4 (p= 0.4 (WT/Het), 0.7 (WT/KO), 0.09 (Het/KO), n=3).  
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Figure 4.14 
Expression of CD5 in Dhh splenocytes. Splenocytes from adult Dhh-WT, Het and KO 
littermates. Splenocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD5 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD5 percentages; CD4
−
CD8
−
 
(p= 0.6 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=3). SP8 (p= 0.7 (WT/Het), 0.4 (WT/KO), 0.6 
(Het/KO), n=3). SP4 (p= 0.2 (WT/Het), 0.4 (WT/KO), 0.1 (Het/KO), n=3). CD5 MFI; 
CD4
−
CD8
−
 (p= 0.5 (WT/Het), 0.8 (WT/KO), 0.2 (Het/KO), n=3). SP8 (p= 0.07 (WT/Het), 0.3 
(WT/KO), 0.1 (Het/KO), n=3). SP4 (p= 0.3 (WT/Het), 0.7 (WT/KO), 0.4 (Het/KO), n=3). 
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Figure 4.15 
Expression of CD69 and CD62L in Dhh splenocytes. Expression of CD69 and CD62L in 
splenocytes from adult Dhh-WT, Het and KO littermates. Splenocytes were stained for anti-CD69,  
anti-CD62L, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
histogram of CD69 expression in SP8 and SP4 cells. (B) Representative bar graph of CD69 
percentages in SP8 and SP4 cells. (C) Representative histogram of CD62L expression in SP8 and 
SP4 cells. (D) Representative bar graph of CD62L percentages in SP8 and SP4 cells. Figures are 
representative of 4 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD69 percentages; SP8 (p= 0.1 
(WT/Het), 0.5 (WT/KO), 0.07 (Het/KO), n=4). SP4 (p= 0.01 (WT/Het), 0.4 (WT/KO), 0.03 
(Het/KO), n=4). CD62L percentages; SP8 (p= 0.3 (WT/Het), 0.5 (WT/KO), 0.7 (Het/KO), n=4). 
SP4 (p= 0.04 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=4). *represents p≤0.05 
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Figure 4.16 
Major T cell populations in Dhh littermates. Percentage of lymph node T cell populations from 
adult Dhh-WT, Het and KO littermates. Cells were stained for anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative dot plot of T cell populations. (B) Representative 
bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 4 independent 
sets of Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. SP8 (p= 0.8 (WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), n=4). SP4 (p= 
0.1 (WT/Het), 0.2 (WT/KO), 0.01 (Het/KO), n=4). *represents p≤0.05.  
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Figure 4.17 
Expression of CD2 in Dhh lymph node T cells. Expression of CD2 in lymph node T cells from 
adult Dhh-WT, Het and KO littermates. Cells were stained for anti-CD2, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. (A) Representative histogram of CD2 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD2 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD2 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD2 percentages; CD4
−
CD8
−
 
(p= 0.7 (WT/Het), 0.4 (WT/KO), 0.7 (Het/KO), n=3). SP8 (p= 0.1 (WT/Het), 0.04 (WT/KO), 0.4 
(Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 0.1 (WT/KO), 0.3 (Het/KO), n=3). CD2 MFI; 
CD4
−
CD8
−
 (p= 0.2 (WT/Het), 0.6 (WT/KO), 0.7 (Het/KO), n=3). SP8 (p= 0.07 (WT/Het), 0.4 
(WT/KO), 0.8 (Het/KO), n=3). SP4 (p= 0.09 (WT/Het), 0.3 (WT/KO), 0.6 (Het/KO), n=3). 
*represents p≤0.05. 
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Figure 4.18 
Expression of CD3 in Dhh lymph node T cells. Expression of CD3 in lymph node T cells from 
adult Dhh-WT, Het and KO littermates. Cells were stained for anti-CD3, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD3 percentages; CD4
−
CD8
−
 
(p= 0.8 (WT/Het), 0.7 (WT/KO), 0.8 (Het/KO), n=3). SP8 (p= 0.5 (WT/Het), 0.3 (WT/KO), 0.7 
(Het/KO), n=3). SP4 (p= 0.5 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=3). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.4 (WT/Het), 0.3 (WT/KO), 0.4 (Het/KO), n=3). SP8 (p= 0.4 (WT/Het), 0.8 
(WT/KO), 0.2 (Het/KO), n=3). SP4 (p= 0.7 (WT/Het), 0.5 (WT/KO), 0.8 (Het/KO), n=3).  
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Figure 4.19 
Expression of CD5 in Dhh lymph node T cells. Expression of CD5 in lymph node T cells from 
adult Dhh-WT, Het and KO littermates. Cells were stained for anti-CD5, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. (A) Representative histogram of CD5 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD5 percentages; CD4
−
CD8
−
 
(p= 0.1 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.9 (WT/Het), 0.5 (WT/KO), 0.09 
(Het/KO), n=3). SP4 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=3). CD5 MFI; 
CD4
−
CD8
−
 (p= 0.4 (WT/Het), 0.07 (WT/KO), 0.4 (Het/KO), n=3). SP8 (p= 0.3 (WT/Het), 0.6 
(WT/KO), 0.08 (Het/KO), n=3). SP4 (p= 0.2 (WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), n=3).  
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Figure 4.20 
Expression of CD69 and CD62L in Dhh lymph node T cells. Expression of CD69 and CD62L 
in lymph node T cells from adult Dhh-WT, Het and KO littermates. Cells were stained for anti-
CD69, anti-CD62L, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
histogram of CD69 expression SP8 and SP4 cells. (B) Representative bar graph of CD69 
percentages in SP8 and SP4 cells. (C) Representative histogram of CD62L expression in SP8 and 
SP4 cells. (D) Representative bar graph of CD62L percentages in SP8 and SP4 cells. Figures are 
representative of 3 independent sets of Dhh littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD69 percentages; SP8 (p= 0.7 
(WT/Het), 0.5 (WT/KO), 0.3 (Het/KO), n=3). SP4 (p= 0.1 (WT/Het), 0.6 (WT/KO), 0.3 (Het/KO), 
n=3). CD62L percentages; SP8 (p= 0.7 (WT/Het), 0.4 (WT/KO), 0.7 (Het/KO), n=3). SP4 (p= 
0.7 (WT/Het), 0.5 (WT/KO), 0.6 (Het/KO), n=3). 
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Figure 4.21 
Spleen SP8 and SP4 early and late activation. Expression of the early activation marker CD69 
and the late activation marker CD25 in spleen SP8 and SP4 cells from adult Dhh-WT, Het and KO 
littermates. Three culturing conditions were applied, unstimulated cells (condition Unstim), cells 
stimulated with anti-CD3 and anti-CD28 (condition Stim), and cells stimulated with anti-CD3, 
anti-CD28 in addition to IL-2 (condition Stim+IL2). Cells were stained for anti-CD69, anti-CD25, 
anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative bar graph of CD69 
percentages in SP8 cells. (B) Representative bar graph of CD69 percentages in SP4 cells.  (C) 
Representative bar graph of CD25 percentages in SP8 cells. (D) Representative bar graph of CD25 
percentages in SP4 cells. Figures are representative of 5 independent sets of Dhh littermates. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD69 percentages; (Unstim); SP8 (p= 0.06 (WT/Het), 0.09 (WT/KO), 0.07 (Het/KO), n=5). SP4 
(p= 0.08 (WT/Het), 0.06 (WT/KO), 0.1 (Het/KO), n=5). CD69; percentages (Stim); SP8 (p= 0.07 
(WT/Het), 0.04 (WT/KO), 0.06 (Het/KO), n=5). SP4 (p= 0.06 (WT/Het), 0.001 (WT/KO), 0.02 
(Het/KO), n=5). CD69 percentages; (Stim+IL2); SP8 (p= 0.06 (WT/Het), 0.05 (WT/KO), 0.07 
(Het/KO), n=5). SP4 (p= 0.08 (WT/Het), 0.04 (WT/KO), 0.08 (Het/KO), n=5). CD25 
percentages; (Unstim) SP8 (p= 0.09 (WT/Het), 0.1 (WT/KO), 0.2 (Het/KO), n=5). SP4 (p= 0.2 
(WT/Het), 0.09 (WT/KO), 0.1 (Het/KO), n=5). CD25 percentages; (Stim); SP8 (p= 0.08 
(WT/Het), 0.05 (WT/KO), 0.07 (Het/KO), n=5). SP4 (p= 0.09 (WT/Het), 0.003 (WT/KO), 0.04 
(Het/KO), n=5). CD25 percentages; (Stim+IL2); SP8 (p= 0.09 (WT/Het), 0.05 (WT/KO), 0.08 
(Het/KO), n=5). SP4 (p= 0.07 (WT/Het), 0.06 (WT/KO), 0.06 (Het/KO), n=5). *represents 
p≤0.05, **represents p≤0.005.  
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Figure 4.22 
 
Intracellular cytokine staining of spleen SP8 and SP4 cells. Intracellular staining of cytokines 
(IFNγ and IL-2) in spleen SP8 cells, and Intracellular staining of cytokines (IFNγ, IL-2, IL-4 and 
IL-17) in spleen SP4 cells from adult Dhh-WT, Het and KO littermates. Cells were cultured with 
PMA, ionomycin and brefeldin-A for 4 hours followed by intracellular staining with anti-IFNγ, 
anti-IL-2, anti-IL-4, anti-IL-17, anti-CD8 and anti-CD4. Cells were analyzed by flow cytometry. 
(A) Representative histogram of IFNγ and IL-2 expression in SP8 cells. (B) Representative bar 
graph of IFNγ and IL-2 percentages in SP8 cells. (C) Representative histogram of IFNγ, IL-2, IL-4 
and IL-17 expression in SP4 cells. (D) Representative bar graph of IFNγ, IL-2, IL-4 and IL-17 
percentages in SP4 cells. Figures are representative of 3 independent sets of Dhh littermates. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
SP8; IFNγ (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.2 (Het/KO), n=3). SP8; IL-2 (p= 0.04 (WT/Het), 
0.09 (WT/KO), 0.07 (Het/KO), n=3). SP4; IFNγ (p= 0.04 (WT/Het), 0.02 (WT/KO), 0.08 
(Het/KO), n=3). SP4; IL-2 (p= 0.4 (WT/Het), 0.2 (WT/KO), 0.1 (Het/KO), n=3). SP4; IL-4 (p= 
0.1 (WT/Het), 0.09 (WT/KO), 0.6 (Het/KO), n=3). SP4; IL-17 (p= 0.5 (WT/Het), 0.1 (WT/KO), 
0.2 (Het/KO), n=3). *represents p≤0.05. 
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4.3       Discussion 
Our data shown that Dhh acts as a negative regulator of T cells during their 
development and differentiation in the thymus and peripheral lymphoid organs. 
Analysis of Dhh-WT, Dhh-Het and Dhh-KO mice shows that in the absence of 
Dhh, the number of thymocytes and splenocytes is increased. However, the 
phenotype of Dhh-Het is unusual in that, although thymocyte and spleonocyte 
numbers were increased in Dhh-KO, we observed a decrease in thymocyte 
numbers and a greater increase in splenocyte numbers in Dhh-Het, suggesting a 
novel role for Dhh in thymocyte and splenocyte homeostasis.  
The influence of Dhh on developing thymocytes starts early in the DN stages, as 
our data have shown a decrease in the DN1 and DN3 cells, indicating a positive 
regulatory role of Dhh during early thymocyte differentiation in the thymus, and 
during pre-TCR complex formation and β selection. Surprisingly, Dhh-Het shows 
an opposite effect to Dhh-KO, with an increase in the number of thymocytes 
during the DN1 and DN3 stages. 
Dhh also influenced thymocyte populations, as our data have shown that Dhh 
decreased the number of DP thymocytes and increased the numbers SP8 
thymocytes, suggesting that Dhh positively regulate thymocyte development 
during the formation of the TCR complex, and negatively regulate positive 
selection of SP8 cells. Furthermore, our data have also shown that Dhh influence 
TCR associated CD3 molecule on SP8 cells, as partial expression of Dhh 
decreased the expression of CD3, whereas the complete knockout showed even a 
greater decrease in CD3 expression. This finding explains the increase of SP8 
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thymocytes in Dhh-KO which can come as a result of a weak TCR signal 
transduction defecting negative selection of SP8 thymocytes.  
We have also examined the expression of CD69 during thymocyte development 
and our results shows that CD69 expression is increased in both the DN and SP4 
cells, suggesting a negative role of Dhh on CD69 expression in the thymus. CD69 
expression in immature thymocytes is believed to be associated with cell death. 
Additionally, CD69 expression on SP4 correlates with positive selection, our 
finding thus suggests that Dhh reduced positive selection of SP4 cells. The 
maturation marker CD62L has also been examined and our data shows that Dhh 
has a dual function as it negatively regulate CD62L expression in DN, and 
positively regulate the expression of CD62L in SP4 cells in a dose dependent 
manner.  
During the transition from the DP so the SP, thymocytes undergo maturation 
through a series of developmental stages before becoming functionally mature 
cells that exit the thymus. We analyzed the cell surface expression of HSA and 
Qa2 to measure the maturation status on DP and SP thymocytes. We found that 
Dhh partially arrested SP4 cell development.  
Dhh also continues to regulate mature T cell populations in the spleen, as our data 
have shown that SP8 splenocytes were increased in Dhh-KO and decreased in the 
Dhh-Het, suggesting a dual influence of Dhh as a negative regulator and positive 
regulator of mature SP8 cells. On the contrary, in the lymph node Dhh seems to 
negatively regulate SP4 cells as our data have shown that SP4 cells were 
increased in Dhh-KO, suggesting a differential role of Dhh in the periphery 
between the spleen and lymph node. We have undertaken T cell characterization 
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in the periphery and our data have shown that Dhh positively regulate the 
expression of CD62L in SP8 and SP4 splenocytes. Furthermore, we tested 
whether Dhh-KO mice display changes in splenocytes differentiation and 
activation, and our data have shown that Dhh negatively regulate the activation of 
SP splenocytes. Interestingly, IL2 production in SP activated cells were increased 
in Dhh-Het. 
A negative regulatory role for Dhh has been previously described (Lau et al. 
2012). In this case, analysis of Dhh mutant mice showed that Dhh negatively 
regulates multiple stages of erythrocyte differentiation, indicating a negative role 
of Dhh, we have also found that Dhh is a negative regulator of T cell production. 
The unusual role of Hh proteins between the heterozygous and knockout has also 
been reported in Ihh (Outram et al. 2009). In this study, foetal Ihh+/− thymi had 
increased thymocyte numbers relative to WT, indicating that Ihh also negatively 
regulates thymocyte development, and our data have shown a similar finding with 
Dhh as a negative regulator of thymocytes and splenocytes during their 
development and in the periphery. 
A possible explanation might be that Hh signalling provides both a positive and a 
negative regulatory signal in order to maintain homeostatic control of developing 
thymocytes and T cells in the periphery. The three Hh proteins are highly 
conserved in vertebrates and act in the same tissues with overlapping or redundant 
functions (Kumar et al. 1996). Although Hh overlapping functions have not been 
well studied, studies on T cell development have shown that the three Hh proteins 
may have overlapping activities and differential functions in order to regulate T 
cell differentiation and homeostasis (Crompton et al. 2007; Outram et al. 2009). 
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4.4       Conclusion 
In this chapter, using Dhh-WT, Dhh-Het and Dhh-KO mice models, our data have 
shown that Dhh play a negative role in T cell production in the thymus as well as 
in the peripheral lymphoid organs. Moreover, analysis of the thymocyte 
development showed that Dhh is involved in regulation of thymocytes from the 
early stages of development in the DN stage through selection and maturation. In 
addition to the thymus, this regulatory role of Dhh continues in the periphery 
through altering the proportions of SP T cells and their activation 
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Chapter 5  
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Chapter Five: Role of Hh signalling in T cell repertoire selection 
 
5.1       Introduction  
5.1.1    Role of Hh proteins in T cell repertoire selection 
During their development within the thymus, T cells undergo critical 
developmental selection to select those cells amongst the immature thymocytes 
that express T cell receptor (TCR) restricted to and tolerant of self-peptides 
presented by the major histocompatibilty complexes (MHC-I, MHC-II). The 
result of this crucial selection is a repertoire of mature T cells that does not attack 
or destroy host tissues but reacts efficiently against the unlimited range of foreign 
antigens. 
Shh has been shown to modulate TCR signal strength during the later stage of T 
cell development, attenuating TCR repertoire selection and influencing T cell 
SP4/SP8 lineage commitment (Hager-Theodorides et al. 2009; Rowbotham, 
Hager-Theodorides, Cebecauer, et al. 2007; Drakopoulou et al. 2010; 
Rowbotham, Hager-Theodorides, Furmanski, et al. 2007; Lowrey et al. 2002; 
Stewart et al. 2002; Furmanski et al. 2012; Furmanski et al. 2013). These findings 
implicate Hh signalling in regulating the events controlling TCR signal strength 
and selection within the thymus. 
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5.1.2    Chapter objectives 
The purpose of this chapter is to investigate the role of Hh signalling in T cell 
selection and lineage choice. To investigate this role, I have generated two mouse 
models; (1) HY-TCR
+
/Dhh-WT, HY-TCR
+
/Dhh-Het and HY-TCR
+
/Dhh-KO, 
generated from crossing HY-TCR
+
 transgenic Dhh
+/− 
female mouse with Dhh
+/−
 
male mouse. (2) Marilyn-TCR
+
/Lck-Gli2ΔC2− and Marilyn-TCR+/Lck-Gli2ΔC2+ 
transgenic mice, generated from back-crossing Marilyn-TCR
+
 Rag2
−/−
 mouse with 
Lck-Gli2ΔC2+ mouse (in which Hh-dependent transcription is inhibited). 
Expression of the Lck-Gli2ΔC2 has been previously shown to increase positive 
and negative selection of a class-I-restricted TCR in the thymus (Furmanski et al. 
2012) and to increase TCR activation of peripheral T cells (Rowbotham et al. 
2008), by increasing TCR signalling (Furmanski et al. 2015). A direct observation 
of T cell populations in the thymus, spleen and lymph node will test the 
hypothesis that Hh signalling plays a role in T cell selection and lineage choice. 
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5.2       Results 
5.2.1    Genotyping HY-Dhh and Marilyn-Gli2ΔC2 littermates 
Two strains of mice were generated; the first is HY-Dhh, created by back-crossing 
HY-TCR transgenic male mice with Dhh
+/−
 mice. The result of this crossing 
resulted in three genotypes of mice, the first bearing MHC class-I restricted TCR 
in addition to the normal complete Dhh expression gene (HY-Dhh
+/+
). The second 
bearing MHC class-I restricted TCR in addition to the Dhh mutated gene on both 
alleles (HY-Dhh
−/−
). The third bearing MHC class-I restricted TCR with a partial 
expression of Dhh (one normal allele and one mutated allele) (HY-Dhh
+/−
). 
The HY-Dhh littermates were genotyped for HY-TCR transgene, Dhh-WT and 
Dhh mutant alleles. PCR analysis using genomic DNA from ear biopsies was 
performed in order to identify the genotype of HY-Dhh littermates, using three 
sets of primers specific for HY-TCR transgene, Dhh-WT and mutant alleles. 
According to this strategy, HY-TCR transgene should generate a PCR product of 
300bp, Dhh-WT allele should generate a PCR product of 442bp, while Dhh-
mutant alleles should generate a PCR product of 110bp. 
HY-Dhh mutants were identified according to the PCR results. Mice with PCR a 
product positive for HY-TCR transgene and Dhh-WT gene and negative for the 
Dhh-mutant gene were genotyped as (HY-Dhh
+/+
). Mice with a PCR product 
positive for HY-TCR transgene and negative for Dhh-WT gene and positive for 
the Dhh-mutant gene were genotyped as (HY-Dhh
−/−
). Mice with a PCR product 
positive for HY-TCR transgene and both, Dhh-WT and Dhh-mutant genes were 
genotyped as (HY-Dhh
+/−
) (Figure 5.1). 
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The second strain used is Marilyn-Gli2ΔC2 created from back-crossing Marilyn-
TCR transgenic Rag2
−/−
 male mice with Gli2ΔC2 transgenic mice. The result of 
this crossing resulted in two genotypes of mice, the first bearing MHC class-II 
restricted TCR without the addition of the Lck-driven Gli2ΔC2 transgene 
(Marilyn-Gli2ΔC2−). The second bearing MHC class-II restricted TCR in addition 
to the Lck-driven Gli2ΔC2 transgene (Marilyn-Gli2ΔC2+). 
The Marilyn-Gli2ΔC2 littermates were genotyped for Marilyn-TCR, Gli2ΔC2 
transgenes and Rag-2 wild-type and mutated genes. PCR analysis using genomic 
DNA from ear biopsies was performed in order to identify the genotype of 
Marilyn- Gli2ΔC2 littermates. PCR analysis of the two littermates was performed 
using four sets of primers specific for Marilyn-TCR, Gli2ΔC2 transgenes and 
Rag-2 WT and mutated genes. According to this strategy, Marilyn-TCR transgene 
should generate a PCR product of 350bp, Gli2ΔC2 transgene should generate a 
PCR product of 850bp, Rag-2 WT gene should generate a PCR product of 973bp, 
Rag-2 mutant gene should generate a PCR product of 1107bp. 
Marilyn-Gli2ΔC2 mutants were identified according to the PCR results. Mice 
with PCR a product positive for Marilyn-TCR and Gli2ΔC2 transgenes were 
genotyped as (Marilyn-Gli2ΔC2+). Mice with a PCR product positive for Marilyn-
TCR transgene and negative for Gli2ΔC2 transgene were genotyped as (Marilyn-
Gli2ΔC2−) (Figure 5.1). 
 
5.2.2    Differences in organ size of HY-Dhh and Marilyn-Gli2ΔC2 
Thymus and spleen of HY-Dhh and Marilyn-Gli2ΔC2 mutant mice were 
compared following anatomical dissection in order to assess their difference and 
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similarities. All observations were carried out between littermates. Size 
comparison was carried out by visual comparison and measuring the horizontal 
width and vertical length of extracted organs. Thymus and spleen extracted from 
HY-Dhh-mutants appeared normal compared to the original genotype of HY-TCR 
transgenic mice and Dhh mice. Thymus extracted from the male Marilyn-
Gli2ΔC2+ was reduced in size as in the Marilyn-TCR transgenic genotype of 
mice. The spleen of male Marilyn-Gli2ΔC2+ appeared reduced in size compared 
to Marilyn-Gli2ΔC2− (Figure 5.2).  
 
5.2.3    Thymocytes and splenocytes in HY-Dhh littermates 
Following anatomical extraction of the thymus and spleen from HY-Dhh 
littermates, the thymocytes and splenocytes were collected for analysis. In regards 
to live cell counts in the thymus, we observed no significant difference in the 
mean cell numbers between the three genotypes of HY-Dhh male and female 
littermates ((p>0.05, n=5), (p>0.05, n=7)) respectively. Similarly in regards to live 
cell counts in the spleen, we observed no significant difference between the three 
genotypes of HY-Dhh male and female littermates ((p>0.05, n=5), (p>0.05, n=7) 
respectively (Figure 5.3)). 
 
5.2.4    Role of Dhh in thymocyte development during Selection in HY-TCR 
mice 
In order to assess the role of Dhh in thymocyte development and differentiation 
during thymocyte selection, thymocytes from HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO male and female mice were analyzed for T3.7, CD8 and CD4 cell 
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surface expression. According to T3.7 expression, cells were sub-grouped into 
two main populations, HY-TCR positive cells (T3.7
+
) and HY-TCR negative cells 
(T3.7
−
). Within the T3.7 positive and negative compartments, cells were sub-
grouped according to the cell surface expression of CD8 and CD4 into four main 
populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
+ 
(DP), CD8
+
CD4
−
 (SP8) and 
CD8
−
CD4
+ 
(SP4).  
Our data indicated that Dhh influences thymocyte selection as we observed 
significant differences in deletion of self-reactive T cells in Dhh-Het and Dhh-KO 
in male mice. In female mice, positive selection of SP cells was also increased, 
indicating a negative role of Dhh during selection. Interestingly, heterozygous 
expression of Dhh seems to act differently from the complete expression of Dhh 
as our data from Dhh-Het display opposing phenotype to Dhh-KO. 
In male Dhh-HY mice, within the T3.7 positive cells, our data show that the 
percentage of DN and DP cells was not different between the three genotypes of 
mice (p>0.05, n=5). The percentage of SP8 cells was higher in the HY/Dhh-KO 
than in the HY/Dhh-WT, but this difference was not statistically different (p>0.05, 
n=5), and was significantly higher than in the HY/Dhh-Het (p≤0.05, n=5). The 
percentage of SP4 cells was significantly lower in the HY/Dhh-Het than in the 
HY/Dhh-WT and HY/Dhh-KO ((p≤0.05, n=5), (p≤0.05, n=5)) respectively 
(Figure 5.4).  
In male mice within the T3.7 negative cells, the percentage of DN cells was not 
different between the three genotypes of mice (p>0.05, n=5). In addition, the 
percentage of DP cells was higher in the HY/Dhh-KO compared to the HY/Dhh-
WT, but this difference was not statistically different (p>0.05, n=5), and 
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significantly higher than in the HY/Dhh-Het (p≤0.05, n=5). The percentage of 
SP8 cells was lower in the HY/Dhh-KO compared to the HY/Dhh-WT, but this 
difference was not significant (p>0.05, n=5), and significantly higher than in the 
HY/Dhh-Het (p≤0.05, n=5). Furthermore, the percentage of SP4 cells was 
decreased in the HY/Dhh-KO compared to the HY/Dhh-WT, but this difference 
was not significantly different (p>0.05, n=5), and significantly higher than in the 
HY/Dhh-Het (p≤0.05, n=5). Interestingly, in the HY/Dhh-Het, the percentage of 
SP4 was significantly lower than in the HY/Dhh-WT (Figure 5.5). 
In female mice within the T3.7 positive cells, the percentage of DN cells between 
the three genotypes of mice was not significantly different (p>0.05, n=4). The 
percentage of DP and SP4 cells was significantly higher in the HY/Dhh-KO than 
in the HY/Dhh-WT ((p≤0.05, n=4), (p≤0.05, n=4)) respectively. In HY/Dhh-Het, 
the percentage of DP cells was significantly higher in the HY/Dhh-WT (p≤0.05, 
n=4). Furthermore, the percentage of SP8 cells was significantly higher in the 
HY/Dhh-Het than in the HY/Dhh-WT (p≤0.05, n=4) (Figure 5.6). 
Within the T3.7 negative cells, the percentage of DN, DP and SP8 cells between 
the three genotypes of mice was not statistically different (p>0.05, n=4). The 
percentage of SP4 cells in the HY/Dhh-KO was significantly higher compared to 
the HY/Dhh-Het (p≤0.05, n=4) (Figure 5.7).  
 
5.2.5    Influence of Dhh on expression of CD3 and CD5 in HY-TCR 
thymocytes 
In order to assess the potential role of Dhh in regulating differentiation and TCR 
signal transduction of HY-TCR thymocytes during development and selection, we 
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analyzed the cell surface expression of molecules associated with TCR signalling 
(CD3 and CD5) within the T3.7
+
 cells for DN, DP, SP8 and SP4 cells in HY/Dhh-
WT, HY/Dhh-Het and HY/Dhh-KO. Furthermore we have compared the mean 
fluorescence intensity (MFI) of staining for these molecules, as high CD5 
expression is associated with high TCR signal strength. 
Our data show that Dhh has no influence on the expression of CD3 and CD5 and 
their MFI in male thymocytes during selection (p>0.05, n=5) (Figure 5.8) and 
(Figure 5.9). Similarly, in female mice, the percentage of CD3 and CD5 and their 
MFI were not different between the three genotypes of mice (p>0.05, n=4) (Figure 
5.10) and (Figure 5.11). 
 
5.2.6     Role of Dhh in thymocyte interactions during development and 
selection in HY-TCR mice 
As CD69 expression correlates with TCR repertoire selection in thymocytes, 
thymocytes from HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO were analyzed for 
CD69 expression within the T3.7
+ 
cells for DN, DP, SP8 and SP4 cells.  
Our data show that Dhh has no influence on the expression of CD69 in 
thymocytes during selection. We found no significant differences in CD69 
expression between the three genotypes of HY-Dhh in male or female mice 
(Figure 5.12). 
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5.2.7     Role of Dhh in thymocyte maturation during development and 
selection in HY-TCR mice 
In order to assess the role of Dhh in influencing cell maturation during single 
positive thymocyte development and selection, thymocytes from HY/Dhh-WT, 
HY/Dhh-Het and HY/Dhh-KO were analyzed for Qa2 and HSA expression within 
the T3.7
+
 cells for  DP, SP8 and SP4 cells. Our data show that Dhh influence T 
cell maturation during selection. Interestingly, heterozygous expression of Dhh 
seems to display a different phenotype from Dhh-WT. 
In male mice, the percentage of DP, SP8 and SP4 cells expressing Qa2 between 
the three genotypes of mice was not statistically significant (p>0.05, n=3). The 
percentage of DP and SP4 cells expressing HSA between the three genotypes of 
mice was not statistically significant (p>0.05, n=3). The percentage of SP8 cells 
expressing HSA was significantly lower than in the HY/Dhh-Het compared to the 
HY/Dhh-WT (p≤0.05, n=3) (Figure 5.13).  
In female mice, the percentage of DP and SP8 cells expressing Qa2 between the 
three genotypes of mice was not statistically significant (p>0.05, n=3). The 
percentage of Qa2 in SP4 cells was significantly higher in the HY/Dhh-KO 
compared to the HY/Dhh-WT (p≤0.05, n=3). The percentage of DP cells 
expressing HSA was significantly lower in the HY/Dhh-KO compared to the 
HY/Dhh-WT (p≤0.05, n=3). However, the percentage of SP8 and SP4 cells 
expressing HSA between the three genotypes of HY-Dhh was not statistically 
different (p>0.05, n=3) (Figure 5.14).  
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5.2.8     Role of Dhh in spleen T cells in HY-TCR mice  
In order to assess the role of Dhh in spleen T cells in the periphery in HY-TCR 
mice, splenocytes from HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO were 
analyzed for T3.7, CD8 and CD4 cell surface expression. According to T3.7 
expression, cells were sub-grouped into two main populations, HY-TCR positive 
cells (T3.7
+
) and HY-TCR negative cells (T3.7
−
). Within the T3.7 positive and 
negative compartments, cells were sub-grouped according to the cell surface 
expression of CD8 and CD4 into three main populations, the CD8
−
CD4
−
 (DN), 
CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+
 (SP4). 
Our data from male mice within the T3.7 positive cells showed an interesting 
finding as the majority of cells were SP8 cells, possibly having escaped deletion 
during their development in the thymus and eventually migrated to the spleen. 
However, we found no significance differences in these cells between the three 
genotypes of mice. 
Our analysis of male splenocytes within the T3.7 positive cells show that the 
percentage of CD8
−
CD4
−
, SP8 and SP4 cells between the three genotypes of HY-
Dhh was not statistically different (p>0.05, n=4). Similarly within the T3.7 
negative cells, the percentage of CD8
−
CD4
−
, SP8 and SP4 cells between the three 
genotypes of HY-Dhh was not statistically different (p>0.05, n=4) (Figure 5.15) 
and (Figure 5.16). 
In female mice, within the T3.7 positive cells, the percentage of CD8
−
CD4
−
, SP8 
and SP4 cells between the three genotypes of HY-Dhh was not statistically 
different (p>0.05, n=3). Similarly, within the T3.7 negative cells, the percentage 
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of CD8
−
CD4
−
, SP8 and SP4 cells between the three genotypes of HY-Dhh was 
not different (p>0.05, n=3) (Figure 5.17) and (Figure 5.18). 
 
5.2.9    Influence of Dhh on expression of CD3 and CD5 in HY-TCR 
splenocytes 
In order to assess the potential influence of Dhh in TCR signal transduction in the 
periphery in HY-TCR mice, splenocytes from HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO were analyzed for CD3, and CD5 expression within the T3.7
+
 cells 
for CD4
−
CD8
−
, SP8 and SP4 cells. Furthermore, we have calculated the mean 
fluorescence intensity (MFI) for each of these molecules to estimate TCR signal 
strength. 
Our data suggests that Dhh influenced CD3 expression in SP4 cells, as our data 
show that the expression of CD3 is reduced in these cells. Our analysis of male 
splenocytes within the T3.7 positive cells, showed that the percentage of 
CD4
−
CD8
−
 and SP8 cells expressing CD3 between the three genotypes of HY-
Dhh was not different (p>0.05, n=4). However, the percentage of SP4 cells 
expressing CD3 in the HY/Dhh-KO was significantly lower than in the HY/Dhh-
WT (p≤0.05, n=4), and lower than in the HY/Dhh-Het, but this difference was not 
significant (p>0.05, n=4). CD3 MFI in CD4
−
CD8
−
, DP and SP8 cells between the 
three genotypes was not statistically different (p>0.05, n=4) (Figure 5.19). 
Additionally, we observed no significant difference in the expression of CD5 or 
its MFI between the three genotypes of mice (p>0.05, n=4) (Figure 5.20). 
Furthermore, our analysis of female splenocytes within the T3.7 positive and 
negative cells, show no difference in the expression of CD3 or CD5 and their MFI 
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in splenocytes between the three genotypes of mice (p>0.05, n=3) (Figure 5.21) 
and (Figure 5.22). 
 
5.2.10    Role of Dhh in splenocyte interactions 
In order to assess the role of Dhh in influencing cell-cell interaction in HY-TCR 
mice, splenocytes from HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO were 
analyzed for CD69 expression within the T3.7
+
 cells for CD4
−
CD8
−
, SP8 and SP4 
cells. 
Our data show that Dhh does not alter the expression of CD69 in splenocytes in 
HY-TCR mice, as our analysis of male and female splenocytes show no 
difference in the expression of CD69 between the three genotypes of mice 
((p>0.05, n=4), (p>0.05, n=3)) respectively (Figure 5.23). 
 
5.2.11     Role of Dhh in lymph node T cells of HY-TCR mice  
In order to assess the role of Dhh in lymph node T cells of HY-TCR mice, cells 
from HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO were analyzed for T3.7, CD8 
and CD4 cell surface expression. According to T3.7 expression, cells were sub-
grouped into two main populations, HY-TCR positive cells (T3.7
+
) and HY-TCR 
negative cells (T3.7
−
). Within the T3.7 positive and negative compartments, cells 
were sub-grouped according to the cell surface expression of CD8 and CD4 into 
three main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+
 
(SP4). 
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Our data show that Dhh influenced the proportions of SP8 in male mice within the 
T3.7 positive cells, suggesting its role in mature T cells. Furthermore, our data 
from female mice within the T3.7 negative cells show that Dhh influenced the 
proportion of SP4 cells, however, this influence seems to be from partial 
expression of Dhh.   
Our analysis of male T cells within the T3.7 positive cells, show that the 
percentage of CD8
−
CD4
−
 and SP4 cells between the three genotypes of mice was 
not different (p>0.05, n=3). The percentage of SP8 cells in the HY/Dhh-KO was 
significantly higher than in the HY/Dhh-WT (p≤0.05, n=3) (Figure 5.24). Within 
the T3.7 negative cells, the percentage of CD8
−
CD4
−
, SP8 and SP4 cells between 
the three genotypes of mice was not different (p>0.05, n=3) (Figure 5.25). 
Furthermore, our data from female T cells, within the T3.7 positive cells, shows 
that the percentage of CD8
−
CD4
−
and SP8 cells between the three genotypes of 
mice was not different (p>0.05, n=3). The percentage of SP4 cells in HY/Dhh-Het 
was significantly higher compared to the HY/Dhh-WT (p≤0.05, n=3) (Figure 
5.26). Similarly, within the T3.7 negative cells, the percentage of CD8
−
CD4
−
 and 
SP8 cells between the three genotypes of mice was not different (p>0.05, n=3). 
However, the percentage of SP4 cells in the HY/Dhh-Het was significantly 
increased compared to the HY/Dhh-WT (p≤0.05, n=3) (Figure 5.27).  
 
5.2.12    Influence of Dhh on expression of CD3 and CD5 in HY-TCR in the 
lymph node 
In order to assess the potential influence of Dhh in TCR signal transduction in the 
lymph node of HY-TCR mice, cells from HY/Dhh-WT, HY/Dhh-Het and 
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HY/Dhh-KO were analyzed for CD3, and CD5 expression within the T3.7
+
 cells 
for CD4
−
CD8
−
, SP8 and SP4 cells. Furthermore, we have calculated the mean 
fluorescence intensity (MFI) for each of these molecules to estimate TCR signal 
strength. 
Our data from male and female mice show that Dhh does not influence the 
expression of CD3 and CD5. Our analysis of male T cells within the T3.7 positive 
cells, show that the percentage of CD4
−
CD8
−
, SP8 and SP4 cells expressing CD3, 
CD5 and their MFI between the three genotypes of mice was not statistically 
different (p>0.05, n=3) (Figure 5.28) and (Figure 5.29). Furthermore,  our analysis 
of female T cells within the T3.7 positive cells, show that the percentage of 
CD4
−
CD8
−
, SP8 and SP4 cells expressing CD3, CD5 and their MFI between the 
three genotypes of mice was not statistically different (p>0.05, n=3) (Figure 5.30) 
and (Figure 5.31). 
 
5.2.13    Thymocytes and splenocytes in Marilyn-Gli2ΔC2 Rag2−/− littermates 
Following anatomical extraction of the thymus and spleen from Marilyn-Gli2ΔC2 
Rag2
−/−
 littermates, the thymocytes and splenocytes were collected for analysis. In 
regards to live cell counts in the thymus, we observed no significant difference in 
the mean cell numbers between the two genotypes of Marilyn-Gli2ΔC2 male and 
female littermates ((p>0.05, n=5), (p>0.05, n=5)) respectively. In regards to live 
cell counts in the spleen, we observed a significant decrease in the male Marilyn-
Gli2ΔC2+ compared to the Marilyn-Gli2ΔC2− (p≤0.005, n=4). Furthermore, in the 
female spleen, we observed no significant difference between the two genotypes 
of Marilyn-Gli2ΔC2 littermates (p>0.05, n=6) (Figure 5.32). 
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5.2.14     Role of Hh signalling in thymocyte development during Selection in 
Marilyn-Gli2ΔC2 Rag2−/− mice 
In order to assess the role of Hh signalling in thymocytes during selection, 
thymocytes from Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ male and female 
mice were analyzed for Vβ6, CD8 and CD4 cell surface expression. Marilyn-TCR 
uses Vβ6, and according to the cell surface expression of CD4 and CD8, cells 
were sub-grouped into four main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
+ 
(DP), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4).  
Our data from male and female mice shows that Hh signalling influences selection 
of thymocytes during their development in the thymus. Our data from male mice, 
showed that the percentage of DN cells was significantly lower in the Marilyn-
Gli2ΔC2+ than in the Marilyn-Gli2ΔC2− (p≤0.05, n=7). In addition, the 
percentage of DP cells was significantly higher in the Marilyn-Gli2ΔC2+ than in 
the Marilyn-Gli2ΔC2− (p≤0.05, n=7). The percentage of SP8 cells was decreased 
in the Marilyn-Gli2ΔC2+ compared to Marilyn-Gli2ΔC2−, but this difference was 
not significant (p>0.05, n=7). The percentage of SP4 cells was significantly higher 
in the Marilyn-Gli2ΔC2+ than in the Marilyn-Gli2ΔC2− (p≤0.005, n=7) (Figure 
5.33).  
Furthermore, in female mice, we observed no difference in the percentage of DN 
cells between the two genotypes of mice (p>0.05, n=6). On the contrary, the 
percentage of DP was significantly reduced in the Marilyn-Gli2ΔC2+ than in the 
Marilyn-Gli2ΔC2− (p≤0.05, n=6). The percentage of SP8 and SP4 cells was 
significantly increased in the Marilyn-Gli2ΔC2+ compared to Marilyn-Gli2ΔC2− 
((p≤0.005, n=6), (p≤0.05, n=6)) respectively (Figure 5.34). These data indicate 
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that inhibition of Hh-dependent transcription by expression of the Gli2ΔC2 
transgene increased positive selection of the transgenic TCR, and differentiation 
from DP to SP cells. 
 
5.2.15    Influence of Hh signalling on the expression of CD3 and CD5 in 
Marilyn-Gli2ΔC2 thymocytes 
In order to assess the potential role of Hh signalling in regulating differentiation 
and TCR signal transduction of Marilyn-Gli2ΔC2 thymocytes during development 
and selection, we analyzed the cell surface expression of molecules associated 
with TCR signalling (CD3 and CD5) in DN, DP, SP8 and SP4 cells in Marilyn-
Gli2ΔC2− and Marilyn-Gli2ΔC2+. Furthermore we have compared the mean 
fluorescence intensity (MFI) of staining for these molecules, as high CD5 
expression is associated with high TCR signal strength. 
Our analysis of male and female show that inhibition of Hh signalling influenced 
the expression of CD3 and CD5 and their MFI. Our analysis of male mice show 
that the percentage of DN, DP and SP8 cells expressing CD3 in the Marilyn-
Gli2ΔC2+ between the two genotypes of mice was not significant (p>0.05, n=6). 
The percentage of SP4 cells expressing CD3 in the Marilyn-Gli2ΔC2+ was 
significantly higher than in the Marilyn-Gli2ΔC2− (p≤0.05, n=6).  Similarly, CD3 
MFI in DN, DP and SP8 between the two genotypes of Marilyn-Gli2ΔC2 was 
statistically not significant (p>0.05, n=6). CD3 MFI in SP4 cells was significantly 
lower in the Marilyn-Gli2ΔC2+ compared to the Marilyn-Gli2ΔC2− (p≤0.05, n=6) 
(Figure 6.35). 
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Furthermore, we examine the expression of CD5 and our analysis show that the 
percentage of DN, DP and SP8 cells between the two genotypes of mice was not 
different (p>0.05, n=6). The percentage of SP4 cells expressing high levels of 
CD5 in the Marilyn-Gli2ΔC2+ was significantly higher than in the Marilyn-
Gli2ΔC2− (p≤0.005, n=6).  Differences in CD5 MFI in DN, DP and SP8 between 
the two genotypes of mice
 
was statistically not significant (p>0.05, n=6), however, 
CD5 MFI in SP4 cells was significantly higher in the Marilyn-Gli2ΔC2+ 
compared to the Marilyn-Gli2ΔC2− (Figure 5.36). As these mice are Rage−/−, the 
influence on CD5 expression cannot be due to changes in the repertoire of TCRs 
that have been selected. 
In female mice, the percentage of DN, DP, SP8 and SP4 cells expressing CD3 
between the two genotypes of Marilyn-Gli2ΔC2 was statistically not significant 
(p>0.05, n=4). Similarly, CD3 MFI in DN, DP, SP8 and SP4 between the two 
genotypes of mice
 
was not different (p>0.05, n=4) (Figure 5.37). 
In regards to CD5 expression, our data show that the percentage of DN cells 
expressing CD5 in the Marilyn-Gli2ΔC2+ was not significantly higher than in the 
Marilyn-Gli2ΔC2− (p>0.05, n=4). The percentage of SP4 cells expressing CD5 in 
the Marilyn-Gli2ΔC2+ was not significantly higher than in the Marilyn-Gli2ΔC2− 
(p>0.005, n=4). CD5 MFI in DN and DP cells between the two genotypes of mice 
was not significantly different (p>0.05, n=4).  CD5 MFI in SP8 and SP4 cells in 
the Marilyn-Gli2ΔC2+ was not significantly higher than in the Marilyn-Gli2ΔC2− 
(p>0.05, n=4) (Figure 5.38). 
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5.2.16     Role of Hh signalling in thymocyte interactions during development 
and selection in Marilyn-Gli2ΔC2 mice 
As CD69 expression correlates with positive selection in thymocytes, cells from 
Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ were analyzed for CD69 expression 
within the DN, DP, SP8 and SP4 cells.  
Our Data show that Hh signalling does not influence the expression of CD69 in 
developing thymocytes during selection, as our analysis of male and female 
thymocytes show that the percentage of DN, DP, SP8 and SP4 cells expressing 
CD69 between the two genotypes of mice was not statistically different ((p>0.05, 
n=3), (p>0.05, n=3)) respectively (Figure 5.39). 
 
5.2.17     Influence of Hh signalling on Gata-3 expression in thymocytes 
during development and selection in Marilyn-Gli2ΔC2 mice 
In order to assess the influence of Hh signalling in the expression of Gata-3 during 
thymocyte development and selection, thymocytes from Marilyn-Gli2ΔC2− and 
Marilyn-Gli2ΔC2+ were analyzed for Gata-3 expression within the DN, DP, SP8 
and SP4 cells. Gata-3 is involved in CD4 lineage commitment and stronger TCR 
signals are believed to lead to higher expression of Gata-3. 
Our data show that Hh signalling influences the expression of Gata3 in developing 
thymocytes. Our analysis of male thymocytes show that the percentage of DN, DP 
and SP8 cells expressing Gata-3 between the two genotypes of mice was not 
different (p>0.05, n=3). Furthermore, the percentage of SP4 cells expressing Gata-
3 in the Marilyn-Gli2ΔC2+ was significantly lower compared to the Marilyn-
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Gli2ΔC2− (p≤0.05, n=3). In female mice, the percentage of DN, DP, SP8 and SP4 
cells expressing Gata-3 between the two genotypes of mice was not statistically 
different (p>0.05, n=3) (Figure 5.40). 
 
5.2.18   Impact of inhibition of Hh signalling on Foxp3 expression in 
thymocytes during development and selection in Marilyn-Gli2ΔC2 mice 
In order to assess the influence of inhibition of Hh signalling on the expression of 
Foxp3 during thymocyte development and selection, thymocytes from Marilyn-
Gli2ΔC2− and Marilyn-Gli2ΔC2+ were analyzed for Foxp3 expression within the 
SP4 cells. Foxp3 is the transcription factor believed to be master regulator of the 
Treg lineage. 
Our data show that inhibition of Hh signalling influenced the expression of Foxp3 
as our analysis of male mice show that the percentage of SP4 cells expressing 
Foxp3 in the Marilyn-Gli2ΔC2+ was significantly higher compared to the 
Marilyn-Gli2ΔC2− (p≤0.005, n=3) (Figure 5.41). However, in female mice, the 
percentage of SP4 cells expressing Foxp3 between the two genotypes of mice
 
was 
not significantly different (p>0.05, n=3) (Figure 5.41). These increases in Foxp3 
expression in the male thymus suggests that inhibition of Hh mediated 
transcription has increased TCR signal strength in the male to a level where cells 
which would not have been positively selected are now selected using a very 
strong signal ( in presence of cognate male peptide). 
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5.2.19     Role of Hh signalling in thymocyte maturation during development 
and selection in Marilyn-Gli2ΔC2 mice 
In order to assess the role of Hh signalling in influencing cell maturation of the 
single positive populations during thymocyte development and selection, 
thymocytes from Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ were analyzed for 
Qa2 and HSA expression in DP, SP8 and SP4 cells. 
Our data show that Hh signalling influence maturation of SP cells during their 
development and maturation within the thymus. Our analysis of male thymocytes 
show that the differences in the percentage of DP, SP8 and SP4 cells expressing 
Qa2 or both, Qa2 and HSA, between the two genotypes of mice was not 
statistically significant (p>0.05, n=3). On the contrary, the percentage of DP cells 
expressing HSA was significantly higher in the Marilyn-Gli2ΔC2+ compared to 
the Marilyn-Gli2ΔC2− (p≤0.05, n=3). Furthermore, the percentage of SP4 cells 
expressing HSA was significantly higher in the Marilyn-Gli2ΔC2+ compared to 
the Marilyn-Gli2ΔC2− (p≤0.05, n=3) (Figure 5.42). This is consistent with more 
immature cells getting selected to the CD4 lineage. 
In female mice, the percentage of DP and SP4 cells expressing Qa2 and, both Qa2 
and HSA between the two genotypes of mice was not statistically significant 
(p>0.05, n=3). The percentage of SP8 cells expressing Qa2 was significantly 
lower in the Marilyn-Gli2ΔC2+ compared to the Marilyn-Gli2ΔC2− (p≤0.005, 
n=3). On the contrary, the percentage of SP8 cells expressing both Qa2 and HSA 
was significantly higher in the Marilyn-Gli2ΔC2+ compared to the Marilyn-
Gli2ΔC2− (p≤0.05, n=3). Furthermore, the percentage of DP, SP8 and SP4 cells 
expressing HSA was significantly higher in the Marilyn-Gli2ΔC2+ compared to 
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the Marilyn-Gli2ΔC2− ((p≤0.005, n=3), (p≤0.05, n=3), (p≤0.005, n=3)) 
respectively (Figure 5.43). These data are consistent with increased positive 
selection of more immature cells. 
 
5.2.20     Influence of Hh signalling in spleen T cells of Marilyn-Gli2ΔC2 mice  
In order to assess the influence of Hh signalling in spleen T cells in the periphery 
in Marilyn-Gli2ΔC2 mice, splenocytes from Marilyn-Gli2ΔC2− and Marilyn-
Gli2ΔC2− were analyzed for CD8 and CD4 cell surface expression. According to 
the cell surface expression of CD4 and CD8, cells were sub-grouped into three 
main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4).  
Our data show that inhibition of Hh signalling also influenced the T cells in the 
periphery, as our analysis of male mice show that the percentage of SP4 cells in 
the Marilyn-Gli2ΔC2+ was significantly higher compared to the Marilyn-
Gli2ΔC2− (p≤0.0005, n=5). On the contrary, the percentage of SP8 and 
CD8
−
CD4
−
 cells between the two genotypes of mice
 
was not different (p>0.05, 
n=5) and (p>0.05, n=5) respectively (Figure 5.44).  
Furthermore, in female mice, the percentage of CD8
−
CD4
−
 and SP4 cells between 
the two genotypes of Marilyn-Gli2ΔC2 was not statistically different (p>0.05, 
n=3). However, the percentage of SP8 cells in the Marilyn-Gli2ΔC2+ was 
significantly higher compared to the Marilyn-Gli2ΔC2− (p≤0.0005, n=3) (Figure 
5.45). Thus, expression of the Gli2ΔC2 transgene allowed the MHC class-II-
restricted TCR to be selected to the CD8 lineage, as CD8 T cells were found in 
the periphery of the female mice.  
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6.2.21    Influence of Hh signalling on the expression of CD3 and CD5 in 
Marilyn-Gli2ΔC2 splenocytes 
In order to assess the potential role of Hh signalling in regulating differentiation 
and TCR signal transduction of Marilyn-Gli2ΔC2 splenocytes, we analyzed the 
cell surface expression of molecules associated with TCR signalling (CD3 and 
CD5) in DN, DP, SP8 and SP4 cells in Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+. 
Furthermore we compared the mean fluorescence intensity (MFI) of staining for 
these molecules, as high CD5 expression is associated with high TCR signal 
strength. 
Our data show that inhibition of Hh signalling influenced the expression of CD3 
and CD5 and their MFI in splenocytes. Our analysis of male splenocytes showed 
that the percentage of CD8
−
CD4
−
 and SP8 cells expressing CD3 between the two 
genotypes of mice
 
was not significant (p>0.05, n=5). However, the percentage of 
SP4 cells expressing high levels of CD3 in the Marilyn-Gli2ΔC2+ was 
significantly higher than in the Marilyn-Gli2ΔC2− (p≤0.05, n=5).  Differences in 
CD3 MFI in CD8
−
CD4
−
 and SP8 cells between the two genotypes of mice
 
were 
not significant (p>0.05, n=5). On the contrary, CD3 MFI in SP4 cells was 
significantly higher than in the Marilyn-Gli2ΔC2− (p≤0.005, n=5) (Figure 5.46). 
In addition, we examined the expression of CD5, and our data show that the 
percentage of CD8
−
CD4
−
 and SP4 cells expressing high levels of CD5 between 
the two genotypes of mice
 
was not significant (p>0.05, n=5). However, the 
percentage of SP8 cells expressing CD5 in the Marilyn-Gli2ΔC2+ was 
significantly higher than in the Marilyn-Gli2ΔC2− (p≤0.05, n=5). Although CD5 
MFI in CD8
−
CD4
−
 and SP8 cells between the two genotypes of mice
 
was not 
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statistically significant (p>0.05, n=5). CD5 MFI in SP4 cells was significantly 
higher than in the Marilyn-Gli2ΔC2− (p≤0.005, n=5) (Figure 5.47). Cell surface 
CD5 expression is believed to correlate with TCR signal strength, and so the 
increase in MFI is consistent with an increase in TCR signal strength. 
In female mice, the percentage of CD8
−
CD4
−
 and SP4 cells expressing CD3 
between the two genotypes of mice
 
was statistically not significant (p>0.05, n=3). 
However, the percentage of SP8 cells expressing high levels of CD3 in the 
Marilyn-Gli2ΔC2+ was significantly higher than in the Marilyn-Gli2ΔC2− 
(p≤0.05, n=4).  In regards to CD3 MFI, our data show no statistical difference in 
CD8
−
CD4
−
 and SP4 cells between the two genotypes of mice
 
(p>0.05, n=4). 
However, CD3 MFI in SP8 cells was significantly higher in Marilyn-Gli2ΔC2+ 
than in the Marilyn-Gli2ΔC2− (p≤0.005, n=4) (Figure 5.48). 
In addition, we examined the expression of CD5 in female mice, and our data 
showed no difference in the percentage of CD5 expressing CD8
−
CD4
−
 cells 
between the two genotypes of mice
 
(p>0.05, n=4). On the contrary, the percentage 
of SP8 cells expressing high levels of cell surface CD5 in the Marilyn-Gli2ΔC2+ 
was significantly higher than in the Marilyn-Gli2ΔC2− (p≤0.005, n=4). The 
percentage of SP4 cells expressing CD5 in the Marilyn-Gli2ΔC2+ was 
significantly lower than in the Marilyn-Gli2ΔC2− (p≤0.05, n=4). Furthermore, 
CD5 MFI in CD8
−
CD4
−
 between the two genotypes of Marilyn-Gli2ΔC2 was not 
significant (p>0.05, n=4). However, CD5 MFI in SP8 and SP4 cells was 
significantly higher than in the Marilyn-Gli2ΔC2− ((p≤0.005, n=4), (p≤0.05, n=4)) 
(Figure 5.49). 
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5.2.22     Influence of Hh signalling in splenocyte activation in Marilyn-
Gli2ΔC2 mice 
In order to assess the influence of Hh signalling on splenocyte activation ex-vivo, 
splenocytes from Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ were analyzed for 
CD69 expression within the CD8
−
CD4
−
, SP8 and SP4 cells. 
Our data show that inhibition of Hh signalling influenced the expression of CD69, 
as our data from male mice show that the percentage of SP4 cells expressing 
CD69 in the Marilyn-Gli2ΔC2+ was significantly higher compared to the Marilyn-
Gli2ΔC2− (p≤0.05, n=3). On the contrary, the percentage of CD8−CD4−, and SP8 
cells expressing CD69 between the two genotypes of mice was not statistically 
different (p>0.05, n=3) (Figure 5.50).  
In female mice, the percentage of CD8
−
CD4
−
 and SP8 cells expressing CD69 
between the two genotypes of mice was not different (p>0.05, n=3). However, the 
percentage of SP4 cells expressing CD69 was significantly lower in the Marilyn-
Gli2ΔC2+ compared to the Marilyn-Gli2ΔC2−  (p≤0.05, n=3) (Figure 5.50).  
 
5.2.23     Influence of Hh signalling in lymph node T cells of Marilyn-Gli2ΔC2 
mice  
In order to assess the effect of inhibition of Hh signalling in lymph node T cells in 
Marilyn-Gli2ΔC2 mice, cells from Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2− 
were analyzed for CD8 and CD4 cell surface expression.  
As in the spleen, our analysis of male mice show that the percentage of SP8 and 
SP4 cells in the Marilyn-Gli2ΔC2+ was significantly higher compared to the 
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Marilyn-Gli2ΔC2− (p≤0.005, n=5) (Figure 5.51). However, in female mice, the 
differences percentage of CD8
−
CD4
−
, SP8 and SP4 cells between the two 
genotypes of mice was not statistically different (p>0.05, n=3) (Figure 5.52). 
 
5.2.24    Influence of inhibition of Hh signalling on the expression of CD3 and 
CD5 in the lymph node of Marilyn-Gli2ΔC2  
We also analyzed the cell surface expression of molecules associated with TCR 
signalling (CD3 and CD5) in DN, DP, SP8 and SP4 cells in Marilyn-Gli2ΔC2− 
and Marilyn-Gli2ΔC2+. Furthermore we compared the mean fluorescence 
intensity (MFI) of staining for these molecules, as high CD5 expression is 
associated with high TCR signal strength. 
Our data from the lymph node confirm our previous finding in the spleen, as we 
found that inhibition of Hh signalling influenced the expression of CD3 and CD5 
in mature cells. Our analysis of male mice show that the percentage of SP8 and 
SP4 cells expressing high levels of CD3 in the Marilyn-Gli2ΔC2+ was 
significantly higher than in the Marilyn-Gli2ΔC2− ((p≤0.005, n=5), (p≤0.05, n=4)) 
respectively. However, CD3 MFI in CD8
−
CD4
−
, SP8 and SP4 cells between the 
two genotypes of mice was not different (p>0.05, n=4) (Figure 5.53). 
In regards to CD5 expression, our data show that the percentage of SP8 and SP4 
cells expressing high levels of CD5 in the Marilyn-Gli2ΔC2+ was significantly 
higher than in the Marilyn-Gli2ΔC2− ((p≤0.05, n=4), (p≤0.005, n=4)) respectively. 
However, CD5 MFI in SP8 cells in the Marilyn-Gli2ΔC2+ was significantly lower 
than in the Marilyn-Gli2ΔC2− (p≤0.05, n=4). Similarly, CD5 MFI in SP4 cells in 
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the Marilyn-Gli2ΔC2+ was significantly higher than in the Marilyn-Gli2ΔC2− 
(p≤0.005, n=4) (Figure 5.54). 
In female mice, our data show that the percentage of CD8
−
CD4
−
, SP8 and SP4 
cells expressing CD3 and CD5 between the two genotypes of mice
 
was 
statistically not significant (p>0.05, n=3). Similarly, CD3 and CD5 MFI in 
CD8
−
CD4
−
, SP8 and SP4 cells between the two genotypes of mice
 
was not 
different (p>0.05, n=3) (Figure 5.55) and (Figure 5.56). 
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Figure 5.1 
 
Genotyping of HY-Dhh and Marilyn-Gli2ΔC2 littermates. (A) The genotyping of HY-Dhh 
littermates by PCR using genomic DNA extracted from ear biopsies. The presence of the HY-TCR 
transgene generated a PCR product of 300bp, the presence of Dhh-wild type (Dhh-WT) allele 
generated a PCR product of 442bp, while the presence of the Dhh-mutated allele (Dhh-KO) 
generated a PCR product of 110bp. (B) The genotyping of Marilyn-Gli2ΔC2 littermates by PCR 
using genomic DNA extracted from ear biopsies. The presence of the Marilyn-TCR transgene 
generated a PCR product of 350bp, the presence of the Gli2ΔC2 transgene generated a PCR 
product of 850bp, the presence of the Rag-2 WT gene generated a PCR product of 973bp, while 
the presence of Rag2 mutated gene generated a PCR product of 1107bp. 
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Figure 5.2 
 
Thymus and spleen of male Marilyn-Gli2ΔC2 littermates. Freshly isolated thymus and spleen 
of 5-weeks old male Marilyn-Gli2ΔC2 littermates. (A) Thymus from male Marilyn-Gli2ΔC2+ 
(left), male Marilyn-Gli2ΔC2− (middle) and a female Marilyn-TCR+ (right) (the female Marilyn-
TCR
+
 thymus was used in this figure for size comparison with male thymus). (B) Spleen from 
male Marilyn-Gli2ΔC2+ (left) and male Marilyn-Gli2ΔC2− (right). 
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Figure 5.3 
 
Thymus and spleen live cell counts in male and female HY-Dhh littermates. Thymocyte and 
splenocyte total counts from adult male and female HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO 
littermates. (A) Live male thymocyte counts. (B) Live male splenocyte counts. (C) Live female 
thymocyte counts. (D) Live female splenocyte counts. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations.  Male thymocytes; (p=0.06 
(WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=5). Male splenocytes; (p=0.1 (WT/Het), 0.3 (WT/KO), 
0.2 (Het/KO), n=5). Female thymocytes; (p=0.3 (WT/Het), 0.2 (WT/KO), 0.1 (Het/KO), n=7). 
Female plenocytes; (p=0.1 (WT/Het), 0.3 (WT/KO), 0.1 (Het/KO), n=7).  
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Figure 5.4 
Major thymocyte populations in male HY-Dhh within the T3.7 positive cells. Percentage of 
thymocyte populations from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO littermates. 
Thymocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
Thymocyte populations were gated within the T3.7
+
 cells.  (A) Representative dot plot of 
thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratios of CD4:C8, DP:CD8 and DP:CD4. Figures are representative of 5 independent sets of male 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. DN (p= 0.4 (WT/Het), 0.6 (WT/KO), 0.1 (Het/KO), n=5). DP (p= 0.2 
(WT/Het), 0.4 (WT/KO), 0.9 (Het/KO), n=5). SP8 (p= 0.07 (WT/Het), 0.5 (WT/KO), 0.04 
(Het/KO), n=5). SP4 (p= 0.01 (WT/Het), 0.2 (WT/KO), 0.009 (Het/KO), n=5). *represents 
p≤0.05. 
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Figure 5.5 
 
Major thymocyte populations in male HY-Dhh within the T3.7 negative cells. Percentage of 
thymocyte populations from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO littermates. 
Thymocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
Thymocyte populations were gated within the T3.7
−
 cells.  (A) Representative dot plot of 
thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratios of CD4:C8, DP:CD8 and DP:CD4. Figures are representative of 5 independent sets of male 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. DN (p= 0.1 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=5). DP (p= 0.1 
(WT/Het), 0.2 (WT/KO), 0.03 (Het/KO), n=5). SP8 (p= 0.1 (WT/Het), 0.9 (WT/KO), 0.05 
(Het/KO), n=5). SP4 (p= 0.01 (WT/Het), 0.8 (WT/KO), 0.0006 (Het/KO), n=5). *represents 
p≤0.05, **represents p≤0.005. 
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Figure 5.6 
 
Major thymocyte populations in female HY-Dhh within the T3.7 positive cells. Percentage of 
thymocyte populations from adult female HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO 
littermates. Thymocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells.  (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratios of CD4:C8, DP:CD8 and DP:CD4. Figures are representative of 4 independent sets of 
female HY-Dhh littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. DN (p= 0.5 (WT/Het), 0.06 (WT/KO), 0.07 (Het/KO), n=4). 
DP (p= 0.05 (WT/Het), 0.02 (WT/KO), 0.1 (Het/KO), n=4). SP8 (p= 0.04 (WT/Het), 0.7 
(WT/KO), 0.1 (Het/KO), n=4). SP4 (p= 0.2 (WT/Het), 0.05 (WT/KO), 0.4 (Het/KO), n=4). 
*represents p≤0.05. 
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Figure 5.7 
 
Major thymocyte populations in female HY-Dhh within the T3.7 negative cells. Percentage of 
thymocyte populations from adult female HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO 
littermates. Thymocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells.  (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratios of CD4:C8, DP:CD8 and DP:CD4. Figures are representative of 4 independent sets of 
female HY-Dhh littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. DN (p= 0.4 (WT/Het), 0.06 (WT/KO), 0.08 (Het/KO), n=4). 
DP (p= 0.6 (WT/Het), 0.3 (WT/KO), 0.6 (Het/KO), n=4). SP8 (p= 0.4 (WT/Het), 0.7 (WT/KO), 
0.5 (Het/KO), n=4). SP4 (p= 0.4 (WT/Het), 0.09 (WT/KO), 0.02 (Het/KO), n=4). *represents 
p≤0.05.  
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Figure 5.8 
 
Expression of CD3 in male HY-Dhh thymocytes within the T3.7 positive cells. Expression of 
CD3 in DN, DP, SP8 and SP4 thymocytes from adult male and HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Thymocytes were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in DN, 
DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male HY-Dhh littermates respectively. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; DN (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.2 (Het/KO), n=5). DP (p= 0.4 (WT/Het), 0.2 
(WT/KO), 0.06 (Het/KO), n=5). SP8 (p= 0.2 (WT/Het), 0.8 (WT/KO), 0.2 (Het/KO), n=5). SP4 
(p= 0.2 (WT/Het), 0.09 (WT/KO), 0.4 (Het/KO), n=5). CD3 MFI; DN (p= 0.4 (WT/Het), 0.7 
(WT/KO), 0.9 (Het/KO), n=5). DP (p= 0.5 (WT/Het), 0.9 (WT/KO), 0.6 (Het/KO), n=5). SP8 (p= 
0.3 (WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), n=5). SP4 (p= 0.7 (WT/Het), 0.4 (WT/KO), 0.8 
(Het/KO), n=5).  
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Figure 5.9 
 
Expression of CD5 in male HY-Dhh thymocytes within the T3.7 positive cells. Expression of 
CD5 in DN, DP, SP8 and SP4 thymocytes from adult male and HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Thymocytes were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD5 expression DN, DP, 
SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in DN, DP, SP8 and SP4 
cells. (C) Representative scatter plot of CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male HY-Dhh littermates respectively. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; DN (p= 0.6 (WT/Het), 0.8 (WT/KO), 0.7 (Het/KO), n=5). DP (p= 0.2 (WT/Het), 
0.06 (WT/KO), 0.3 (Het/KO), n=5). SP8 (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=5). 
SP4 (p= 0.3 (WT/Het), 0.1 (WT/KO), 0.5 (Het/KO), n=5). CD5 MFI; DN (p= 0.8 (WT/Het), 0.5 
(WT/KO), 0.7 (Het/KO), n=5). DP (p= 0.8 (WT/Het), 0.3 (WT/KO), 0.5 (Het/KO), n=5). SP8 (p= 
0.4 (WT/Het), 0.7 (WT/KO), 0.9 (Het/KO), n=5). SP4 (p= 0.3 (WT/Het), 0.5 (WT/KO), 0.7 
(Het/KO), n=5).  
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Figure 5.10 
 
Expression of CD3 in female HY-Dhh thymocytes within the T3.7 positive cells. Expression of 
CD3 in DN, DP, SP8 and SP4 thymocytes from adult female HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Thymocytes were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in DN, 
DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are 
representative of 4 independent sets of female HY-Dhh littermates respectively. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; DN (p= 0.3 (WT/Het), 0.2 (WT/KO), 0.7 (Het/KO), n=4). DP (p= 0.8 (WT/Het), 0.2 
(WT/KO), 0.3 (Het/KO), n=4). SP8 (p= 0.3 (WT/Het), 0.8 (WT/KO), 0.3 (Het/KO), n=4). SP4 (p= 
0.5 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=4). CD3 MFI; DN (p= 0.08 (WT/Het), 0.1 
(WT/KO), 0.2 (Het/KO), n=4). DP (p= 0.08 (WT/Het), 0.09 (WT/KO), 0.06 (Het/KO), n=4). SP8 
(p= 0.07 (WT/Het), 0.09 (WT/KO), 0.08 (Het/KO), n=4). SP4 (p= 0.06 (WT/Het), 0.1 (WT/KO), 
0.07 (Het/KO), n=4).  
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Figure 5.11 
 
Expression of CD5 in female HY-Dhh thymocytes within the T3.7 positive cells. Expression of 
CD5 in DN, DP, SP8 and SP4 thymocytes from adult female HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Thymocytes were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD5 expression in DN, 
DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in DN, DP, SP8 and SP4 
cells. (C) Representative scatter plot of CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are 
representative of 4 independent sets of female HY-Dhh littermates respectively. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; DN (p= 0.6 (WT/Het), 0.7 (WT/KO), 0.4 (Het/KO), n=4). DP (p= 0.8 (WT/Het), 0.5 
(WT/KO), 0.3 (Het/KO), n=4). SP8 (p= 0.5 (WT/Het), 0.3 (WT/KO), 0.8 (Het/KO), n=4). SP4 (p= 
0.2 (WT/Het), 0.1 (WT/KO), 0.6 (Het/KO), n=4). CD5 MFI; DN (p= 0.2 (WT/Het), 0.1 
(WT/KO), 0.3 (Het/KO), n=4). DP (p= 0.1 (WT/Het), 0.08 (WT/KO), 0.1 (Het/KO), n=4). SP8 
(p= 0.3 (WT/Het), 0.5 (WT/KO), 0.7 (Het/KO), n=4). SP4 (p= 0.7 (WT/Het), 0.3 (WT/KO), 0.8 
(Het/KO), n=4). 
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Figure 5.12 
Expression of CD69 in male and female HY-Dhh thymocytes within the T3.7
 
 positive cells. 
Expression of CD69 in DN, DP, SP8 and SP4 thymocytes from adult male and female HY/Dhh-
WT, HY/Dhh-Het and HY/Dhh-KO littermates. Thymocytes were stained for anti-T3.7, anti-
CD69, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of 
CD69 expression in male DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD69 
percentages in male DN, DP, SP8 and SP4 cells. (C) Representative histogram of CD69 
expression in female DN, DP, SP8 and SP4 cells. (D) Representative bar graph of CD69 
percentages in female DN, DP, SP8 and SP4 cells. Figures are representative of 4 independent sets 
of male and female HY-Dhh littermates. Mean and standard deviation of each population are 
given. Bars represent mean ± standard deviations. Male CD69 percentages; DN (p= 0.5 
(WT/Het), 0.4 (WT/KO), 0.2 (Het/KO), n=4). DP (p= 0.3 (WT/Het), 0.4 (WT/KO), 0.1 (Het/KO), 
n=4). SP8 (p= 0.4 (WT/Het), 0.7 (WT/KO), 0.2 (Het/KO), n=6). SP4 (p= 0.5 (WT/Het), 0.1 
(WT/KO), 0.1 (Het/KO), n=6). Female CD69 percentages; DN (p= 0.1 (WT/Het), 0.1 (WT/KO), 
0.5 (Het/KO), n=4). DP (p= 0.5 (WT/Het), 0.9 (WT/KO), 0.5 (Het/KO), n=4). SP8 (p= 0.8 
(WT/Het), 0.7 (WT/KO), 0.6 (Het/KO), n=6). SP4 (p= 0.6 (WT/Het), 0.8 (WT/KO), 0.4 (Het/KO), 
n=6). 
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Figure 5.13 
 
Expression of Qa2 and HSA in male HY-Dhh thymocytes within the T3.7 positive cells. 
Expression of Qa2 and HSA in DP, SP8 and SP4 cells from adult male HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Thymocytes were stained for anti-Qa2, anti-CD24, anti-CD8 and 
anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of Qa2 expression in 
DP, SP8 and SP4 cells. (B) Representative bar graph of Qa2 percentages in DP, SP8 and SP4 cells. 
(C) Representative histogram of HSA expression in DP, SP8 and SP4 cells. (D) Representative bar 
graph of HSA percentages in DP, SP8 and SP4 cells. Figures are representative of 3 independent 
sets of male HY-Dhh littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. Qa2 percentages; DP (p= 0.5 (WT/Het), 0.6 (WT/KO), 0.8 
(Het/KO), n=3). SP8 (p= 0.2 (WT/Het), 0.6 (WT/KO), 0.3 (Het/KO), n=3). SP4 (p= 0.3 (WT/Het), 
0.06 (WT/KO), 0.2 (Het/KO), n=3). HSA percentages; DP (p= 0.1 (WT/Het), 0.3 (WT/KO), 0.1 
(Het/KO), n=3). SP8 (p= 0.05 (WT/Het), 0.1 (WT/KO), 0.1 (Het/KO), n=3). SP4 (p= 0.7 
(WT/Het), 0.1 (WT/KO), 0.3 (Het/KO), n=3). *represents p≤0.05. 
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Figure 5.14 
 
Expression of Qa2 and HSA in female HY-Dhh thymocytes within the T3.7 positive cells. 
Expression of Qa2 and HSA in DP, SP8 and SP4 cells from adult female HY/Dhh-WT, HY/Dhh-
Het and HY/Dhh-KO littermates. Thymocytes were stained for anti-Qa2, anti-CD24, anti-CD8 and 
anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of Qa2 expression in 
DP, SP8 and SP4 cells. (B) Representative bar graph of Qa2 percentages in DP, SP8 and SP4 cells. 
(C) Representative histogram of HSA expression in DP, SP8 and SP4 cells. (D) Representative bar 
graph of HSA percentages in DP, SP8 and SP4 cells. Figures are representative of 3 independent 
sets of female HY-Dhh littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. Qa2 percentages; DP (p= 0.4 (WT/Het), 0.1 
(WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.5 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=3). SP4 (p= 
0.2 (WT/Het), 0.04 (WT/KO), 0.1 (Het/KO), n=3). HSA percentages; DP (p= 0.6 (WT/Het), 0.04 
(WT/KO), 0.08 (Het/KO), n=3). SP8 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.5 (Het/KO), n=3). SP4 
(p= 0.4 (WT/Het), 0.3 (WT/KO), 0.7 (Het/KO), n=3). *represents p≤0.05. 
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Figure 5.15 
 
Major splenocyte populations in male HY-Dhh within the T3.7 positive cells. Percentage of 
splenocyte populations from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO littermates. 
Splenocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
Splenocyte populations were gated within the T3.7
+
 cells.  (A) Representative dot plot of 
splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. 
Figures are representative of 5 independent sets of male HY-Dhh littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD4
−
CD8
−
 (p= 
0.4 (WT/Het), 0.1 (WT/KO), 0.1 (Het/KO), n=5). SP8 (p= 0.4 (WT/Het), 0.1 (WT/KO), 0.4 
(Het/KO), n=5). SP4 (p= 0.4 (WT/Het), 0.1 (WT/KO), 0.6 (Het/KO), n=5).  
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Figure 5.16 
 
Major splenocyte populations in male HY-Dhh within the T3.7 negative cells. Percentage of 
splenocyte populations from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO littermates. 
Splenocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
Splenocyte populations were gated within the T3.7
−
 cells.  (A) Representative dot plot of 
splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. 
Figures are representative of 5 independent sets of male HY-Dhh littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD4
−
CD8
−
 (p= 
0.8 (WT/Het), 0.8 (WT/KO), 0.7 (Het/KO), n=5). SP8 (p= 0.9 (WT/Het), 0.5 (WT/KO), 0.7 
(Het/KO), n=5). SP4 (p= 0.2 (WT/Het), 0.6 (WT/KO), 0.1 (Het/KO), n=5).  
218 
 
 
 
 
Figure 5.17 
 
Major splenocyte populations in female HY-Dhh within the T3.7 positive cells. Percentage of 
splenocyte populations from adult female HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO 
littermates. Splenocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Splenocyte populations were gated within the T3.7
+
 cells.  (A) Representative dot plot 
of splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. 
Figures are representative of 3 independent sets of female HY-Dhh littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD4
−
CD8
−
 (p= 
0.7 (WT/Het), 0.6 (WT/KO), 0.5 (Het/KO), n=3). SP8 (p= 0.5 (WT/Het), 0.1 (WT/KO), 0.2 
(Het/KO), n=3). SP4 (p= 0.08 (WT/Het), 0.1 (WT/KO), 0.2 (Het/KO), n=3).  
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Figure 5.18 
 
Major splenocyte populations in female HY-Dhh within the T3.7 negative cells. Percentage of 
splenocyte populations from adult female HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-KO 
littermates. Splenocytes were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Splenocyte populations were gated within the T3.7
+
 cells.  (A) Representative dot plot 
of splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 percentages. 
Figures are representative of 3 independent experiments sets of female HY-Dhh littermates. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD4
−
CD8
−
 (p= 0.6 (WT/Het), 0.3 (WT/KO), 0.5 (Het/KO), n=3). SP8 (p= 0.5 (WT/Het), 0.7 
(WT/KO), 0.4 (Het/KO), n=3). SP4 (p= 0.8 (WT/Het), 0.3 (WT/KO), 0.5 (Het/KO), n=3).  
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Figure 5.19 
 
Expression of CD3 in male HY-Dhh splenocytes within the T3.7 positive cells. Expression of 
CD3 in CD4
−
CD8
−
, SP8 and SP4 cells from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-
KO littermates. Splenocytes were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD3 expression in male CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in male CD4−CD8−, SP8 and 
SP4 cells. (C) Representative scatter plot of CD3 MFI in male CD4
−
CD8
−
, SP8 and SP4 cells. 
Figures are representative of 4 independent sets of male HY-Dhh littermates respectively. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD3 percentages; CD4
−
CD8
−
 (p= 0.3 (WT/Het), 0.09 (WT/KO), 0.3 (Het/KO), n=4). SP8 (p= 
0.2 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=4). SP4 (p= 0.2 (WT/Het), 0.03 (WT/KO), 0.8 
(Het/KO), n=4). CD3 MFI; CD4
−
CD8
−
 (p= 0.1 (WT/Het), 0.4 (WT/KO), 0.5 (Het/KO), n=4). 
SP8 (p= 0.7 (WT/Het), 0.9 (WT/KO), 0.1 (Het/KO), n=4). SP4 (p= 0.2 (WT/Het), 0.5 (WT/KO), 
0.4 (Het/KO), n=4). *represents p≤0.05. 
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Figure 5.20 
 
Expression of CD5 in male HY-Dhh splenocytes within the T3.7 positive cells. Expression of 
CD5 in CD4
−
CD8
−
, SP8 and SP4 cells from adult male HY/Dhh-WT, HY/Dhh-Het and HY/Dhh-
KO littermates. Splenocytes were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD5 expression in male CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in male CD4−CD8−, SP8 and 
SP4 cells. (C) Representative scatter plot of CD5 MFI in male CD4
−
CD8
−
, SP8 and SP4 cells. 
Figures are representative of 4 independent sets of male HY-Dhh littermates respectively. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD5 percentages; CD4
−
CD8
−
 (p= 0.3 (WT/Het), 0.6 (WT/KO), 0.5 (Het/KO), n=4). SP8 (p= 0.2 
(WT/Het), 0.5 (WT/KO), 0.5 (Het/KO), n=4). SP4 (p= 0.4 (WT/Het), 0.5 (WT/KO), 0.1 (Het/KO), 
n=4). CD3 MFI; CD4
−
CD8
−
 (p= 0.3 (WT/Het), 0.4 (WT/KO), 0.1 (Het/KO), n=4). SP8 (p= 0.2 
(WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), n=4). SP4 (p= 0.8 (WT/Het), 0.2 (WT/KO), 0.6 (Het/KO), 
n=4).  
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Figure 5.21 
 
Expression of CD3 in female HY-Dhh splenocytes within the T3.7 positive cells. Expression of 
CD3 in CD4
−
CD8
−
, SP8 and SP4 cells from adult female HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Splenocytes were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in female 
CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in female 
CD4
−
CD8
−
, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in female CD4
−
CD8
−
, 
SP8 and SP4 cells. Figures are representative of 3 independent sets of female HY-Dhh littermates 
respectively. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. CD3 percentages; CD4
−
CD8
−
 (p= 0.8 (WT/Het), 0.3 (WT/KO), 0.3 
(Het/KO), n=3). SP8 (p= 0.6 (WT/Het), 0.1 (WT/KO), 0.1 (Het/KO), n=3). SP4 (p= 0.8 (WT/Het), 
0.3 (WT/KO), 0.3 (Het/KO), n=3). CD3 MFI; CD4
−
CD8
−
 (p= 0.7 (WT/Het), 0.3 (WT/KO), 0.3 
(Het/KO), n=3). SP8 (p= 0.4 (WT/Het), 0.9 (WT/KO), 0.4 (Het/KO), n=3). SP4 (p= 0.1 (WT/Het), 
0.3 (WT/KO), 0.6 (Het/KO), n=3).  
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Figure 5.22 
 
Expression of CD5 in female HY-Dhh splenocytes within the T3.7 positive cells. Expression of 
CD5 in CD4
−
CD8
−
, SP8 and SP4 cells from adult female HY/Dhh-WT, HY/Dhh-Het and 
HY/Dhh-KO littermates. Splenocytes were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD5 expression in female 
CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in female 
CD4
−
CD8
−
, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in female CD4
−
CD8
−
, 
SP8 and SP4 cells. Figures are representative of 3 independent sets of female HY-Dhh littermates 
respectively. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. CD5 percentages; CD4
−
CD8
−
 (p= 0.6 (WT/Het), 0.5 (WT/KO), 0.7 
(Het/KO), n=3). SP8 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 
0.7 (WT/KO), 0.5 (Het/KO), n=3). CD5 MFI; CD4
−
CD8
−
 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.4 
(Het/KO), n=3). SP8 (p= 0.2 (WT/Het), 0.6 (WT/KO), 0.8 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 
0.3 (WT/KO), 0.7 (Het/KO), n=3).  
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Figure 5.23 
 
Expression of CD69 in male and female HY-Dhh splenocytes within the T3.7 
 
positive cells. 
Expression of CD69 in CD4
−
CD8
−
, SP8 and SP4 cells from adult male and female HY/Dhh-WT, 
HY/Dhh-Het and HY/Dhh-KO littermates. Splenocytes were stained for anti-T3.7, anti-CD69, 
anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of CD69 
expression in male CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD69 
percentages in male CD4
−
CD8
−
, DP, SP8 and SP4 cells. (C) Representative histogram of CD69 
expression in female CD4
−
CD8
−
, SP8 and SP4 cells. (D) Representative bar graph of CD69 
percentages in female CD4
−
CD8
−
, DP, SP8 and SP4 cells. Figures are representative of 4 and 3 
independent sets of male and female HY-Dhh littermates respectively. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. Male CD69 
percentages; CD4
−
CD8
−
 (p= 0.1 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.1 
(WT/Het), 0.2 (WT/KO), 0.8 (Het/KO), n=3). SP4 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.3 (Het/KO), 
n=3). Female CD69 percentages; CD4
−
CD8
−
 (p= 0.8 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), 
n=3). SP8 (p= 0.8 (WT/Het), 0.3 (WT/KO), 0.4 (Het/KO), n=3). SP4 (p= 0.9 (WT/Het), 0.8 
(WT/KO), 0.7 (Het/KO), n=3). 
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Figure 5.24 
 
Major lymph node T cell populations in male HY-Dhh within the T3.7 positive cells. 
Percentage of T cell populations in the lymph node from adult male HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Cell populations were gated within the T3.7
+
 cells.  (A) 
Representative dot plot of lymph node T cell populations. (B) Representative bar graph of 
CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 3 independent sets of male 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.5 (WT/Het), 0.2 (WT/KO), 0.08 (Het/KO), n=3). 
SP8 (p= 0.7 (WT/Het), 0.04 (WT/KO), 0.1 (Het/KO), n=3). SP4 (p= 0.4 (WT/Het), 0.3 (WT/KO), 
0.8 (Het/KO), n=3). *represents p≤0.05.  
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Figure 5.25 
 
Major lymph node T cell populations in male HY-Dhh within the T3.7 negative cells. 
Percentage of T cell populations in the lymph node from adult male HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Cell populations were gated within the T3.7
−
 cells.  (A) 
Representative dot plot of lymph node T cell populations. (B) Representative bar graph of 
CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 3 independent sets of male 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.5 (WT/Het), 0.8 (WT/KO), 0.7 (Het/KO), n=3). 
SP8 (p= 0.1 (WT/Het), 0.6 (WT/KO), 0.3 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 0.2 (WT/KO), 
0.1 (Het/KO), n=3).  
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Figure 5.26 
 
Major lymph node T cell populations in female HY-Dhh within the T3.7 positive cells. 
Percentage of T cell populations in the lymph node from adult female HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Cell populations were gated within the T3.7
+
 cells.  (A) 
Representative dot plot of lymph node T cell populations. (B) Representative bar graph of 
CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 3 independent sets of female 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.06 (WT/Het), 0.5 (WT/KO), 0.6 (Het/KO), n=3). 
SP8 (p= 0.4 (WT/Het), 0.3 (WT/KO), 0.1 (Het/KO), n=3). SP4 (p= 0.04 (WT/Het), 0.2 (WT/KO), 
0.2 (Het/KO), n=3). *represents p≤0.05.  
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Figure 5.27 
Major lymph node T cell populations in female HY-Dhh within the T3.7 negative cells. 
Percentage of T cell populations in the lymph node from adult female HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Cell populations were gated within the T3.7
−
 cells.  (A) 
Representative dot plot of lymph node T cell populations. (B) Representative bar graph of 
CD4
−
CD8
−
, SP8 and SP4 percentages. Figures are representative of 3 independent sets of female 
HY-Dhh littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.6 (WT/Het), 0.4 (WT/KO), 0.8 (Het/KO), n=3). 
SP8 (p= 0.1 (WT/Het), 0.08 (WT/KO), 0.5 (Het/KO), n=3). SP4 (p= 0.04 (WT/Het), 0.2 
(WT/KO), 0.2 (Het/KO), n=3). *represents p≤0.05.   
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Figure 5.28 
 
Expression of CD3 in male HY-Dhh lymph node T cells within the T3.7 positive cells. 
Expression of CD3 in CD4
−
CD8
−
, SP8 and SP4 cells from adult male HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of male HY-Dhh littermates. Mean and standard deviation of 
each population are given. Bars represent mean ± standard deviations. CD3 percentages; 
CD4
−
CD8
−
 (p= 0.2 (WT/Het), 0.5 (WT/KO), 0.7 (Het/KO), n=3). SP8 (p= 0.08 (WT/Het), 0.7 
(WT/KO), 0.6 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 0.8 (WT/KO), 0.4 (Het/KO), n=3). CD3 
MFI; CD4
−
CD8
−
 (p= 0.3 (WT/Het), 0.6 (WT/KO), 0.8 (Het/KO), n=3). SP8 (p= 0.2 (WT/Het), 
0.4 (WT/KO), 0.7 (Het/KO), n=3). SP4 (p= 0.4 (WT/Het), 0.8 (WT/KO), 0.4 (Het/KO), n=3).  
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Figure 5.29 
 
Expression of CD5 in male HY-Dhh lymph node T cells within the T3.7 positive cells. 
Expression of CD5 in CD4
−
CD8
−
, SP8 and SP4 cells from adult male HY/Dhh-WT, HY/Dhh-Het 
and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, 
and analyzed by flow cytometry. (A) Representative histogram of CD5 expression in CD4
−
CD8
−
, 
SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in CD4−CD8−, SP8 and SP4 
cells. (C) Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 3 independent sets of male HY-Dhh littermates. Mean and standard deviation of 
each population are given. Bars represent mean ± standard deviations. CD5 percentages; 
CD4
−
CD8
−
 (p= 0.08 (WT/Het), 0.2 (WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.2 (WT/Het), 0.07 
(WT/KO), 0.3 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 0.4 (WT/KO), 0.6 (Het/KO), n=3). CD5 
MFI; CD4
−
CD8
−
 (p= 0.2 (WT/Het), 0.4 (WT/KO), 0.8 (Het/KO), n=3). SP8 (p= 0.7 (WT/Het), 
0.5 (WT/KO), 0.2 (Het/KO), n=3). SP4 (p= 0.7 (WT/Het), 0.1 (WT/KO), 0.4 (Het/KO), n=3).  
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Figure 5.30 
 
Expression of CD3 in female HY-Dhh lymph node T cells within the T3.7 positive cells. 
Expression of CD3 in CD4
−
CD8
−
, SP8 and SP4 cells from adult female HY/Dhh-WT, HY/Dhh-
Het and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD3 expression in 
CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages in CD4−CD8−, 
SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. 
Figures are representative of 3 independent sets of female HY-Dhh littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.8 (WT/Het), 0.3 (WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.8 
(WT/Het), 0.5 (WT/KO), 0.6 (Het/KO), n=3). SP4 (p= 0.9 (WT/Het), 0.6 (WT/KO), 0.5 (Het/KO), 
n=3). CD3 MFI; CD4
−
CD8
−
 (p= 0.4 (WT/Het), 0.3 (WT/KO), 0.4 (Het/KO), n=3). SP8 (p= 0.2 
(WT/Het), 0.6 (WT/KO), 0.7 (Het/KO), n=3). SP4 (p= 0.1 (WT/Het), 0.8 (WT/KO), 0.7 (Het/KO), 
n=3).  
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Figure 5.31 
 
Expression of CD5 in female HY-Dhh lymph node T cells within the T3.7 positive cells. 
Expression of CD5 in CD4
−
CD8
−
, SP8 and SP4 cells from adult female HY/Dhh-WT, HY/Dhh-
Het and HY/Dhh-KO littermates. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-
CD4, and analyzed by flow cytometry. (A) Representative histogram of CD5 expression in 
CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages in CD4−CD8−, 
SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. 
Figures are representative of 3 independent sets of female HY-Dhh littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; CD4
−
CD8
−
 (p= 0.5 (WT/Het), 0.1 (WT/KO), 0.3 (Het/KO), n=3). SP8 (p= 0.6 
(WT/Het), 0.1 (WT/KO), 0.3 (Het/KO), n=3). SP4 (p= 0.6 (WT/Het), 0.6 (WT/KO), 0.4 (Het/KO), 
n=3). CD5 MFI; CD4
−
CD8
−
 (p= 0.6 (WT/Het), 0.2 (WT/KO), 0.4 (Het/KO), n=3). SP8 (p= 0.3 
(WT/Het), 0.6 (WT/KO), 0.9 (Het/KO), n=3). SP4 (p= 0.3 (WT/Het), 0.7 (WT/KO), 0.4 (Het/KO), 
n=3). 
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Figure 5.32 
 
Thymus and spleen live cell counts in male and female Marilyn-Gli2ΔC2 littermates. 
Thymocyte and splenocyte total counts from adult male and female Marilyn-Gli2ΔC2− and 
Marilyn-Gli2ΔC2+ littermates. (A) Live male thymocyte counts. (B) Live male splenocyte counts. 
(C) Live female thymocyte counts. (D) Live female splenocyte counts. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. Male 
thymocytes; (p=0.6, n=5). Male splenocytes; (p=0.03, n=4). Female thymocytes; (p=0.6, n=5). 
Female splenocytes; (p=0.2, n=6). *represents p≤0.05. 
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Figure 5.33 
 
Major thymocyte populations in male Marilyn-Gli2ΔC2 mice. Percentage of thymocyte 
populations from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Thymocytes 
were stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) 
Representative dot plot of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 
and SP4 percentages. (C) Ratios of CD4:CD8, DP:CD8 and DP:CD4. Figures are representative of 
7 independent sets of male Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. DN (p= 0.008, n=7). DP (p= 
0.02, n=7). SP8 (p= 0.3, n=7). SP4 (p=0.004, n=7). *represents p≤0.05, **represents p≤0.005.  
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Figure 5.34 
 
Major thymocyte populations in female Marilyn-Gli2ΔC2 mice. Percentage of thymocyte 
populations from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Thymocytes 
were stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) 
Representative dot plot of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 
and SP4 percentages. (C) Ratios of CD4:CD8, DP:CD8 and DP:CD4. Figures are representative of 
6 independent sets of female Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. DN (p= 0.06, n=6). DP (p= 
0.007, n=6). SP8 (p= 0.002, n=6). SP4 (p=0.03, n=6). *represents p≤0.05. **represents p≤0.005.  
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Figure 5.35 
Expression of CD3 in male Marilyn-Gli2ΔC2 thymocytes. Expression of CD3 and CD5 in DN, 
DP, SP8 and SP4 thymocytes from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Thymocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 6 
independent sets of male Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.08, 
n=6). DP (p= 0.1, n=6). SP8 (p= 0.3, n=6). SP4 (p= 0.02, n=6). CD3 MFI; DN (p= 0.2, n=6). DP 
(p= 0.5, n=6). SP8 (p= 0.7, n=6). SP4 (p= 0.01, n=6). *represents p≤0.05. 
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Figure 5.36 
Expression of CD5 in male Marilyn-Gli2ΔC2 thymocytes. Expression of CD5 in DN, DP, SP8 
and SP4 thymocytes from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
Thymocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 6 
independent sets of male Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.2, 
n=6). DP (p= 0.5, n=6). SP8 (p= 0.6, n=6). SP4 (p= 0.001, n=6). CD5 MFI; DN (p= 0.2, n=6). 
DP (p= 0.09, n=6). SP8 (p= 0.07, n=6). SP4 (p= 0.03, n=6). *represents p≤0.05, **represents 
p≤0.005. 
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Figure 5.37 
Expression of CD3 in female Marilyn-Gli2ΔC2 thymocytes. Expression of CD3 in DN, DP, 
SP8 and SP4 thymocytes from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
Thymocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 6 
independent sets of female Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.3, 
n=6). DP (p= 0.2, n=6). SP8 (p= 0.6, n=6). SP4 (p= 0.3, n=6). CD3 MFI; DN (p= 0.06, n=6). DP 
(p= 0.07, n=6). SP8 (p= 0.1, n=6). SP4 (p= 0.09, n=6).  
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Figure 5.38 
Expression of CD5 in female Marilyn-Gli2ΔC2 thymocytes. Expression of CD5 in DN, DP, 
SP8 and SP4 thymocytes from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
Thymocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in DN, DP, SP8 and SP4 cells. (C) Representative 
scatter plot of CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are representative of 6 
independent sets of female Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.1, 
n=6). DP (p= 0.1, n=6). SP8 (p= 0.06, n=6). SP4 (p= 0.7, n=6). CD3 MFI; DN (p= 0.07, n=6). 
DP (p= 0.08, n=6). SP8 (p= 0.07, n=6). SP4 (p= 0.06, n=6).  
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Figure 5.39 
 
Expression of CD69 in male and female Marilyn-Gli2ΔC2 thymocytes. Expression of CD69 in 
DN, DP, SP8 and SP4 thymocytes from adult male and female Marilyn-Gli2ΔC2− and Marilyn-
Gli2ΔC2+ littermates. Thymocytes were stained for anti-CD69, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of CD69 expression in male DN, DP, 
SP8 and SP4 cells. (B) Representative bar graph of CD69 percentages in male DN, DP, SP8 and 
SP4 cells. (C) Representative histogram of CD69 expression in female DN, DP, SP8 and SP4 
cells. (D) Representative bar graph of CD69 percentages in female DN, DP, SP8 and SP4 cells. 
Figures are representative of 3 independent sets of male and female Marilyn-Gli2ΔC2 littermates. 
Mean and standard deviation of each population are given. Bars represent mean ± standard 
deviations. Male CD69 percentages; DN (p= 0.1, n=3). DP (p= 0.5, n=3). SP8 (p= 0.07, n=3). 
SP4 (p= 0.5, n=3). Female CD69 percentages; DN (p= 0.6, n=3). DP (p= 0.09, n=3). SP8 (p= 
0.2, n=3). SP4 (p= 0.3, n=3). 
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Figure 5.40 
 
Expression of Gata-3 in male and female Marilyn-Gli2ΔC2 thymocytes. Expression of Gata-3 
in DN, DP, SP8 and SP4 thymocytes from adult male and female Marilyn-Gli2ΔC2− and Marilyn-
Gli2ΔC2+ littermates. Thymocytes were stained for anti-Gata3, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of Gata-3 expression in male DN, DP, 
SP8 and SP4 cells. (B) Representative bar graph of Gata-3 percentages in male DN, DP, SP8 and 
SP4 cells. (C) Representative histogram of Gata-3 expression in female DN, DP, SP8 and SP4 
cells. (D) Representative bar graph of Gata-3 percentages in female DN, DP, SP8 and SP4 cells. 
Figures are representative of 3 independent sets of male and female Marilyn-Gli2ΔC2 littermates. 
Mean and standard deviation of each population are given. Bars represent mean ± standard 
deviations. Male Gata-3 percentages; DN (p= 0.1, n=3). DP (p= 0.4, n=3). SP8 (p= 0.09, n=3). 
SP4 (p= 0.04, n=3). Female Gata-3 percentages; DN (p= 0.3, n=3). DP (p= 0.7, n=3). SP8 (p= 
0.7, n=3). SP4 (p= 0.4, n=3). *represents p≤0.05. 
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Figure 5.41 
 
Expression of Foxp3 in male and female Marilyn-Gli2ΔC2  SP4 thymocytes. Expression of 
Foxp3 in SP4 cells from adult male and female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Thymocytes were stained for anti-Foxp3, anti-CD25, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. (A) Representative histogram of Foxp3 expression in male SP4 cells. 
(B) Representative bar graph of Foxp3 percentages in male SP4 cells. (C) Representative 
histogram of Foxp3 expression in female SP4 cells. (D) Representative bar graph of Foxp3 
percentages in female SP4 cells. Figures are representative of 3 independent sets of male and 
female Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. Male Foxp3 percentage; SP4 (p= 0.05, n=3). Female 
Foxp3 percentages; SP4 (p= 0.3, n=3). *represents p≤0.05. 
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Figure 5.42 
 
Expression of Qa2 and HSA in male Marilyn-Gli2ΔC2 thymocytes. Expression of Qa2 and 
HSA in DP, SP8 and SP4 cells from adult Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
Thymocytes were stained for anti-Qa2, anti-CD24, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative dot plot of Qa2
+
, Qa2
+
HSA
+
 and HSA
+
 expression in DP, SP8 and 
SP4 cells. (B) Representative bar graph of Qa2+, Qa2+HSA+ and HSA+ percentages in DP, SP8 
and SP4 cells. Figures are representative of 3 independent sets of male Marilyn-Gli2ΔC2 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. Qa2
+
 percentages; DP (p= 0.5, n=3). SP8 (p= 0.6, n=3). SP4 (p= 0.1, n=3). 
Qa2
+
HSA
+
 percentages; DP (p= 0.7, n=3). SP8 (p= 0.08, n=3). SP4 (p= 0.5, n=3). HSA
+
 
percentages; DP (p= 0.04, n=3). SP8 (p= 0.1, n=3). SP4 (p= 0.001, n=3).*represents p≤0.05, 
**represents p≤0.005. 
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Figure 5.43 
 
Expression of Qa2 and HSA female Marilyn-Gli2ΔC2 thymocytes. Expression of Qa2 and 
HSA in DP, SP8 and SP4 cells from adult Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
Thymocytes were stained for anti-Qa2, anti-CD24, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative dot plot of Qa2
+
, Qa2
+
HSA
+
 and HAS
+
 expression in DP, SP8 and 
SP4 cells. (B) Representative bar graph of Qa2+, Qa2+HSA+ and HSA+ percentages in DP, SP8 
and SP4 cells. Figures are representative of 3 independent sets of female Marilyn-Gli2ΔC2 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. Qa2
+
 percentages; DP (p= 0.7, n=3). SP8 (p= 0.002, n=3). SP4 (p= 0.3, 
n=3). Qa2
+
HSA
+
 percentages; DP (p= 0.1, n=3). SP8 (p= 0.05, n=3). SP4 (p= 0.1, n=3). HSA
+
 
percentages; DP (p= 0.004, n=3). SP8 (p= 0.02, n=3). SP4 (p= 0.003, n=3).*represents p≤0.05, 
**represents p≤0.005. 
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Figure 5.44 
 
Major splenocyte populations in male Marilyn-Gli2ΔC2 mice. Percentage of splenocyte 
populations from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Splenocytes 
were stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry.  (A) 
Representative dot plot of splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, 
SP8 and SP4 percentages. Figures are representative of 5 independent sets of male Marilyn-
Gli2ΔC2 littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.4, n=5). SP8 (p= 0.07, n=5). SP4 (p= 0.0003, n=5). 
***represents p≤0.0005. 
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Figure 5.45 
 
Major splenocyte populations in female Marilyn-Gli2ΔC2 mice. Percentage of splenocyte 
populations from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Splenocytes 
were stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry.  (A) 
Representative dot plot of splenocyte populations. (B) Representative bar graph of CD4
−
CD8
−
, 
SP8 and SP4 percentages. Figures are representative of 3 independent sets of female Marilyn-
Gli2ΔC2 littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.001, n=3). SP4 (p= 0.5, 
n=3).**represents p≤0.005. 
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Figure 5.46 
Expression of CD3 in male Marilyn-Gli2ΔC2 splenocytes. Expression of CD3 in CD4−CD8−, 
SP8 and SP4 cells from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
splenocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male Marilyn-Gli2ΔC2 littermates respectively. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.1, n=5). SP8 (p= 0.08, n=5). SP4 (p= 0.05, n=5). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.07, n=5). SP8 (p= 0.3, n=5). SP4 (p= 0.002, n=5). *represents p≤0.05, 
**represents p≤0.005.  
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Figure 5.47 
Expression of CD5 in male Marilyn-Gli2ΔC2 splenocytes. Expression of CD5 in CD4−CD8−, 
SP8 and SP4 cells from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
splenocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD5 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male Marilyn-Gli2ΔC2 littermates respectively. Mean and 
standard deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; CD4
−
CD8
−
 (p= 0.3, n=5). SP8 (p= 0.02, n=5). SP4 (p= 0.1, n=5). CD5 MFI; 
CD4
−
CD8
−
 (p= 0.07, n=5). SP8 (p= 0.4, n=5). SP4 (p= 0.003, n=5). *represents p≤0.05, 
**represents p≤0.005.  
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Figure 5.48 
Expression of CD3 female Marilyn-Gli2ΔC2 splenocytes. Expression of CD3 in CD4−CD8−, 
SP8 and SP4 cells from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
splenocytes were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 4 independent sets of female Marilyn-Gli2ΔC2 littermates respectively. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD3 percentages; CD4
−
CD8
−
 (p= 0.7, n=4). SP8 (p= 0.006, n=4). SP4 (p= 0.3, n=4). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.7, n=4). SP8 (p= 0.002, n=4). SP4 (p= 0.06, n=4). *represents p≤0.05, 
**represents p≤0.005.  
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Figure 5.49 
Expression of CD5 in female Marilyn-Gli2ΔC2 splenocytes. Expression of CD5 in CD4−CD8−, 
SP8 and SP4 cells from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. 
splenocytes were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative histogram of CD5 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 4 independent sets of female Marilyn-Gli2ΔC2 littermates respectively. Mean 
and standard deviation of each population are given. Bars represent mean ± standard deviations. 
CD5 percentages; CD4
−
CD8
−
 (p= 0.6, n=4). SP8 (p= 0.003, n=4). SP4 (p= 0.01, n=4). CD5 
MFI; CD4
−
CD8
−
 (p= 0.07, n=4). SP8 (p= 0.002, n=4). SP4 (p= 0.05, n=4).*represents p≤0.05, 
**represents p≤0.005.  
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Figure 5.50 
 
Expression of CD69 in male and female Marilyn-Gli2ΔC2 splenocytes. Expression of CD69 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult male and female Marilyn-Gli2ΔC2− and Marilyn-
Gli2ΔC2+ littermates. Thymocytes were stained for anti-CD69, anti-CD8 and anti-CD4 and 
analyzed by flow cytometry. (A) Representative histogram of CD69 expression in male  
CD4
−
CD8
−
, SP8 and SP4 cells. (B) Representative bar graph of CD69 percentages in male 
CD4
−
CD8
−
, SP8 and SP4 cells. (C) Representative histogram of CD69 expression in female 
CD4
−
CD8
−
, SP8 and SP4 cells. (D) Representative bar graph of CD69 percentages in female 
CD4
−
CD8
−
, SP8 and SP4 cells. Figures are representative of 3 independent sets of male and 
female Marilyn-Gli2ΔC2 littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. Male CD69 percentages; CD4
−
CD8
−
 (p= 0.3, n=3). 
SP8 (p= 0.7, n=3). SP4 (p= 0.007, n=3). Female CD69 percentages; CD4
−
CD8
−
 (p= 0.06, n=3). 
SP8 (p= 0.1, n=3). SP4 (p= 0.01, n=3).*represents p≤0.05. 
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Figure 5.51 
 
Major T cell populations in the lymph node of male Marilyn-Gli2ΔC2 mice. Percentage of T 
cell populations from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Cells were 
stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry.  (A) Representative 
dot plot of T cell populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and SP4 
percentages. Figures are representative of 5 independent sets of male Marilyn-Gli2ΔC2 littermates. 
Mean and standard deviation of each population are given. Bars represent mean ± standard 
deviations. CD4
−
CD8
−
 (p= 0.5, n=5). SP8 (p= 0.0002, n=5). SP4 (p= 0.0004, n=5).***represents 
p≤0.0005 
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Figure 5.52 
 
Major T cell populations in the lymph node of female Marilyn-Gli2ΔC2 mice. Percentage of T 
cell populations from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ littermates. Cells 
were stained for anti-vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry.  (A) 
Representative dot plot of T cell populations. (B) Representative bar graph of CD4
−
CD8
−
, SP8 and 
SP4 percentages. Figures are representative of 3 independent sets of female Marilyn-Gli2ΔC2 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. CD4
−
CD8
−
 (p= 0.1, n=3). SP8 (p= 0.2, n=3). SP4 (p= 0.1, n=3).  
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Figure 5.53 
Expression of CD3 in male Marilyn-Gli2ΔC2 lymph node T cells. Expression of CD3 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Cells were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male Marilyn-Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.5, n=5). SP8 (p= 0.002, n=5). SP4 (p= 0.03, n=5). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.2, n=5). SP8 (p= 0.6, n=5). SP4 (p= 0.3, n=5). *represents p≤0.05, **represents 
p≤0.005. 
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Figure 5.54 
Expression of CD5 in male Marilyn-Gli2ΔC2 lymph node T cells. Expression of CD5 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult male Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Cells were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD5 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of male Marilyn-Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; CD4
−
CD8
−
 (p= 0.1, n=5). SP8 (p= 0.01, n=5). SP4 (p= 0.0006, n=5). CD5 MFI; 
CD4
−
CD8
−
 (p= 0.2, n=5). SP8 (p= 0.04, n=5). SP4 (p= 0.003, n=5). *represents p≤0.05, 
**represents p≤0.005. 
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Figure 5.55 
Expression of CD3 in female Marilyn-Gli2ΔC2 lymph node T cells. Expression of CD3 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Cells were stained for anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD3 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD3 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD3 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of female Marilyn-Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD3 
percentages; CD4
−
CD8
−
 (p= 0.3, n=3). SP8 (p= 0.4, n=3). SP4 (p= 0.7, n=3). CD3 MFI; 
CD4
−
CD8
−
 (p= 0.2, n=3). SP8 (p= 0.1, n=3). SP4 (p= 0.4, n=3).  
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Figure 5.56 
Expression of CD5 in female Marilyn-Gli2ΔC2 lymph node T cells. Expression of CD5 in 
CD4
−
CD8
−
, SP8 and SP4 cells from adult female Marilyn-Gli2ΔC2− and Marilyn-Gli2ΔC2+ 
littermates. Cells were stained for anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. (A) Representative histogram of CD5 expression in CD4
−
CD8
−
, SP8 and SP4 cells. (B) 
Representative bar graph of CD5 percentages in CD4
−
CD8
−
, SP8 and SP4 cells. (C) 
Representative scatter plot of CD5 MFI in CD4
−
CD8
−
, SP8 and SP4 cells. Figures are 
representative of 5 independent sets of female Marilyn-Gli2ΔC2 littermates. Mean and standard 
deviation of each population are given. Bars represent mean ± standard deviations. CD5 
percentages; CD4
−
CD8
−
 (p= 0.2, n=3). SP8 (p= 0.3, n=3). SP4 (p= 0.3, n=3). CD5 MFI; 
CD4
−
CD8
−
 (p= 0.4, n=3). SP8 (p= 0.3, n=3). SP4 (p= 0.6, n=3). 
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5.3       Discussion 
Our data indicated that Dhh influences thymocyte selection as we observed 
increased escape of deletion of self-reactive T cells in the absence of Dhh in male 
HY-Dhh mice. We have also shown that partial expression of Dhh reduced 
deletion of transgenic T cells, indicating a redundant role of Dhh in TCR 
repertoire selection. A similar escape of deletion has been also found in the male 
HY-TCR¯ cells, where endogenous TCR genes rearrangement still exists. This 
fnding is consistent with previously shown data that Dhh acts as a negative 
regulator of T cells during their development and differentiation in the thymus and 
lymphoid organs (chapter 4).  
The female HY-TCR
+
 cells revealed a negative regulatory role of Dhh during 
thymocyte positive selection. The proportions of DP and SP8 cells were increased 
in Dhh-knockout, indicating a negative role of Dhh during SP8 positive selection. 
Interestingly, SP8 in Heterogeneous mice have shown a greater selection of SP8 
cells, suggesting a dose dependent regulatory function of Dhh during selection of 
SP8 cells. Additionally, thymocyte maturation has been examined through 
measuring the expression of Qa2 and HSA, and our data have shown that Dhh 
reduce maturation of SP8 cells in male and female HY-TCR
+
 cells. In the spleen, 
we observed no influence on mature HY-TCR
+
 cells, however, Dhh reduced the 
proportions of SP4 cells expressing CD3, indicating its role in influencing 
splenocytes in the periphery. 
Furthermore, analysis of Marilyn-TCR
+
 male mice showed a negative regulatory 
role of Hh signalling during thymocyte development and maturation in the 
thymus. These data indicate that inhibition of Hh-dependent transcription 
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increased positive selection of the transgenic TCR, and differentiation from DP to 
SP cells. Our analysis showed that the proportions of Marilyn-TCR
+
 SP4 cells has 
been found to be increased in the absence of Hh signalling, suggesting a negative 
regulatory role of Hh during negative selection of SP4 cells. In Marilyn-TCR
+ 
female mice, the proportions of DP cells were decreased, possibly as cells 
undergo further development. Furthermore, examining the maturation marker Qa2 
and HSA in DP and SP cells revealed that Hh signalling reduced thymocyte 
maturation in the DP and SP stage in male mice, and in DP and SP cells in female 
mice. These findings are consistent with previously shown data which indicate 
that inhibition of Hh-dependent transcription increased positive and negative 
selection in the thymus and TCR activation of peripheral T cells (Furmanski et al. 
2012; Rowbotham et al. 2008; Furmanski et al. 2015). 
In the spleen, we observed a reduction in the proportions of SP4 in male mice, and 
SP8 and SP4 cells in female mice. This observation confirms our finding in the 
thymus, in that the thymus allowed the escape of transgenic T cells reaching the 
spleen. However, the spleen size was reduced, as well as their total live cell 
counts. This could be due to the increase in Foxp3
+
 cells. In the female spleen, in 
the absence of intrinsic Hh signalling, the proportions of SP8 and SP4 cells are 
increased as a result of increased positive selection.  
Furthermore, the expression of TCR associated molecules CD3 and CD5 in SP 
cells increase during thymocyte development in the thymus, and CD5 MFI also 
increase in the absence of Hh signalling indicating a possible role of these 
molecules during selection of transgenic T cells. A similar phenotype have been 
also shown in the spleen and lymph node of Marilyn-TCR
+
 mice, suggesting that 
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Hh signalling also regulate TCR signal transduction in mature T cells in the 
periphery.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
261 
 
5.4       Conclusion 
In this chapter, our data indicated that Dhh influences thymocyte negative and 
positive selection as we observed increased escape of deletion of self-reactive T 
cells in male HY-Dhh mice, and increased proportions of DP and SP8 cells in 
female mice in the absence of Dhh. We have also shown that partial expression of 
Dhh reduced deletion of transgenic T cells, indicating a dose dependent regulatory 
function of Dhh during selection. Moreover, our data have shown that Dhh reduce 
maturation of SP8 cells promoting the inhibited clonal deletion of transgenic SP8 
cells in these mice. In the spleen, Dhh reduced the proportions of SP4 cells 
expressing CD3, indicating its role in influencing splenocytes activation in the 
periphery. 
Furthermore, our data from Marilyn-TCR
+
 male mice indicate that inhibition of 
Hh-dependent transcription increased positive selection of the transgenic TCR, 
and differentiation from DP to SP cells. Moreover, Hh signalling reduced 
thymocyte maturation through attenuating TCR signal transduction. Moreover, 
inhibition of Hh-dependent transcription resulted in a reduced size of the spleen 
and a reduced total live splenocyte counts, suggesting an autoreactive nature of T 
cells that escaped deletion in the thymus.  
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Chapter 6  
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Chapter Six: Role of Shh in T cell development 
 
6.1      Introduction  
6.1.1    Shh in T cell development 
Shh has been found to be expressed in the thymus by epithelial cells throughout 
the subcapsular region, medulla and cortico-medullary region in both mice and 
human (Outram et al. 2000; Shah et al. 2004; Virts et al. 2006; El Andaloussi et 
al. 2006; Sacedón et al. 2003). Thymus stromal cells and circulating lymphoid 
cells has been found to be responsive to Shh signalling (Outram et al. 2000; 
Rowbotham, Hager-Theodorides, Cebecauer, et al. 2007; Sacedón et al. 2003; Li 
et al. 2002).  
Our laboratory has previously established that Shh is an essential regulator of T 
cells during their development in the thymus. Analysis of foetal thymocyte 
development in Shh deficient embryos revealed that Shh is an essential regulator 
for thymocyte differentiation and proliferation during the transition from the DN1 
to the DN2 stage (Shah et al. 2004; Hager-Theodorides et al. 2005). Shh deficient 
mice exhibited reduced thymocyte numbers and proliferation with partial arrest at 
the DN1 stage compared to WT littermates (Shah et al. 2004).  
At the transition from the DN to the DP stage, our laboratory has found that Shh 
negatively regulates thymocyte differentiation (Outram et al. 2000; Rowbotham et 
al. 2009). Our lab has also shown that the DP thymocytes are Hh-responsive and 
that thymocyte-intrinsic Shh signalling plays a role in modulating the production 
of SP4 and SP8 thymocytes, whereas repression of physiological Shh signalling in 
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thymocytes altered the proportions of DP and SP4 thymocytes (Crompton et al. 
2007; Rowbotham, Hager-Theodorides, Cebecauer, et al. 2007; Furmanski et al. 
2012).  
 
6.1.2   Chapter objectives 
The purpose of this chapter is to investigate the role of Shh during T cell 
development and maturation in the thymus. I studied the functions of Shh in the 
thymus, by investigating differences in differentiation and transition from one 
developmental stage to the next on Shh-treatment in-vitro. 
This was done using an in-vitro system of FTOC and TCR transgenic mice in 
which T cell repertoire selection is biased by expressing rearranged transgenic 
TCR αβ chains. The first model is HY transgenic mice bearing MHC class-I 
restricted TCR which recognizes the male antigen. The second model is Marilyn 
transgenic mice, bearing MHC class-II restricted TCR that recognize the male 
antigen on a Rag2-deficient background. These mice develop thymocytes in 
which lineage commitment is skewed by the specificity of their rearranged 
transgenic TCR, allowing us to investigate whether or not Shh will have an 
influence in determining lineage choice and TCR repertoire selection in these 
mice.  
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6.2      Results  
6.2.1   Genotyping HY-TCR and Marilyn-TCR male and female littermates 
Two mouse models were utilized in which T cell repertoire selection is biased by 
expression of rearranged transgenic TCR αβ chains (HY-TCR, and Marilyn-TCR 
transgenic mice on a Rag2-deficient background). These mice develop 
thymocytes in which lineage commitment is skewed by the specificity of their 
rearranged transgenic TCR.  
HY-TCR and Marilyn-TCR transgenic mice were maintained by continuous 
breeding of male and female mice. Each littermate was genotyped for sex 
determination in embryos and neonatal mice. DNA from ear biopsies was 
amplified by PCR for YMT2/B sequence, which is a member of the Ssy family 
present on the long arm of the Y-chromosome. Male DNA should generate a PCR 
product of 350bp. According to the PCR results, mice with a PCR product 
positive for the male gene were genotyped as male mice. Mice with a PCR 
product negative for the male gene were genotyped as female mice (Figure 6.1). 
 
6.2.2   Thymus phenotype of HY-TCR mice 
Embryonic (E17.5) and adult thymus of male and female HY-TCR transgenic 
mice were compared following anatomical dissection in order to asses thymocyte 
populations within the HY-TCR
+
 (T3.7
+
) and HY-TCR
−
 (T3.7
−
) compartments. 
within the within the T3.7
+
 cells, embryonic male HY-TCR transgenic mice show 
immature thymocytes prior deletion of mature transgenic T cells, whereas adult 
male HY-TCR mice show severe deletion of male self-reactive T cells. 
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Embroynic and adult female HY-TCR mice display inverted ratio of CD4:CD8 
within the T3.7
+
 cells as a result of increased selection of SP8 cells (Figure 6.2). 
 
6.2.3   Influence of Shh on thymocyte development in HY-TCR transgenic 
FTOCs 
In order to assess the influence of Shh on thymocyte development and TCR 
repertoire selection, fetal thymic organ cultures (FTOCs) from male and female 
HY-TCR transgenic mice from embryonic day 17.5 (E17.5) were treated with 
recombinant mouse Shh protein (rmShh) for 7 days and compared to 
control/untreated cultures. Cells were analyzed for T3.7, CD8 and CD4 cell 
surface expression. According to T3.7 expression, cells were sub-grouped into 
two main populations, HY-TCR positive cells (T3.7
+
) and HY-TCR negative cells 
(T3.7
−
). Within the T3.7 positive and negative compartments, cells were sub-
grouped according to the cell surface expression of CD8 and CD4 into four main 
populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
+ 
(DP), CD8
+
CD4
−
 (SP8) and 
CD8
−
CD4
+ 
(SP4).  
To test influence of Shh in negative selection we analyzed male FTOCs. Our 
analysis of male FTOCs within the T3.7 positive cells revealed a significant 
increase in the proportions of CD8SP cells in Shh-treated cultures compared to 
non-treated cultures, indicating that Shh-treatment inhibited negative selection of 
transgenic T cells (p≤0.05, n=18). Furthermore, percentage of DP cells was 
significantly increased in Shh-treated cultures compared to control cultures 
consistent with inhibition of negative selection (Figure 6.3). 
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To test influence of Shh-treatment on positive selection we analyzed female 
FTOCs. The proportions of T3.7
+
 SP8 were significantly decreased in Shh-treated 
culture compared to non-treated cultures (p≤0.05, n=21), indicating decreased 
positive selection of these cells (Figure 6.4).  
Male and female FTOCs within the T3.7 negative display a positive influence of 
Shh on the proportions of thymocytes that did not express the self-reactive T cell 
deletion. In male FTOCs, the proportions of T3.7
−
 DP and SP cells were 
significantly increased in Shh-treated cultures compared to non-treated cultures 
(p≤0.05, n=18) (Figure 6.5). In female FTOCs, the proportions of T3.7− SP cells 
were significantly increased in Shh-treated compared to non-treated cultures 
(p≤0.05, n=21) (Figure 6.6). 
 
6.2.4    Influence of Shh on expression of CD3 and CD5 in HY-TCR 
thymocytes 
In order to assess the potential role of Shh in regulating differentiation and TCR 
signal transduction of HY-TCR thymocytes during development and selection, we 
analyzed the cell surface expression of molecules associated with TCR signalling 
(CD3 and CD5) within the T3.7 positive cells for DN, DP, SP8 and SP4 cells. 
Furthermore we have compared the mean fluorescence intensity (MFI) of staining 
for these molecules, as high CD5 expression is associated with high TCR signal 
strength. 
Our analysis of male and female FTOCs within the T3.7
+
 cells show no influence 
of Shh on the expression of CD3 and CD5 in thymocytes from Shh-treated 
cultures compared to non-treated cultures ((p>0.05, n=8) and (p>0.05, n=11)) 
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respectively. Similarly, we observed no difference in CD3 and CD5 MFI in both 
male and female FTOCs ((p>0.05, n=8), (p>0.05, n=11)) respectively (Figure 
6.7), (Figure 6.8), (Figure 6.9) and (Figure 6.10). 
In addition we examined the influence of Shh on thymocyte development in male 
and female FTOCs within the T3.7
−
 cells, and our data revealed no influence of 
Shh on the expression of CD3 and CD5 or their MFI in Shh-treated cultures 
compared to non-treated culture ((p>0.05, n=8), (p>0.05, n=11)) respectively 
(Figure 6.11), (Figure 6.12), (Figure 6.13) and (Figure 6.14). 
 
6.2.5    Influence of Shh on Gata-3 expression in developing thymocytes in 
HY-TCR mice 
In order to assess the role of Shh in the expression of Gata-3 during thymocyte 
development and repertoire selection of thymocytes, we analyzed Gata-3 
expression in HY-TCR thymocytes.   
Gata-3 is required by T cells for the execution of several developmental steps 
during their development in the thymus. However, our analysis of male and 
female FTOCs show no difference in the expression of Gata-3 in thymocytes in 
T3.7
+
 cells in Shh-treated cultures compared to non-treated culture ((p>0.05, n=5), 
(p>0.05, n=7)) respectively (Figure 6.15) and (Figure 6.16). 
Similarly, within the T3.7
−
 cells, our data show no influence of Shh in male and 
female FTOCs ((p>0.05, n=5), (p>0.05, n=7)) respectively (Figure 6.15) and 
(Figure 6.16). 
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6.2.6   Thymus phenotype of Marilyn-TCR mice 
Embryonic (E17.5) and adult thymus of male and female Marilyn-TCR transgenic 
mice were compared following anatomical dissection in order to asses thymocyte 
populations. Both embryonic and adult male thymus showed clonl deletion of the 
self-reactive DP and CD4SP populations and no CD4
high
 single positive. 
Interestingly, embroynic female Marilyn-TCR transgenic mice also show 
immature thymocytes with increased proportions of ISPCD8 cells accompanied 
with a severe reduction of the SP4 population, consistent with poor and delayed 
positive selection of this TCR. This observation led us to investigate thymocyte 
development at different time points. Our analysis shows that SP4 cells in female 
Marilyn-TCR transgenic mice start to appear around 2-weeks after birth, 
suggesting a delayed maturation in Marilyn-TCR transgenic mice. This is 
consistent with the phenotype of the male thymus, where no CD4
high
 SP cells were 
decreased. According to this finding we decided to apply our analysis for male 
mice at two time points, at E17.5 and 21-days, and at 21-days for female mice 
(Figure 6.17) and (Figure 6.18). 
 
6.2.7   Influence of Shh on thymocyte development in Marilyn-TCR 
transgenic mice 
In order to assess the influence of Shh on thymocyte development and TCR 
repertoire selection, fetal thymic organ cultures (FTOCs) from embryonic day 
17.5 (E17.5) from male Marilyn-TCR transgenic mice, and thymic organ cultures 
(thymic fragments) from 21-weeks old male and female Marilyn-TCR transgenic 
mice were used for analysis. Thymic cultures were treated with recombinant 
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mouse Shh protein (rmShh) for 7 days and compared to control/untreated cultures. 
Cells were analyzed for Vβ6 (Marilyn-TCR+), CD8 and CD4 cell surface 
expression, and sub-grouped according to the cell surface expression of CD8 and 
CD4 into four main populations, the CD8
−
CD4
−
 (DN), CD8
+
CD4
+ 
(DP), 
CD8
+
CD4
−
 (SP8) and CD8
−
CD4
+ 
(SP4). Analysis of male embryos revealed no 
influence of Shh on thymocytes during their development in the thymus (Figure 
6.19). However, analysis of male neonates revealed an increase in the SP4 
population, suggesting that Shh-treatment had reduced clonal deletion. 
Neonatal thymic cultures from male Marilyn-TCR transgenic mice revealed a 
significant increase in the proportions of SP4 cells in Shh-treated cultures 
compared to non-treated cultures, indicating a positive influence of Shh on T cells 
during selection as it inhibited deletion of  transgenic T cells (p≤0.05, n=11). As a 
result the ratios of CD4:CD8 were decreased as well as the ratios of DP:CD8 and 
DP:CD4 (Figure 6.20). On the contrary, we observed no significant differences in 
thymocyte populations in neonatal thymic cultures from female mice (p>0.05, 
n=7) (Figure 6.21).  
 
6.2.8    Influence of Shh on expression of CD3 and CD5 in Marilyn-TCR 
thymocytes 
In order to assess the potential role of Shh in regulating differentiation and TCR 
signal transduction of Marilyn-TCR thymocytes during development and 
selection, we analyzed the cell surface expression of molecules associated with 
TCR signalling (CD3 and CD5) for DN, DP, SP8 and SP4 cells. Furthermore we 
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have compared the mean fluorescence intensity (MFI) of staining for these 
molecules, as high CD5 expression is associated with high TCR signal strength. 
Our analysis of male FTOCs show no influence of Shh on the expression of CD3 
and CD5 in thymocytes from Shh-treated cultures compared to non-treated 
cultures ((p>0.05, n=8), (p>0.05, n=8)) respectively. Similarly, we observed no 
difference in CD3 and CD5 MFI in these mice (p>0.05, n=8) (Figure 6.22) and 
(Figure 6.23). 
In neonatal male cultures, the percentage of CD3 expression in DP was 
significantly increased in Shh-treated cultures compared to non-treated cultures 
(p≤0.05, n=11). This finding indicate a possible correlation between the increased 
proportions of SP4 cells which escaped deletion we observed in these mice, and 
TCR signal strength in DP cells (Figure 6.24). Additionally, we observed no 
significant difference in the percentage of CD3 in male DN and SP cells, and in 
female thymocyte populations ((p>0.05, n=11), (p>0.05, n=7)) respectively. CD3 
MFI also appeared to show no difference in Shh-treated cultures compared to non-
treated cultures ((p>0.05, n=11), (p>0.05, n=7)) respectively (Figure 6.24) and 
(Figure 6.26). 
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Figure 6.1 
Genotyping male and female littermates. Sex determination of HY-TCR and Marilyn-TCR 
transgenic littermates by PCR using genomic DNA extracted from ear biopsies. (A) HY-TCR 
littermates. (B) Marilyn-TCR littermates. The presence of a male allele generated a PCR product 
of 350bp, while its absence indicates a female genotype. 
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Figure 6.2 
Thymus phenotype of HY-TCR mice. Thymocyte populations in adult and embryo (E17.5) of 
HY-TCR transgenic mice. (A) Thymocyte populations in male HY-TCR transgenic mice. (B) 
Thymocyte population in female HY-TCR transgenic mice. Cells were stained for anti-T3.7, anti-
CD8 and anti-CD4 followed by flow cytometry analysis.  
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Figure 6.3 
Influence of Shh on major thymocyte population in male HY-TCR transgenic mice within 
the T3.7 positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP and SP8 percentages. (C) 
Ratio of DP:CD8 and DP:CD4. Figures are representative of 18 independent sets of E17.5 male 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. DN (p= 0.4, n=18), DP (p= 0.03, n=18), SP8 (p= 0.04, n=18), SP4 (p= 0.01, 
n=18). *represents p≤0.05.  
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Figure 6.4 
Influence of Shh on major thymocyte population in female HY-TCR transgenic mice within 
the T3.7 positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratio of DP:CD8 and DP:CD4. Figures are representative of 21 independent sets of E17.5 female 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. DN (p= 0.3, n=21), DP (p= 0.4, n=21), SP8 (p= 0.03, n=21), SP4 (p= 0.06, 
n=21). *represents p≤0.05.  
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Figure 6.5 
Influence of Shh on major thymocyte population in male HY-TCR transgenic mice within 
the T3.7 negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratio of DP:CD8 and DP:CD4. Figures are representative of 18 independent sets of E17.5 male 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. DN (p= 0.07, n=18), DP (p= 0.04, n=18), SP8 (p= 0.03, n=18), SP4 (p= 0.04, 
n=18). *represents p≤0.05.  
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Figure 6.6 
Influence of Shh on major thymocyte population in female HY-TCR transgenic mice within 
the T3.7 negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative dot plot 
of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratio of DP:CD8 and DP:CD4. Figures are representative of 21 independent sets of E17.5 female 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. DN (p= 0.06, n=21), DP (p= 0.9, n=21), SP8 (p= 0.01, n=21), SP4 (p= 0.04, 
n=21). *represents p≤0.05.  
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Figure 6.7 
Expression of CD3 in thymocytes from male HY-TCR transgenic mice within the T3.7 
positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative 
histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 8 independent sets of male HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.7, n=8), DP (p= 0.7, 
n=8), SP8 (p= 0.8, n=8), SP4 (p= 0.2, n=8). CD3 MFI; DN (p= 0.4, n=8), DP (p= 0.2, n=8), SP8 
(p= 0.4, n=8), SP4 (p= 0.7, n=8).  
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Figure 6.8 
Expression of CD5 in thymocytes from male HY-TCR transgenic mice within the T3.7 
positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative 
histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 8 independent sets of male HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.5, n=8), DP (p= 0.6, 
n=8), SP8 (p= 0.7, n=8), SP4 (p= 0.5, n=8). CD5 MFI; DN (p= 0.4, n=8), DP (p= 0.5, n=8), SP8 
(p= 0.3, n=8), SP4 (p= 0.4, n=8).  
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Figure 6.9 
Expression of CD3 in thymocytes from female HY-TCR transgenic mice within the T3.7 
positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative 
histogram of CD3 percentages in DN, DP, SP8 and SP4 cells. (B) Representative scatter plot of 
CD3 MFI in DN, DP, SP8 and SP4 cells. (C) Representative dot plot of CD3 expression in DN, 
DP, SP8 and SP4 cells. Figures are representative of 11 independent sets of female HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.2, n=11), DP (p= 0.7, 
n=11), SP8 (p= 0.4, n=11), SP4 (p= 0.7, n=11). CD3 MFI; DN (p= 0.3, n=11), DP (p= 0.2, n=11), 
SP8 (p= 0.9, n=11), SP4 (p= 0.4, n=11).  
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Figure 6.10 
Expression of CD5 in thymocytes from female HY-TCR transgenic mice within the T3.7 
positive cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
+
 cells. (A) Representative 
histogram of CD5 percentages in DN, DP, SP8 and SP4 cells. (B) Representative scatter plot of 
CD5 MFI in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, DP, 
SP8 and SP4 cells. Figures are representative of 11 independent sets of female HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.6, n=11), DP (p= 0.7, 
n=11), SP8 (p= 0.9, n=11), SP4 (p= 0.6, n=11). CD5 MFI; DN (p= 0.5, n=11), DP (p= 0.3, n=11), 
SP8 (p= 0.7, n=11), SP4 (p= 0.2, n=11).  
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Figure 6.11 
Expression of CD3 in thymocytes from male HY-TCR transgenic mice within the T3.7 
negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative 
histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 8 independent sets of male HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.8, n=8), DP (p= 0.6, 
n=8), SP8 (p= 0.8, n=8), SP4 (p= 0.4, n=8). CD3 MFI; DN (p= 0.3, n=8), DP (p= 0.5, n=8), SP8 
(p= 0.1, n=8), SP4 (p= 0.2, n=8).  
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Figure 6.12 
Expression of CD5 in thymocytes from male HY-TCR transgenic mice within the T3.7 
negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative 
histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 8 independent sets of male HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.4, n=8), DP (p= 0.7, 
n=8), SP8 (p= 0.9, n=8), SP4 (p= 0.4, n=8). CD5 MFI; DN (p= 0.2, n=8), DP (p= 0.6, n=8), SP8 
(p= 0.3, n=8), SP4 (p= 0.2, n=8).  
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Figure 6.13 
Expression of CD3 in thymocytes from female HY-TCR transgenic mice within the T3.7 
negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative 
histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 11 independent sets of female HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.4, n=11), DP (p= 0.6, 
n=11), SP8 (p= 0.3, n=11), SP4 (p= 0.8, n=11). CD3 MFI; DN (p= 0.2, n=11), DP (p= 0.5, n=11), 
SP8 (p= 0.9, n=11), SP4 (p= 0.8, n=11). 
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Figure 6.14 
Expression of CD5 in thymocytes from female HY-TCR transgenic mice within the T3.7 
negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-T3.7, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow 
cytometry. Thymocyte populations were gated within the T3.7
−
 cells. (A) Representative 
histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative of 11 independent sets of female HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.7, n=11), DP (p= 0.4, 
n=11), SP8 (p= 0.6, n=11), SP4 (p= 0.4, n=11). CD5 MFI; DN (p= 0.5, n=11), DP (p= 0.6, n=11), 
SP8 (p= 0.7, n=11), SP4 (p= 0.3, n=11).  
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Figure 6.15 
Expression of Gata-3 in thymocytes from male HY-TCR transgenic mice within the T3.7 
positive and negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-Gata3, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Thymocyte populations were gated within the T3.7
+
 cells and T3.7
−
 
cells independently. (A) Representative histogram of Gata-3 expression in DN, DP, SP8 and SP4 
within the T3.7
+
 cells. (B) Representative bar graph of Gata-3 percentages in DN, DP, SP8 and 
SP4 within the T3.7
+
 cells. (C) Representative histogram of Gata-3 expression in DN, DP, SP8 and 
SP4 within the T3.7
−
 cells. (D) Representative bar graph of Gata-3 percentages in DN, DP, SP8 
and SP4 within the T3.7
−
 cells. Figures are representative of 5 independent sets of male HY-TCR 
transgenic littermates respectively. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. Male Gata-3 percentages (T3.7
+
); DN (p= 0.3, n=5), 
DP (p= 0.2, n=5), SP8 (p= 0.2, n=5), SP4 (p= 0.1, n=5). Male Gata-3 percentages (T3.7
−
); DN 
(p= 0.4, n=5), DP (p= 0.6, n=5), SP8 (p= 0.7, n=5), SP4 (p= 0.3, n=5).  
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Figure 6.16 
Expression of Gata-3 in thymocytes from female HY-TCR transgenic mice within the T3.7 
positive and negative cells. Foetal thymic organ cultures (FTOCs) were cultured with or without 
rmShh for 7-days. Cells were stained for anti-T3.7, anti-Gata3, anti-CD8 and anti-CD4, and 
analyzed by flow cytometry. Thymocyte populations were gated within the T3.7
+
 cells and T3.7
−
 
cells independently. (A) Representative histogram of Gata-3 expression in DN, DP, SP8 and SP4 
within the T3.7
+
 cells. (B) Representative bar graph of Gata-3 percentages in DN, DP, SP8 and 
SP4 within the T3.7
+
 cells. (C) Representative histogram of Gata-3 expression in DN, DP, SP8 and 
SP4 within the T3.7
−
 cells. (D) Representative bar graph of Gata-3 percentages in DN, DP, SP8 
and SP4 within the T3.7
−
 cells. Figures are representative of 7 independent sets of female HY-
TCR transgenic littermates respectively. Mean and standard deviation of each population are 
given. Bars represent mean ± standard deviations. Female Gata-3 percentages (T3.7
+
); DN (p= 
0.08, n=7), DP (p= 0.3, n=7), SP8 (p= 0.2, n=7), SP4 (p= 0.8, n=7). Female Gata-3 percentages 
(T3.7
−
); DN (p= 0.8, n=7), DP (p= 0.5, n=7), SP8 (p= 0.4, n=7), SP4 (p= 0.6, n=7).  
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Figure 6.17 
Thymus phenotype of male Marilyn-TCR transgenic mice. Thymocyte populations in male 
Marilyn-TCR transgenic mice. Cells were stained for anti-Vβ6, anti-CD8 and anti-CD4 and 
analyzed by flow cytometry. (A) Representative dot plot of embryonic (E17.5) and adult 
thymocyte populations. (B) Representative dot plot of thymocyte population at 3 time points; (7-
days), (14-days) and (21-days). (C) Representative bar graph of SP4 cells percentage at 3 time-
points; (7-days), (14-days) and (21-days).  
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Figure 6.18 
Thymus phenotype of female Marilyn-TCR transgenic mice. Thymocyte populations in female 
Marilyn-TCR transgenic mice. Cells were stained for anti-Vβ6, anti-CD8 and anti-CD4 and 
analyzed by flow cytometry. (A) Representative dot plot of embryonic (E17.5) and adult 
thymocyte populations. (B) Representative dot plot of thymocyte population at 3 time points; (7-
days), (14-days) and (21-days). (C) Representative bar graph of SP4 cells percentage at 3 time-
points; (7-days), (14-days) and (21-days).  
 
290 
 
 
Figure 6.19 
Influence of Shh on major embryonic thymocyte populations in male Marilyn-TCR 
transgenic mice. Fetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-
days. Cells were stained for anti-Vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry. 
(A) Representative dot plot of thymocyte populations. (B) Representative bar graph of DN, DP, 
SP8 and SP4 percentages. (C) Ratios of CD4:CD8, DP:CD8 and DP:CD4. Figures are 
representative of 14 independent sets of E17.5 male littermates. Mean and standard deviation of 
each population are given. Bars represent mean ± standard deviations. DN (p= 0.6, n=14), DP (p= 
0.6, n=14), SP8 (p= 0.7, n=14), SP4 (p= 0.9, n=14).  
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Figure 6.20 
Influence of Shh on major neonatal thymocyte populations in male Marilyn-TCR transgenic 
mice. Thymic fragments were cultured with or without rmShh for 7-days. Cells were stained for 
anti-Vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative dot plot of 
thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 percentages. (C) 
Ratios of CD4:CD8, DP:CD8 and DP:CD4. Figures are representative of 11 independent sets of 
21-days old male littermates. Mean and standard deviation of each population are given. Bars 
represent mean ± standard deviations. DN (p= 0.6, n=11), DP (p= 0.1, n=11), SP8 (p= 0.4, n=11), 
SP4 (p= 0.03, n=11). *represents p≤0.05. 
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Figure 6.21 
Influence of Shh on major neonatal thymocyte populations in female Marilyn-TCR 
transgenic mice. Thymic fragments were cultured with or without rmShh for 7-days. Cells were 
stained for anti-Vβ6, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
dot plot of thymocyte populations. (B) Representative bar graph of DN, DP, SP8 and SP4 
percentages. (C) Ratios of CD4:CD8, DP:CD8 and DP:CD4. Figures are representative of 7 
independent sets of 21-days old female littermates. Mean and standard deviation of each 
population are given. Bars represent mean ± standard deviations. DN (p= 0.7, n=7), DP (p= 0.6, 
n=7), SP8 (p= 0.1, n=7), SP4 (p= 0.6, n=7).  
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Figure 6.22 
Expression of CD3 in embryonic thymocytes from male Marilyn-TCR transgenic mice. 
Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-days. Cells were 
stained for anti-Vβ6, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) 
Representative histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative 
bar graph of CD3 percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of 
CD3 MFI in DN, DP, SP8 and SP4 cells. Figures are representative 8 independent sets of male 
Marilyn-TCR transgenic littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD3 percentages; DN (p= 0.8, n=8), DP (p= 0.3, 
n=8), SP8 (p= 0.5, n=8), SP4 (p= 0.6, n=8). CD3 MFI; DN (p= 0.7, n=8), DP (p= 0.4, n=8), SP8 
(p= 0.9, n=8), SP4 (p= 0.5, n=8).  
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Figure 6.23 
Expression of CD5 in embryonic thymocytes from male Marilyn-TCR transgenic mice. 
Foetal thymic organ cultures (FTOCs) were cultured with or without rmShh for 7-days. Cells were 
stained for anti-Vβ6, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) 
Representative histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative 
bar graph of CD5 percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of 
CD5 MFI in DN, DP, SP8 and SP4 cells. Figures are representative 8 independent sets of male 
Marilyn-TCR transgenic littermates. Mean and standard deviation of each population are given. 
Bars represent mean ± standard deviations. CD5 percentages; DN (p= 0.7, n=8), DP (p= 0.5, 
n=8), SP8 (p= 0.8, n=8), SP4 (p= 0.5, n=8). CD5 MFI; DN (p= 0.3, n=8), DP (p= 0.7, n=8), SP8 
(p= 0.6, n=8), SP4 (p= 0.4, n=8).  
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Figure 6.24 
 
Expression of CD3 in neonatal thymocytes from male Marilyn-TCR transgenic mice. Thymic 
fragments were cultured with or without rmShh for 7-days. Cells were stained for anti-Vβ6, anti-
CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of 
CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 percentages 
in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in DN, DP, SP8 and 
SP4 cells. Figures are representative 11 independent sets of male Marilyn-TCR transgenic 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. CD3 percentages; DN (p= 0.08, n=11), DP (p= 0.01, n=11), SP8 (p= 0.5, 
n=11), SP4 (p= 0.1, n=11). CD3 MFI; DN (p= 0.6, n=11), DP (p= 0.4, n=11), SP8 (p= 0.3, n=11), 
SP4 (p= 0.9, n=11). *represents p≤0.05.  
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Figure 6.25 
 
Expression of CD5 in neonatal thymocytes from male Marilyn-TCR transgenic mice. Thymic 
fragments were cultured with or without rmShh for 7-days. Cells were stained for anti-Vβ6, anti-
CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative histogram of 
CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 percentages 
in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, DP, SP8 and 
SP4 cells. Figures are representative 11 independent sets of male Marilyn-TCR transgenic 
littermates. Mean and standard deviation of each population are given. Bars represent mean ± 
standard deviations. CD5 percentages; DN (p= 0.5, n=11), DP (p= 0.5, n=11), SP8 (p= 0.2, 
n=11), SP4 (p= 0.6, n=11). CD5 MFI; DN (p= 0.3, n=11), DP (p= 0.7, n=11), SP8 (p= 0.3, n=11), 
SP4 (p= 0.8, n=11).  
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Figure 6.26 
 
Expression of CD3 in neonatal thymocytes from female Marilyn-TCR transgenic mice. 
Thymic fragments were cultured with or without rmShh for 7-days. Cells were stained for anti-
Vβ6, anti-CD3, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
histogram of CD3 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD3 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD3 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative 8 independent sets of female Marilyn-TCR 
transgenic littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD3 percentages; DN (p= 0.5, n=7), DP (p= 0.5, n=7), SP8 (p= 0.2, 
n=7), SP4 (p= 0.02, n=7). CD3 MFI; DN (p= 0.4, n=7), DP (p= 0.7, n=7), SP8 (p= 0.9, n=7), SP4 
(p= 0.6, n=7).  
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Figure 6.27 
 
Expression of CD5 in neonatal thymocytes from female Marilyn-TCR transgenic mice. 
Thymic fragments were cultured with or without rmShh for 7-days. Cells were stained for anti-
Vβ6, anti-CD5, anti-CD8 and anti-CD4, and analyzed by flow cytometry. (A) Representative 
histogram of CD5 expression in DN, DP, SP8 and SP4 cells. (B) Representative bar graph of CD5 
percentages in DN, DP, SP8 and SP4 cells. (C) Representative scatter plot of CD5 MFI in DN, 
DP, SP8 and SP4 cells. Figures are representative 8 independent sets of female Marilyn-TCR 
transgenic littermates. Mean and standard deviation of each population are given. Bars represent 
mean ± standard deviations. CD5 percentages; DN (p= 0.1, n=7), DP (p= 0.6, n=7), SP8 (p= 0.3, 
n=7), SP4 (p= 0.6, n=7). CD5 MFI; DN (p= 0.8, n=7), DP (p= 0.1, n=7), SP8 (p= 0.3, n=7), SP4 
(p= 0.4, n=7).  
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6.3       Discussion 
In this study we have shown that Shh is a regulator of the differentiation and 
selection of T cells during their development and maturation in the thymus. Our 
analysis of FTOCs from TCR-transgenic mice that express the male specific 
class-I restricted HY-TCR showed that Shh influence thymocyte development in 
their transition from DP to SP cell population, in both males and females. 
In males, CD8SP and DP cells that express the transgenic TCR are negatively 
selected. We found that Shh treatment increased the proportions of HY-TCR
+
 
CD8SP and DP cells indicating that Shh signalling inhibited negative selection of 
transgenic T cells. In female HY-TCR mice, positive selection of the transgenic 
TCR, in the absence of its clonal deletion, shows differentiation to the CD8 
lineage. On Shh treatment, we found reduced proportions of CD8SP cells in both 
HY-TCR
+
 and HY-TCR
−
 thymocytes indicating decreased positive selection of 
these cells. This is consistent with previous reports that the CD4:CD8 ratio is 
increased in Shh
−/−
 thymus and GliΔC2 transgenic thymus (Rowbotham, Hager-
Theodorides, Cebecauer, et al. 2007; Furmanski et al. 2012). Interestingly, SP4 
was also increased by Shh-treatment in both TCR
−
 and TCR
+
 thymocytes. The 
increase in the SP4 population might be the result of increased endogenous TCR 
rearrangement on Shh-treatment.  
Our analysis of neonates thymic cultures from Marilyn-TCR transgenic mice 
model have also shown that Shh influences differentiation to SP cells in both 
males and females. The Marilyn-TCR recognizes a class-II restricted male 
antigen, and as these mice are on Rag2-deficient background, no rearrangement of 
endogenous TCR genes is possible, and only the Marilyn-TCR is expressed. 
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Therefore, in male mice there is extensive clonal deletion of DP and SP4 
populations, whereas in female there is bias toward the SP4 lineage, and SP8 cells 
are reduced. 
We carried out thymus organ culture using fragments of measured thymus. In 
male cultures, Shh-treatment increased SP4 cells suggesting that Shh-treatment 
had reduced clonal deletion. This is consistent with our finding in the male HY-
TCR thymus, and shows that Shh can influence negative selection in both SP4 and 
SP8 lineages. In the female untreated organ cultures, treatment with Shh arrested 
differentiation at the fact that there was no influence of Shh-treatment on SP 
populations in female Marilyn mice which are also on Rag2-deficient background, 
supports the idea that the increase in SP4 in female HY-TCR mice was a result of 
increased endogenous rearrangement. Additionally, our data from Marilyn-TCR 
male mice have shown that Shh regulate the expression of TCR associated 
molecule, CD5, during thymocyte development in the DP stage. 
These experiments are consistent with a previous study shown that DP 
thymocytes are Hh-responsive, and that thymocyte-interensic Shh signalling plays 
a role in modulating the production of SP4 and SP8. Whereas repression of 
physiological Shh signalling in thymocytes altered the proportions of DP and SP4 
thymocytes (Crompton et al. 2007; Rowbotham, Hager-Theodorides, Cebecauer, 
et al. 2007; Furmanski et al. 2012). 
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6.4       Conclusion 
In this chapter, we have utilized T cell receptor transgenic mice models (TCR-
transgenics) to investigate the role of Shh in T cell development and repertoire 
selection. Our data from thymic organ cultures have shown that Shh influence T 
cell selection and maturation during the later stages of T cell development in their 
transiton from DP to SP cell population. 
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Chapter Seven: Summary and future direction 
 
7.1       Summary 
The basis of immune tolerance and adaptive immunity is associated with the 
ability of the immune system to orchestrate a series of developmental steps that 
take the undifferentiated stem cells to finally become mature thymocytes. T cell 
development takes place within the unique micro-environment of the thymus. 
Through a complex well orchestrated network of signals within the thymus, 
developing thymocytes acquire all necessary cell surface ligands, cytokines and 
extra-cellular matrix components to develop and mature, producing a repertoire of 
diverse and functional non-self reactive T cells.  
Development of T cells in the thymus requires the dynamic migration of 
developing thymocytes through the thymus. Thymus architectural stroma and 
travelling thymocytes have to communicate with each other both in close 
proximity and remotely. Such crosstalk signals come in the form of morphogens 
produced by thymic stromal cells and migrating thymocytes to accomplish 
maturation, proliferation and selection during their constant motion. The 
Hedgehog (Hh) family of secreted intracellular signalling molecules plays a major 
role in many patterning processes and organogenesis during embryonic 
development and are involved in the homeostasis and renewal of adult tissues.  
In this thesis, our data revealed that both, intrinsic inhibition and activation of Hh 
signalling in thymocytes altered the proportions of SP4 cells that express GFP, 
suggesting a regulatory role of Gli in SP4 thymocytes. Hh signalling promotes 
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target gene transcription through the activation of glioblastoma-associated Gli 
family of transcription factors, Gli1, Gli2 and Gli3. Both Gli1 and Gli2 are 
transcription activators dependent on Hh signalling, however, Gli3 functions as a 
transcriptional regulator independent of Hh signalling (Wang et al. 2000; Pan et 
al. 2006; Bai et al. 2002). Gli3 has been previously shown to control thymocyte 
negative selection and TCR signal strength through Hh-dependent and 
independent mechanisms, moreover, it has been shown that defective Gli3 
expression resulted in an inappropriate production of MHC class I-selected CD4 
cells (Hager-Theodorides et al. 2009). This is consistent with our finding as the 
proportions of SP4 cells expressing GFP were increased in both Hh-suppressed 
and Hh-activated mouse models. Moreover, CD3 expression was reduced in SP 
cells when Hh-signalling was active and increased when Hh-signalling was 
inhibited, indicating a regulatory role of Hh in TCR signal transduction through 
the expression of CD3 molecule. Additionally, we have undertaken further 
characterization of SP4 cells through examining the expression of the master 
regulator of Treg lineage, Foxp3. Our data have shown that Hh-signalling 
influences the phenotype of SP4 cells in the thymus and spleen. In contrast, 
suppression of Hh-signalling in T cells reduced the expression of Foxp3 in SP4 
cells suggesting a Hh-dependent regulatory role on these cells. 
We investigated Hh-signalling and gene expressions by microarray analysis and 
our data have shown that Hh-signalling is attenuating gene transcription of 
various genes that may have a direct effect on T cell development and selection 
within the thymus.  Several novel genes were found to be differentially expressed 
in DP thymocytes from mouse models where the physiological Hh-signalling is 
suppressed. Such a differential expression pattern of these genes in developing 
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thymocytes led us to ask if they play a role in T cell development and maturation 
within the thymus and the role of Hh signalling in their expression and regulation. 
Our data suggested that the expression of Gli2 (glioma-asssociated oncogene-2), 
was upregulated when Hh-signalling was suppressed by at least 2-fold compared 
to WT. This increase was probably due to the very design of this mice model, 
where it expresses a truncated form of Gli2 which acts as a repressor of Hh-
dependent transcription, so the microarray identified the transgenic transcript. The 
microarray data analysis also revealed that Gnb4 (Heterotrimeric guanine 
nucleotide binding protein β-4 subunit) was upregulated by 2.6 fold when Hh-
signalling was suppressed compared to WT and its expression was validated using 
qRT-PCR.  Gnb4 plays a key role in the signal transduction from membrane 
receptors to intracellular receptors. Activated G-protein coupled receptors result in 
the activation of many signal transduction cascades via the α-subunit and βγ-
dimers. The effect of βγ-mediated signalling involves the regulation of cell growth 
and proliferation via Ras activation and it is now known that genetic variations in 
genes encoding G-protein subunit β4 are associated with cancer (Riemann et al. 
2009; Schwindinger & Robishaw 2001). Furthermore, the microarray data also 
showed an increase in the expression of CCL19 (chemokine ligand-19) when Hh 
is suppressed by at least 2 fold compared to WT. CCL19 plays a role in 
lymphocyte recirculation and homing. It is involved in T cell trafficking in the 
thymus and migration to lymphoid organs. It is possible that Hh-signalling plays a 
role in regulating the expression of CCL19 in thymocytes during their 
development and selection as they constantly travel along the different 
compartments of the thymus.   
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Hh family member Dhh negatively regulates multiple stages of erythrocyte 
differentiation. Using Dhh-WT, Het and KO mice, we found Dhh also played a 
negative role in T cell production in the thymus and peripheral lymphoid organs 
and was critical in regulating negative and positive selection of self-reactive T 
cells in a dose dependent manner. In the absence of Dhh, the number of 
thymocytes and splenocytes increased, however, the phenotype of Dhh-Het was 
unusual in that, although thymocyte and splenocytes numbers increased in Dhh-
KO, we observed a decrease in thymocyte numbers and yet, a greater number of 
splenocytes in Dhh-Het were observed, suggesting a differential role for Dhh in 
thymocyte and splenocyte homeostasis.  
The influence of Dhh start early in the DN stages as  a decrease in the DN1 and 
DN3 cells occurs, indicating a positive regulatory role of Dhh in thymocyte 
differentiation in the thymus, and during pre-TCR complex formation and β 
selection. Surprisingly, Dhh-Het shows an opposite effect to Dhh-KO, with an 
increase in the number of thymocytes during the DN1 and DN3 stages.  
Dhh also influenced the later stages of thymocyte development, as the number of 
DP thymocytes decreased, whilst the number of SP8 thymocytes increased, 
suggesting that Dhh positively regulate thymocyte development during the 
formation of TCR complex, and negatively regulate positive selection of SP8 
cells. Furthermore, Dhh influenced TCR associated CD3 molecule on SP8 cells, 
as partial expression of Dhh decreased the expression of CD3, whereas complete 
knockout showed a further decrease in CD3 expression. This finding explains the 
increase of SP8 thymocytes in Dhh-KO which maybe is a result of a weak TCR 
signal transduction defecting negative selection of SP8 thymocytes.  
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The expression of CD69 during thymocyte development was also examined, 
CD69 expression increased in both DN and SP4 cells, suggesting a negative role 
of Dhh on CD69 expression in the thymus. CD69 expression in immature 
thymocytes is believed to be associated with increased cell death on the contrary, 
CD69 expression in mature SP thymocytes correlated with positive selection. Our 
finding thus suggests that Dhh reduced positive selection of SP4 cells through 
attenuating the expression of CD69. The maturation marker CD62L was also been 
examined and we found Dhh to exert a dual function as it negatively regulated 
CD62L expression in DN thymocytes, and positively regulated the expression of 
CD62L in SP4 cells in a dose dependent manner. During the transition from DP to 
SP, thymocytes undergo maturation through a series of developmental stages 
before becoming functionally mature cells that exit the thymus. We analyzed the 
cell surface expression of HSA and Qa2 to measure the maturation status on DP 
and SP thymocytes, we found that Dhh partially arrested SP4 cell development.  
Dhh also continues to regulate mature T cells in the spleen, as SP8 splenocytes 
were increased in Dhh-Het, suggesting a dual influence of Dhh as a negative 
regulator and positive regulator of mature SP8 cells. On the contrary in the lymph 
node, Dhh seemed to negatively regulate SP4 cells as SP4 cells were increased in 
Dhh-KO, suggesting a differential role of Dhh in the periphery between the spleen 
and lymph node. T cell characterization in the periphery has shown that Dhh 
positively regulated the expression of CD62L in SP8 and SP4 splenocytes. In 
regards to T cell activation, Dhh negatively regulated the activation of SP 
splenocytes. Interestingly, IL2 production in SP8 activated cells was increased in 
Dhh-Het.  
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A negative regulatory role for Dhh has been previously described (Lau et al. 
2012). In this case, analysis of Dhh mutant mice showed that Dhh negatively 
regulates multiple stages of erythrocyte differentiation, indicating a negative role 
of Dhh, the study described here also suggests that Dhh is a negative regulator of 
T cell production. The unusual role of Hh proteins between the heterozygous and 
knockout has also been reported in Ihh (Outram et al. 2009). In this study, foetal 
Ihh
+/−
 thymi had increased thymocyte numbers relative to WT, indicating that Ihh 
also negatively regulates thymocyte development, and our data have shown a 
similar finding with Dhh as a negative regulator of thymocytes and splenocytes 
during their development and in the periphery. 
Analysis of TCR transgenic mice indicated that Dhh influences thymocyte 
selection as we observed increased escape of deletion of self-reactive T cells in 
the absence of Dhh in male HY-Dhh mice.  Partial expression of Dhh reduced 
deletion of transgenic T cells, indicating a redundant role of Dhh in TCR 
repertoire selection. A similar escape of deletion has been also found in the male 
HY-TCR¯ cells, where endogenous TCR genes rearrangement still exists. This 
finding is consistent with data that Dhh acts as a negative regulator of T cells 
during their development and differentiation in the thymus and lymphoid organs. 
The female HY-TCR
+
 cells revealed a negative regulatory role of Dhh during 
thymocyte positive selection. The proportions of DP and SP8 cells were increased 
in Dhh-KO, indicating a negative role of Dhh during SP8 positive selection. 
Interestingly, SP8 in heterogeneous mice show greater selection of SP8 cells, 
suggesting a dose dependent regulatory function of Dhh during selection of SP8 
cells. Additionally, thymocyte maturation has been examined through measuring 
the expression of Qa2 and HSA, and our data indicated that Dhh reduce 
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maturation of SP8 cells in male and female HY-TCR
+
 cells. In the spleen, we 
observed no influence on mature HY-TCR
+
 cells, however, Dhh reduced the 
proportions of SP4 cells expressing CD3, indicating its role in influencing 
splenocytes in the periphery. 
Furthermore, analysis of Marilyn-TCR
+
 male mice showed a negative regulatory 
role of Hh signalling during thymocyte development and maturation in the 
thymus. These data indicate that inhibition of Hh-dependent transcription 
increased positive selection of the transgenic TCR, and differentiation from DP to 
SP cells. Our analysis showed that the proportions of Marilyn-TCR
+
 SP4 cells has 
been found to be increased in the absence of Hh signalling, suggesting a negative 
regulatory role of Hh during negative selection of SP4 cells. In Marilyn-TCR
+ 
female mice, the proportions of DP cells were decreased, possibly as cells 
undergo further development. Examining the maturation marker Qa2 and HSA in 
DP and SP cells revealed that Hh signalling reduced thymocyte maturation in the 
DP and SP stage in male mice, and in DP and SP cells in female mice. These 
findings are consistent with previous  data which indicated that inhibition of Hh-
dependent transcription increased positive and negative selection in the thymus 
and TCR activation of peripheral T cells (Furmanski et al. 2012; Rowbotham et 
al. 2008; Furmanski et al. 2015). 
In the spleen, we observed a reduction in the proportions of SP4 in male mice, and 
SP8 and SP4 cells in female mice. This observation confirmed our finding in the 
thymus, in that the thymus allowed the escape of transgenic T cells reaching the 
spleen. However, the spleen size was reduced, as well as their total live cell 
counts. This could be due to the increase in Foxp3
+
 cells. In the female spleen, in 
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the absence of intrinsic Hh signalling, the proportions of SP8 and SP4 cells are 
increased as a result of increased positive selection.  
The expression of TCR associated molecules CD3 and CD5 in SP cells increased 
during thymocyte development in the thymus, and CD5 MFI also increased in the 
absence of Hh signalling indicating a possible role of these molecules during 
selection of transgenic T cells. A similar phenotype have been also shown in the 
spleen and lymph node of Marilyn-TCR
+
 mice, suggesting that Hh signalling also 
regulate TCR signal transduction in mature T cells in the periphery.  
Our data suggested that Shh regulates the differentiation and selection of T cells 
during their development and maturation in the thymus. Our analysis of FTOCs 
from TCR-transgenic mice which express the male specific class-I restricted HY-
TCR showed that Shh influences thymocyte development in their transition from 
DP to SP cell population. In male mice, we found that Shh treatment increased the 
proportions of HY-TCR
+
 CD8SP and DP cells, indicating that Shh signalling 
inhibited negative selection of transgenic T cells. In female mice, Shh treatment 
reduced the proportions of CD8SP in both HY-TCR
+
 and HY-TCR
−
 thymocytes 
indicating decreased positive selection of these cells. Interestingly, SP4 was also 
increased by Shh-treatment in both TCR
+
 and TCR
−
 thymocytes. The increase in 
the SP4 population might be the result of increased endogenous TCR 
rearrangement on Shh-treatment. Furthermore, our analysis of neonate thymic 
cultures from TCR-transgenic mice which express the male specific class-II 
restricted Marilyn-TCR also showed that Shh influences differentiation to SP 
cells. In male cultures, Shh-treatment increased SP4 cells suggesting that Shh 
reduced clonal deletion. This is consistent with our findings in the male HY-TCR 
thymus, that Shh can influence negative selection in both SP4 and SP8 lineages. 
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In female cultures, treatment with Shh arrested differentiation as there was no 
influence of Shh-treatment on SP populations. This observation supports the idea 
that the increase in SP4 in female HY-TCR mice was a result of increased 
endogenous rearrangement, as TCR rearrangement still exist in HY-TCR mouse 
model as they are not on Rag-deficient background, unlike Marilyn-TCR mouse 
model where TCR rearrangement still exist as these mice are on Rag2-deficient 
background. Additionally, our data from Marilyn-TCR male mice showed that 
Shh regulate the expression of CD5 during thymocyte development in the DP 
stage. 
Lastly, our data provided both, negative and positive regulatory functions of Hh-
signalling during T cell development and selection in the thymus as well as during 
T cell maturation and activation in the periphery. Immature T cells must undergo 
several developmental steps to become functionally mature T cells, and it is 
evident from our findings that Hh-signalling varies during these stages. A possible 
explanation might be that Hh signalling provides both a positive and a negative 
regulatory signal in order to maintain homeostatic control of developing 
thymocytes and T cells in the periphery. The three Hh proteins are highly 
conserved in vertebrates and act in the same tissues with overlapping or redundant 
functions (Kumar et al. 1996). Although Hh overlapping functions have not been 
well studied, studies on T cell development have shown that the three Hh proteins 
may have overlapping activities and differential functions in order to regulate T 
cell differentiation and homeostasis (Crompton et al. 2007; Outram et al. 2009). 
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7.2       Future directions 
In this thesis we show for the first time the role of Dhh as a negative regulator of 
T cells development and maturation, and it will be of interest to further investigate 
the role of Dhh on the proliferation of activated T cells using the same mouse 
models for comparison. Furthermore, using HY-TCR or Marilyn-TCR with Hh-
active or Hh-suppressed models to investigate T cells which escaped deletion 
through activation experiments will further characterize the nature of these 
autoreactive cells. 
We have confirmed the role of Shh and Dhh in regulating negative a positive 
selection in thymocytes, however, investigating the role of Ihh in T cell repertoire 
selection through utilizing Ihh-TCR-transgenic mice models will provide a better 
understanding of the regulatory mechanism of Hh proteins and their influence 
during co-expression or separately. 
Several novel genes have been found to be expressed differentially in Hh-
supressed mouse model compared to WT, and it will be of interest to further 
investigate the role they play in T cell development and maturation. Using 
silencing RNA (siRNA) and retroviral vector techniques in HY-TCR transgenic 
model to investigate the impact of Hh-signalling on thymocyte repertoire selection 
in conjunction with the expression of CCL19 and the downstream signalling 
regulation of Gnb4 expression will provide more understanding of their role in T 
cell development and maturation. 
Investigating the impact of Hh-signalling on T cells in disease will shed the light 
on the mechanism and role of Hh proteins during T cell development and 
maturation as well as their activation in the periphery. Using a mouse model 
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infected with a pathogen, such as Herpes simplex virus, Mycobacterium 
tuberculosis, or Listeria monocytogenes, will test the functions of Hh-signalling 
on T cells under stress. Similarly, investigating Hh-signalling components in 
autoimmune diseases (AIDs) as well as T cell activation and cytokine production, 
will provide more understanding of the aetiology behind these diseases.  
Finally, it is critical in any research project conducted to validate findings using 
alternative methods and laboratory techniques. This is essential in providing a 
solid conclusion especially when the experiment yields few numbers of cells. In 
this thesis we have come across such difficulty in (Chapter 3), as the number of 
cells which expressed Gli-GFP
+
 were low in GBS-GFP/Gli2ΔN2, GBS-
GFP/Gli2ΔC2 and GBS-GFP/WT. This observation makes it critical to use 
alternative methods to complement and verify our data, such as qPCR or 
immunohistochemistry (IHC). Confirming our observations by alternative 
methodologies will allow us to further investigate the consequence and effect of 
our findings. Taken together, this thesis has revealed novel aspects of Hh-
signalling involved in the regulation of T cell development and function, and has 
provided a useful roadmap to further explore T cell biology. 
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